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SECTION 1 
REFLECTIVE COMMENTARY 
The overarching title of my doctoral programme is that of 'Doctórate in Professional 
Studies (Orthopaedic Medicine Education)'. My project to conclude my programme 
has been undertaken as Module DPS 5140. This commentary sets out to provide a 
justification for the project, and will place the project in context both with respect to my 
whole doctoral programme and the wider professional context. An outline plan and 
background to the project will be provided and référence will be made to the Strands of 
collaboration, the choice of methodology and the resources and facilities used. I shall 
put forward my aims and objectives for my project and contextualise my selected 
research and development area. The cohérence of the project will be demonstrated 
through drawing its components together and reflecting on the project process. The 
commentary will be explicit in its référence to the Level 5 descriptora (Section 2, 
Appendix 1) and how thèse have been satisfied through the development and 
completion of the project. 
INTRODUCTION 
The title of my project is 'the Development of an Injection therapy Module'. I undertook 
this project because I had been charged to develop an injection therapy module for the 
Society of Orthopaedic Medicine (SOM) (see below), as part of a postgraduate 
pathway towards an MSc in Orthopaedic Medicine at Middlesex University (MU). The 
project has three clear parts that link to form the cohérent project as shown in the table 
below. This 'wrap around' reflective commentary forms the final component to 
demónstrate the cohésion both within the project itself and its place in my doctoral 
programme. Within this commentary the term 'project' is reserved for the whole project 
only. 
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THE PROJECT - Development of an Injection therapy Module 
1. The development of the injection therapy Module Handbook in satisfaction of 
the Middlesex University requirements, as evidenced by the production of the 
Handbook itself. 
2. The completion of the manuscript for a textbook in theory and techniques 
(working title: 'Musculoskeletal Injection Skills'1), as evidenced by its 
submission to its publisher, Butterworth Heinemann, Oxford. 
3. The investigation of the facilitating factors and barriers to practice of 
physiotherapists implementing their injection skills, as evidenced by the 
preparation and submission of a paper for publication by a high quality peer 
reviewed journal. 
4. A commentary critically reflecting on the impact of the project on orthopaedic 
medicine education, and the physiotherapy profession, and an explanation of 
how the three previous components link together. 
BACKGROUND TO THE PROJECT 
A background to the project is necessary to be able to place the project within its 
various contexts. Its place within the MSc Orthopaedic Medicine programme, arising 
from the collaborative partnership between the SOM and MU, will be highlighted, as 
well as its contribution to the SOM's educational aims and the orthopaedic medicine 
approach in the management of musculoskeletal lesions. The project's place within 
physiotherapy post-graduate training will be discussed, allied to its impact within the 
interdisciplinary framework in the provision of health care. At the same time, the 
project sits within my doctoral programme that itself has impact in the contextual areas 
above. 
I shall begin by providing a background to orthopaedic medicine itself and the SOM, 
and shall clarify the importance of my own role in orthopaedic medicine education, 
specifically in context of the past, present and proposed developments within the 
Society's educational course. 
Orthopaedic medicine is a specialism in medicine that is dedicated to the examination, 
diagnosis and non-surgical treatment of disorders of the musculoskeletal system (i.e. 
1 Kesson M., Atkins E., Davies I. (In press) Musculoskeletal Injection Skills Oxford: Butterworth 
Heinemann 
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disorders of joints, ligaments, muscles and tendons; the means by which we move). It 
developed from the foundations of the specialism as originated in 1929 by 
Dr James Cyriax MD MRCP at St Thomas' Hospital, London. The SOM is a bi-
disciplinary organisation of medical practitioners and chartered physiotherapists (or 
those holding an equivalent overseas qualification) that was established in 1979 to 
continue the work of Dr Cyriax in light of continuing research, and to promote the 
theory and practice of orthopaedic medicine through educational courses. The Society 
is a limited company and a registered charity that is governed by an elected Council 
whose members act as directors of the company and trustees of the charity. A 
background to the Society and its Membership course is given in Appendix 2 (Section 
2). 
Courses in orthopaedic medicine contribute to post-graduate programmes in medicine 
and physiotherapy and the Society's three-modular courses take place throughout the 
year at a variety of different venues both nationally and internationally. The 2001 
course programme comprises thirty-five modules that will be attended by approximately 
900 students, with numbers of students on each module ranging between 24-36. Full 
membership of the SOM is gained through successful completion of the Society's 
summative examinations that include a true/false written paper and a practical 
examination. 
Courses dedicated to teaching orthopaedic medicine are also promoted by other 
organisations, for example Orthopaedic Medicine International and Orthopaedic 
Medicine Seminars, but it may be substantiated without difficulty that the Society is the 
largest and arguably fastest growing organisation in terms of its membership, its 
teaching activities and its developments in education. The Irish Society of Orthopaedic 
Medicine is an established Society that is accredited by the SOM and runs educational 
courses as according to the SOM's guidelines. 
The Chartered Society of Physiotherapy (CSP), as a professional body, is responsible 
for the validation of education and skills training of its members. It has an important 
role in the consideration of the professional practice issues surrounding the application 
of techniques, including the soft tissue injections used in the management of 
musculoskeletal lesions. Intra-articular (into the joint) and intralesional (directed at the 
specific site of the soft tissue structure) injections, normally of steroid and local 
anaesthetic, are applicable as a treatment option in the management of 
musculoskeletal lesions, but their inclusion within the scope of physiotherapy practice 
3 
was initially resisted since they were not based on the core skills of massage, exercise 
and electrotherapy. 
Williams (1986), quotes the Charter of the CSP that says 'The objects for which the 
CSP was established and incorporated are: to improve the training, education and 
professional status of persons engaged in the practice of massage, medical 
gymnastics, electrotherapeutic or kindred methods of treatment and to foster and 
develop these'. Her paper focuses on the importance of fostering and developing the 
use of these treatments with continuing research, and she poses the question are 
we rather sliding off into other academic worlds that really belong to other professions, 
and ignoring our own?' Her message was that 'physiotherapy is handling' and that 
opinion was representative of the CSP's view that injectionss were not based on the 
core skills of the Charter, and that their invasive nature debarred them from inclusion 
within the interpretation of 'kindred methods of treatment'. 
Due to the bi-disciplinary nature of the SOM, the theory and practice of steroid and 
local anaesthetic injections has always formed part of the syllabus of courses in 
orthopaedic medicine, being taught to medical practitioners and physiotherapists alike. 
From the earliest stages, physiotherapists have been required to know the theory 
underpinning injection therapy and the key points of applying injection techniques, but 
have been restricted from applying them in the clinical setting through the stance of the 
CSP and through ethical convention and professional tradition, each to the detriment of 
professional autonomy. These and other barriers to practice are explored within my 
research paper included in Section 5. Dr Cyriax himself strongly supported the motion 
that physiotherapists should be able to inject, with particular acknowledgement of their 
knowledge of anatomy that was crucial to ensure accuracy in diagnosis and needle 
placement, and so to enhance effectiveness in the application of musculoskeletal 
injections. 
The World Confederation for Physical Therapy (WCPT) is an international 
confederation of 83 national physical therapy (physiotherapy) organisations that was 
formed in 1951 to share information worldwide with the aim of improving the quality of 
global health care. The WCPT is dedicated to encouraging high standards of physical 
therapy through research, education and practice, and to developing guidelines for 
practice to which member organisations and individuals can aspire. The CSP is a 
member organisation of WCPT. WCPT organises an international congress every four 
years and at its 10 t h congress in 1982 a keynote address was given that put forward 
the following dictum: 
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'A profession should not be regarded as an Institution which protects acquired 
modes of functioning in its own niche. It should not be regarded as a body of 
knowledge and skills the possessors of which are conservative and fearful of 
change. Instead it should be regarded as developing and changing functions -
as something both open and dynamie. It defines its own goals - anticipates 
changes, participates in the development of society and readily re-examines its 
boundaries and the content ofits activities' 
Paatro (1982) 
The implication was that for a profession to progress a proactive challenge should be 
applied to the boundaries of practice in response to developments within society and 
the demands of Services to the public. In that respect, Paatro's Statement was 
prophetic in predicting the move within physiotherapy nationally and globally and it is 
interesting to note the progression of the profession over the intervening fifteen-year 
period following William's view (1986), especially in relation to extension of scope of 
practice, as discussed below. 
It was always the intention that injections would enter into practice via specialism at a 
post-graduate stage. The WCPT Declarations of Principle concerning Education are 
reproduced in Appendix 3 (Section 2). The CSP's views were important in its role in 
monitoring and acerediting post-graduate training programmes towards specialisation. 
The WCPT published a 'position statement' (1995) affirming 'the right of Member 
Organisations to make national policies which permit practice specialisation where 
such activity is considered by them to benefit the public and the profession by 
promoting higher Standards of physical therapy'. Important 'definitions and guidelines' 
were adopted to 'harmonise and co-ordinate the development of practice specialisation' 
that are also reproduced in Appendix 3 (Section 2). 
It is important to note that the WCPT issues 'guidelines' as such, to encourage high 
professional Standards and ethical principles. The issue of regulation of practice 
towards the achievement of the same aims is an interesting point for discussion. In the 
event of adverse outeome following physiotherapy Intervention the recipient would 
generally have three routes for investigation and redress. Firstly, the CSP as a 
professional body would have the authority to investigate any complaint from the 
perspective of professional misconduet and breach of code of professional practice. 
Secondly, the circumstances could be investigated though the processes of civil law in 
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respect of 'assaulf. If found guilty then the outcome could be considered by the 
professional body and also the regulating authority, the third avenue, as follows. A 
complaints procedura is in place within the Council for Professions Supplementary to 
Mediane (CPSM), that is the body for 'State registration' of physiotherapy and allied 
professions. State Registration is a requirement for working within the National Health 
Service, but is not a requirement for working within the private sector. The CPSM has 
a defined regulatory role to ensure that ethical principles are satisfied, and the removal 
of State registration would limit freedom of professional practice. 
Ellis (1999) points out that regulation can protect the public from unqualified people and 
that a regulated professional group tends to have a position of Standing or trust within a 
Community. She examines different Systems of regulation in physical therapy and sets 
out how regulation can also help to ensure that high professional Standards are 
maintained nationally and globally. Ellis asserts that once a proper system of 
registration is in place, the maintenance of Standards becomes easier, because 
Professionals can be held accountable. She notes that within some countries 
mandatory continuing professional development schemes are in place to maintain 
Standards and the trend, as in the United Kingdom, is towards annual renewal of 
registration to be linked to the demonstration of that development. The maintenance of 
high professional Standards would be at the heart of a professional's practice and the 
stance of the CSP was, and is, respected in this regard. 
Thus whilst 'regulation' can imply more than the 'policing' of a profession, nonetheless 
it appeared that the CSP, in defining scope of practice, was effectively restricting 
practice. For those physiotherapists involved in the teaching and practice of 
orthopaedic medicine this represented a professional injustice, since in spite of 
identifying injection therapy as the treatment of choice, following assessment and 
clinical diagnosis, physiotherapists were being denied the Option of affecting a eure. 
The WCPT 'Declarations of Principle' (1995) relating to autonomy states: 
'The central element of professional autonomy is the assurance that individual 
physical therapists have the freedom to exercise professional "judgement in 
health promotion, prevention and the care and treatment of clients within the 
limits of the therapist's prevailing knowledge and competence.' 
With the continued development of autonomy within physiotherapy came the extended 
role of the profession in orthopaedics and rheumatology, where orthopaedic and 
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rheumatology 'assistants' or 'practitioners' were being created, whose role included the 
administration of local steroid injection. Hockin and Bannister (1994) examined the 
extended role of a physiotherapist in an outpatient orthopaedic clinic and identified that 
22% of patients had received physiotherapist administered steroid injection. With the 
existence of such a fait accompli and the moves of continuing professional 
development in encouraging the process of developing practice towards skill 
specialism (Bergman, 1990), the CSP was pressed to extend the scope of practice of 
physiotherapy to include intra-articular and intralesional injections in December 1995, 
provided that the physiotherapist was 'appropriately trained'. 
The definition of 'appropriate training' allowed for interpretation in that physiotherapists 
could be directly supervised, mainly in orthopaedic or rheumatology departments, or 
could attend dedicated injection therapy courses (at that stage still to be introduced), 
where the principles of intra-articular and intralesional injections could be taught as part 
of the syllabus. Courses in orthopaedic medicine were an obvious starting point for the 
introduction of 'appropriate training' for physiotherapists. 
The Association of Chartered Physiotherapists in Orthopaedic Medicine (ACPOM) is a 
clinical interest group within the CSP. ACPOM is open to membership for individual 
physiotherapists who have an interest in orthopaedic medicine and a proportion of 
physiotherapy members of the SOM will be members of both. After the introduction of 
musculoskeletal injections within the scope of physiotherapy practice, an injection 
therapy module was developed through ACPOM that led to the award of a 'Diploma in 
Injection Therapy'. Several SOM members attended the initial courses, particularly 
from its teaching body. A number of cohorts of students have been trained in injection 
therapy via this route and the courses continue to be well organised and popular. 
However, the nature of injection therapy training requires a high tutor to student ratio, 
with the outcome that the ACPOM courses became heavily oversubscribed. 
To increase the availability of injection training courses, the governing SOM Council 
agreed that the SOM should design an add-on course for physiotherapists, i.e. a 
Module D, which would dedicate itself to the training of physiotherapists in injection 
skills. Dr Ian Davies, at the time a teaching Fellow of the SOM and member of Council, 
was appointed as 'course principal' to take the lead in designing the content, 
programme and teaching materials of the course, with support from the SOM education 
committee and medical practitioners belonging to the British Institute of 
Musculoskeletal Medicine (BIMM), an organisation that has a close professional 
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association with the SOM. I was part of the development team and pilot group of this 
injection therapy module. 
The Society's Membership course had been presented for accréditation in 1994 
through the so-called 'PAGE' (Physiotherapy Access to Continuing. Education) 
Scheme, where it was assessed by the Joint Panel of the CSP and the University of 
Greenwich and awarded 40 points at Level 3 2, within the University of Greenwich 
System for accréditation. If required, the reader is referred to my 'Review of Previous 
Learning' (January, 2000) that provides full détails of my rôle in achieving accréditation 
for the Membership course. The relevant extract is included within this présentation as 
Appendix 4 (Section 2). 
With respect to the injection therapy module, Module D, I was charged with the 
responsibility for preparing the supporting module documentation that was to be 
presented to the University of Greenwich towards the achievement of accréditation for 
the injection module in its.own right. My éducation committee colleague, Anne-Marie 
Ainscough-Potts, was my chief collaborative partner in this endeavour and we both 
attended the accréditation meeting in 1998 to présent the module to the panel that was 
drawn from représentatives of the University of Greenwich and the CSP, where it was 
awarded 10 points at Level 3. 
The éducation committee of the SOM is a sub-committee of its main goveming Council 
and comprises the current eight course principals, each of whom has been considered 
by the éducation committee to have the knowledge and organisational capabilities to 
run each course module in the manner in which it is accredited. The éducation 
committee is concerned with ail the affairs of éducation in the Society but is answerable 
to Council to which it must report at each Council meeting. I was appointed as a 
course principal in 1994. 
In my submission 'Review of Previous Learning' (January, 2000), I identified those 
areas pertaining to éducation within the SOM for which I had key responsibility at the 
time. Thèse were highlighted as being the development and maintenance of university 
partnerships, the préparation of supporting course documentation and the 
représentation of the SOM at accréditation events. Up to that time, most of my efforts 
had been directed towards the moves towards the achievement and maintenance of 
accréditation with the University of Greenwich, that was itself in partnership with the 
2 Level 3: approximately équivalent to the level of learning assessed within the third year of an 
undergraduate course. 
8 
CSP. In order to clarify my role with respect to my project, it is necessary for me to 
reflect on my development as an orthopaedic medicine educator, particularly within the 
context of the SOM, throughout the period that has followed since the original 
accreditation by the University of Greenwich. 
Ever since the course had been accredited through the original 'PACE' scheme 
described above, it had been the aim of the SOM to move its course towards a 
master's level option. The Society's Membership course is deemed to be successful as 
a useful, comprehensive clinical skills course that enables students to enhance their 
skills of clinical reasoning in the assessment, diagnosis and treatment of 
musculoskeletal conditions. From that perspective it sits neatly within the Level 3 
framework and there was a reticence to 'throw out the baby with the bathwater" with 
further developments towards master's level that might be introduced. The Society 
certainly did not want to alienate those students who had no wish to study at master's 
level but nonetheless wanted to absorb and integrate the tenets of orthopaedic 
medicine into their clinical practice. 
The expertise had not been within the Society's education committee to provide an 
option that would satisfy the requirements of Level 4 (master's level) learning, whilst 
allowing the students to 'step off at the stage of achieving Membership of the SOM, or 
even before. Furthermore, at that time there had been several internal changes within 
the University of Greenwich post-graduate courses team and attempts to move things 
onwards within that partnership, with respect to developing the course to master's 
level, were unfortunately unsatisfactory. 
Through a chance introduction in 1999, the SOM had forged an embryonic 
collaborative partnership with Middlesex University (MU), School of Health, Biological 
and Environmental Sciences (HeBES) to discuss the possibility of developing a 
master's programme in Orthopaedic Medicine, i.e. an 'MSc Orthopaedic Medicine', 
that, if it came to fruition, would be the first master's programme dedicated to the 
specialism. 
The Society of Orthopaedic Medicine and its Membership course had to 'pass muster" 
in terms of quality and educational credibility before progress could continue and 
rigorous checks were made in order for the Society to gain 'Institutional Approval'. The 
'Programme Planning' Stage followed in preparation for validation of the MSc 
Orthopaedic Medicine programme. 
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My expérience in completing a master's programme in post-compulsory éducation and 
training, developing the Society's course in satisfaction of the requirements for 
accréditation by the University of Greenwich and my attendance at accréditation 
events, had prepared me well for the next stage of developing the course, with the 
support that was being offered by MU. It was inévitable that the responsibility for taking 
the course onwards should be given to me within the Society's éducation committee, 
and I was delighted to take on the challenge. 
In accordance with the programme planning processes within the School of HeBES, I 
was appointed as Link Tutor to liaise between the SOM and MU. My counterpart was 
Dr Kay Caldwell, who also has responsibility as a postgraduate programme co-
ordinator. The relationship and support provided by the personnel within the MU 
School of HeBES, was stimulating and refreshing in its facilitation towards the 
development of the master's programme. It was emphasised that the ethos of the 
university was to give crédit for each stage of leaming achieved and that viewpoint was 
most compatible with the existing framework of the Society's course and its aims for 
development. 
The MSc Orthopaedic Medicine programme was designed to commence at the Post­
graduate Diploma level, with successful completion of the Society's Membership 
Course as a pre-requisite for entry to the programme as a Post-graduate Certificate in 
Orthopaedic Medicine. In order to satisfy the requirements for the Post-graduate 
Certificate as part of the validation process, it was vital that the Society's Membership 
course itself should be developed to become accredited at 60 crédits at Level 4, or 
master's level, by Middlesex University. As a guide, the Levels Descriptors central to 
work based learning and independent study, as mapped onto the Levels 1-4 framework 
of the Middlesex Académie Scheme, are included as Appendix 5 (Section 2). I was 
responsible for developing and submitting the necessary documentation and the 
Membership course was accredited by MU School of HeBES in autumn, 2000. The 
option for students to exit at the stage of achieving Membership of the SOM remained, 
and indeed it was also possible for students to opt out prior to the Society's 
Membership examinations, where certificates of attendance would be issued for each 
module attended. In this way the course would build on its Level 4 underpinning but 
allowing several options for study within its flexible framework. The structure and 
pathway of the master's programme is given as Appendix 6 (Section 2). 
My rôle as link tutor involved the attendance of a séries of programme planning 
meetings that were held at the Enfield campus of MU (Enfield, Middlesex). By good 
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fortune and coïncidence this campus was near to my home and therefore a convenient 
venue for me. 
The times of the meetings were always negotiated to have the minimum impact on my 
own professional commitments. In taking on the responsibility for the development of 
the master's programme, it was accepted that I would originate any documentation that 
was required from the SOM's perspective that would then be circulated to the other 
éducation committee members for comment, and that would then be incorporated into 
the final drafts. That method of communication had worked well for similar projects in 
the past and it was a satisfactory process to allow for input from ail members, as well 
as providing an assurance to me that I had the informed support of my colleagues. 
I believe that it is appropriate at this point to highlight that members of the SOM's 
Council and éducation committee take on the commitment as a voluntary, 'spare time' 
rôle. Members of the éducation committee may also be elected members of Council, 
and this is my own situation, as well as that of four of my éducation committee 
colleagues. Council meets four times each year at meetings that commence in the 
early evening and the éducation committee holds two full-day meetings twice a year, 
with a considérable amount of work relating to Society business carrying on throughout 
the year. Without exception, members of both Council and the éducation committee 
have existing füll time clinical or undergraduate teaching commitments as médical 
practitioners and physiotherapists, and the course principals have an additional 
commitment to teaching and running the Society's courses that involves each of them 
in being away for up to eight, four- or five-day modules each year. 
To ensure that the ownership of the masters programme rested with the éducation 
committee as a whole, it would have been désirable and ideal for several members of 
the éducation committee to have attended each planning meeting, just as there were 
always two or more représentatives from MU. However, although one of my éducation 
committee colleagues from Kent was able to join me for two of the six meetings, it was 
not practicable for the other members to attend from further corners of the country, and 
an arguably unreasonable demand on their time. This was understood wholeheartedly 
by the MU link tutor but I did need to give myself, and her, the assurance that although 
the key respon responsimine I would be liaising closely with each of my colleagues 
at ail stages of the development of the programme. 
I did take best care to ensure that it was the Society's remit that I was working to, 
rather than my own, and I determined to remain professional^ focused in that 
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endeavour with my personal development as a by-product of the process. It was most 
important to maintain the Society's corporate ownership of the programme and to allow 
ail members of the Society to feel part of the development of the course, with equal 
access to a programme that would represent the final focus of all the work of ail the 
medical and physiotherapy contributors to the development of the specialism and the 
Society's progress in éducation over the years. Nonetheless, I would suggest that the 
circumstances of my being the key person able to attend and contribute to the 
programme planning meetings further enhanced the importance of my role in 
developing the master's programme. 
I was able to work autonomously in taking the Membership course forwards towards 
the development of the master's programme but remained mindful of my responsibility 
to the SOM Council through the éducation committee and ultimately the Society as an 
organisation. 
I prepared ail the documentation in préparation for the validation event in collaboration 
with my MU Link Tutor colleague and attended the validation event itself to introduce 
and speak to the master's programme from the clinical perspective. A tutor 
représentative and student of orthopaedic medicine also attended the meeting and 
contributed to the discussions. MU validated the MSc Orthopaedic Medicine 
programme on 25 January 2001. It was an exciting achievement for the SOM and 
marked an important stage in attaining académie credibility for the Society's 
Membership course. Following the achievement of validation the roles of Kay Caldwell 
and myself were redefined as 'programme co-ordinators'. Details of my role within the 
SOM have been provided above, particularly in developing the educational aspects of 
its course. In context of my over-arching doctoral programme, I believe that my role 
has been pivotai in taking orthopaedic medicine forwards and facilitating the 
achievement of the SOM's educational aims. 
In sharing the MSc between the SOM and MU, it was important that optional modules 
should be provided by the Society as well as those already existing within the MU 
catalogue, that were relevant to the programme. In developing the master's 
programme, it was proposed that the Society's existing injection therapy and 
Fellowship training modules should be developed to master's level to be available as 
the option modules 'Theory and Practice of Injection therapy, (IPS 4020)' and 
'Préparation for Teaching Orthopaedic Medicine, (IPS 4010)'. 
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As mentioned above, injection therapy is a treatment option in orthopaedic and 
musculoskeletal medicine and provides a focus for a therapeutic intervention resulting 
from the differential diagnosis of musculoskeletal lesions. From the outset, the SOM 
believed it to be essential that the quality of training courses for physiotherapists to 
learn how to inject should be in accordance with stringent levels of scrutiny. This belief 
was in accordance with point 5 of the WCPT position statement on specialisation that 
states The qualification of a physical therapy specialist will include a formal process for 
testing and acknowledging the appropriate advanced clinical knowledge and skills of 
the speciality' (Section 2, Appendix 3). Within the development of the master's 
programme was the opportunity to focus on the development of the Society's injection 
therapy module in support of the Society's role in the effective training of 
physiotherapists in injection therapy skills. 
As listed in Appendix 2, (Section 2), the Society's educational course consists of three 
modules, Modules A, B and C with inter-modular course work. The injection therapy 
module, Module D, was already in existence but accredited as a Level 3 module. From 
our discussions within the education committee on the nature of the learning involved, 
we believed that it was appropriate for the injection therapy module to be developed 
towards master's level, with reference to the Level 4 descriptors (Section 2, Appendix 
5). As part of my mandate from the SOM to develop the MSc Orthopaedic Medicine, I 
decided to focus on the development of the injection therapy module to master's level 
within that programme, as the medium project required in completion of my doctoral 
programme. I set out to address important issues and perspectives in the development 
of a high quality training module by drawing from the blend of my existing experience in 
orthopaedic medicine and education, and specifically from my experience in developing 
the Society's Membership course towards master's level. 
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THE PROJECT 
In spite of the injection therapy module's place as a core skills module within the 
master's programme, I did not want to confine the project by entitling it 'the 
Development of an Injection Therapy Module to Master's Level'. The module's 
development can be considered to be infinite. It has moved from its conception as 
Module D to being 'relaunched' at master's level and will continue to be developed in 
light of its own intrinsic évaluation and also as a proactive response to professionally 
related extrinsic drivers linked to the development of skill specialism. 
The module's impact on the physiotherapy profession lies in its value as a post-
graduate training course for specialist practice. The project will address the demands 
of its stakeholders within its associated contexts and will demonstrate the Strands of 
collaboration established towards its development. 
The project sits at the heart of several contexts that are best represented as a séries of 
concentric circles that illustrate the contextual relationships and their increasingly 
widening professional scope. The diagram is reproduced as Figure 1 on the following 
page. 
The injection therapy module is placed at the centre of the circles. Moving outwards its 
first relationship is to the surrounding MSc Orthopaedic Medicine programme where it 
sits as a clinical skills option module. The collaborative partnership between the SOM 
and MU is the next context represented with the MSc programme, and the injection 
therapy module within, representing the outcome of that partnership. 
Moving further outwards, the collaborative partnership allowed for the fulfilment of the 
aims of the SOM. The SOM was committed to moving its educational course towards 
the development of a master's option and the SOM then has its place as a teaching 
body in context of the specialism of orthopaedic medicine itself. Since the injection 
therapy module is a post-graduate course targeted at those physiotherapists who are 
practising in the field of orthopaedic medicine, and who have successfully completed 
the Society's Membership course, I have selected the profession of physiotherapy as 
the next contextual surround. That itself is embraced by the girdle of an 
interdisciplinary collaborative framework, particularly with respect to the partnership 
between physiotherapists and médical practitioners. 
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Figure 1 
F igure 2 
Each stage of the contextual relationship can also be applied to my doctoral 
programme that is aligned across the concentric arrangement as illustrated in Figure 2. 
Stakeholders can be identified within each circular relationship that have an interest in 
the development of the injection therapy module. Returning to the heart of the 
illustration, the injection therapy module leader is experienced in the administration of 
injections in musculoskeletal conditions, but is looking to my role in developing the 
supporting framework of the module through the fulfilment of my project's aims. 
Similarly the collaborative partnership with MU depends on my input towards the 
development of a core skills option module that can be offered as part of the MSc 
Orthopaedic Medicine programme. The SOM is committed to offering an injection 
therapy module to provide comprehensive postgraduate training in this skill specialism 
that forms an essential part of the orthopaedic medicine approach to management of 
musculoskeletal lesions. The Society also has a stake in my completion of the project, 
therefore, towards the development of a high quality injection therapy training module 
that can be offered as a sequel to its Membership course. 
With respect to the physiotherapy profession and the juxtaposed interdisciplinary 
framework for working, the project is vital in facilitating the development of specialism 
towards a total professional approach in the management of musculoskeletal lesions. 
Furthermore, the importance of continuing professional development is well recognised 
as a fundamental need for all individuals engaged in the provision of health care 
services, and a professional requirement for those engaged in clinical practice. The 
module sits well within that framework for the continued development of skill specialism 
in medicine and physiotherapy. 
For clarity the table detailing the key elements of the project is repeated below. 
THE PROJECT - Development of an Injection therapy Module 
1. The development of the injection therapy Module Handbook in satisfaction of 
the Middlesex University requirements, as evidenced by the production of the 
Handbook itself. 
2. The completion of the manuscript for a textbook in injection theory and 
techniques (working title: 'Musculoskeletal Injection Skills'), as evidenced by 
its submission to its publisher, Butterworth Heinemann, Oxford. 
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3. The investigation of the facilitating factors and barriers to practice of 
physiotherapists implementing their injection skills, as evidenced by the 
préparation and submission of a paper for publication by a high quality peer 
reviewed journal. 
4. A commentary critically reflecting.on the impact of the project on orthopaedic 
medicine éducation, and the physiotherapy profession, and an explanation of 
how the three previous components link together. 
An explanation follows to justify the inclusion of each of the components within the 
project. Each component will then be discussed in tum to allow me to develop my role 
in completing the project and to address the project itself in terms of internai cohérence 
and impact in the wider context. The project's place as the ultímate contribution to my 
whole doctoral programme will be made apparent and explicit référence to the Level 5 
descriptors will be made. 
As a member of the Society's éducation committee, and latterly as its Chair, I have 
been an integral part of the team developing the académie content of the whole course 
and the original injection therapy module within that. From the outset we believed that 
it was crucial that the module leader and those teaching on the module should be 
drawn from those who are highly experienced in the use of the technique, and medical 
input was paramount. The course content and learning resources, including the course 
manual, would need to reflect that expertise. At présent, I have not taken the 
development of my own injection therapy skills forwards in my clinical practice and I 
shall expand on that point within my critique of both the 'textbook' and the 
'investigation'. I was, and am, clear on the extent of my own role in developing and 
supporting the module on the basis of my own qualifications. 
From the educational standpoint I took a pragmatic view on what was 'wanting' in the 
module, linked to the contribution that I could make to the development and support of 
the injection therapy module. In line with current educational theory, a student centred 
approach to teaching and learning underpins the Society's Membership course and I 
was careful to consider the module from the student's perspective, as well as that of 
the teacher. 
Having been a student within several programmes myself, I found the administrative 
handbooks invaluable for the information they provided concerning the framework of 
thef2Uand referred to them frequently throughout the duration of the respective 
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courses. No such handbook was in place for the injection therapy module, Module D, 
and I viewed the handbook as an essential starting point. With my personal expérience 
as a Student and having developed the documentation for the master's programme, 
including the programme handbook and validation document, I was best placed to 
produce a Module Handbook that would give general information and detail on the 
administrative aspects of the module in context of the MSc Orthopaedic Medicine 
programme. Thus, as a token of my authority in that role, I elected to include the 
production of the Module Handbook to be a component of my project. I was prepared 
to seek the advice of Dr Kay Caldwell, my collaborative MU MSc Orthopaedic Medicine 
programme co-ordinator, to ensure consistency with the existing MU, School of HeBES 
module documentation. 
As part of my doctoral programme I have presented the textbook 'Orthopaedic 
Medicine: a Practical Approach'3, a collaborative project with my colleague Monica 
Kesson, to daim récognition and accréditation of leaming (RAL) within Part 2 of the 
programme. The book had been written to be the 'book of the Membership course' and 
had established itself as a core reader in that role in support of students and teachers 
alike. Its success in that regard had led to the création of a textbook to support the 
existing injection therapy module and that was already underway at the start of my 
project, in collaboration with my colleagues Monica Kesson and Dr lan Davies. 
However, against the background of the development of the injection therapy module 
to master's level, and the module's place in the MSc Orthopaedic Medicine 
programme, it needed to be looked at afresh before its ultímate submission for 
publication, to ensure that it was appropriate as a dedicated specialist textbook and a 
key core reader to support the module. Its role was essential in this respect and I 
therefore included the book as a component of the overall project. 
I mentioned above that at présent I am not developing my injection therapy skills 
further within my clinical practice, but to clarify, I have injected as part of the clinical 
supervision stage of the pilot injection therapy module. In fulfilling the requirements of 
clinical supervision and in implementing the skill, I had encountered barriere to training 
and practice. From my own expérience, I believed that it would be would be explore the 
expériences of physiotherapists in implementing their injection therapy skills to be able 
to identify those barriere to practice that might be met, but also to be able to counter 
thèse by identifying factors that might facilítate the implementation of the skills. I 
intended that the findings of the study would inform the module to allow a proactive 
J Kesson M., Atkins E. (1998) Orthopaedic Medicine - a Practical Approach Oxford: Butterworth 
Heinemann 
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approach in the advice given to students, to enable them to apply their skills following 
training. As well as directly affecting the Society's training modules, and more 
indirectly other injection therapy training modules, this will also have important impact 
on the profession of physiotherapy as a whole as it moves to fully integrate this 
technique into its scope of practice. The investigation was therefore selected as the 
third component of my project. ' 
It is my intention to extend the study referred to above following the completion of my 
project, to be able to reflect on the expérience of students and the findings of my 
original investigation from a différent perspective. My aim will be to generate theory to 
inform the continued development of injection therapy training and to forge a doser link 
between éducation and implementation. 
Since I would not consider myself to be experienced in the application of injection 
therapy in clinical practice, it will be for the module leader and those appointed to the 
development team to have chief responsibility for the content and design of the course 
and the préparation of teaching materials. However, although my input into thèse will 
be secondary, my previous expérience in course design and préparation of teaching 
materials, and my input as programme co-ordinator will be important nonetheless, both 
to support the development team and to ensure cohérence of the programme as a 
whole. 
Each part of the project was worked on simultaneously and the findings and expérience 
of each informed the other. Within the following sections I shall reflect on each of the 
components listed above in turn, before drawing the projed together within my 
commentary and conclusion. 
My 'Programme Planning and Rationale' assignment, had stated deadlines for each 
component of the project: 
The first 'deadline' as such will relate to the textbook manuscript that has to be 
submitted by 31 October 00. At présent, the pathway towards the MSc in 
Health Studies (Orthopaedic Medicine) is edicine) is a commence in the second 
semester of the académie year 00-01, and the Module Handbook will need to 
have been produced and the programme validated by then. I intend to start 
conducting interviews for the third part of the prdject as soon as ethical issues 
have been satisfied, and would aim to have the paper ready for submission for 
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consideration by a professional Journal by no later than January 01, i.e. 
Semester 1, 00-01. 
The first lesson leamed in pursuing the project was that in spite of being determined to 
adopt a proactive approach throughout, nonetheless I feil victim to external Stressors 
that led me to develop my skills of reacting to and managing the challenges they 
presented. Details of those challenges and how they were met will be included within 
my evaluation of the processes included below. 
MODULE HANDBOOK 
The Module Handbook is included as Section 3 of this project présentation. 
In a sensé the pressure to meet the original deadline of having the handbook ready in 
time for the second semester of the académie year 2000-01 was removed, since it was 
agreed that the MSc Orthopaedic Medicine should begin in the first semester of the 
académie year 2001-02. However, this also took the pressure off the appointed 
module leader and his collaborative médical practitioner partner that were detailed to 
prépare the course material, particularty the Course Manual and the Pre-Course 
Handbooks. That affected me in that I had wanted the various written materials to form 
a set, such that the boundaries of content of each would be clear, and there were 
éléments appertaining to the course design and content that needed to be included 
within the handbook that had not been finalised within the context of the module's 
préparation. 
I should point out that the injection therapy module will be available as a stand-alone 
module irrespective of whether or not students are enrolled on the MSc Orthopaedic 
Medicine programme. On reflection, I needed to consider those students who might 
enrol on the injection therapy module but who might not be registered for the MSc 
Orthopaedic Medicine, and decided that some overlap of information would be both 
désirable and acceptable. The module leader also gave full support for my 
requirements by focussing specifically on the areas that needed to be finalised for the 
purposes of the handbook. 
I prepared the Module Handbook, but since it was important that it was consistent with 
the format for handbooks available for other MU modules provided by the School of 
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HeBES, I collaborated with my co-programme co-ordinator, Dr Kay Caldwell, in 
acknowledgement of her considérable expérience in preparing such material. I 
particularly needed advice on access to gênerai University information, student support 
services, information and learning resources and module évaluation. 
Although the préparation of the handbook was fairly straightforward and in that, the 
'easiest' component of the project to compile, nonetheless I believe that that in itself 
was a reflection of my accumulated expérience in preparing documentation for the 
master's programme. That expérience had facilitated the process and had enhanced 
my confidence in performing the task. 
A draft copy of the handbook is included in Section 3, preceded by a testimonial from 
my collaborative programme co-ordinator relating to its final production. 
LEVEL 5 DESCRIPTORS 
Cognitive 
The Module Handbook is intended as a token of my development in orthopaedic 
medicine éducation and as a single component of the project it is least aligned to the 
satisfaction of the Level 5 descriptors. I had identified that it was a requirement, or tool, 
to support the student of injection therapy and it was a product of the synthesis of my 
existing expérience in producing course materials and documentation, with fresh ideas 
for its development in collaboration with the module leader and the MU programme co-
ordinator, to ensure consistency with other MU School of HeBES handbooks. 
Transférable skills 
The key transférable skills evidenced through its production relate to problem solving, 
planning and management, with autonomy in its production whilst engaging in 
collaborative working and communication. 
Operational context 
I was responsible for the Module Handbook's production and was aware of my 
responsibility to the stakeholders that include: 
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• the future students on the injection therapy module 
• the module leader 
• the collaborative partnership between ML) and the SOM in co-ordinating the 
MSc Orthopaedic Medicine programme 
• the SOM in its aim to provide a high quality training module 
• orthopaedic medicine as a specialism 
• the profession of physiotherapy to support the development of specialism within 
practice 
• the interdisciplinary collaboration towards improved patient care in the 
management of musculoskeletal lesions. 
TEXTBOOK 
The draft of the Textbook as submitted is included for reference as Section 4 of this 
project presentation. 
As referred to above, the preparation of the textbook, 'Musculoskeletal Injection Skills', 
was already underway when I began the project of developing the injection therapy 
module. It had initially been commissioned as the textbook to accompany the original 
injection therapy module, Module D, and I collaborated with my colleagues Monica 
Kesson and Dr Ian Davies in its preparation as my respective physiotherapy and 
medical practitioner co-authors. 
I mentioned above that, at present, I am not developing my injection therapy skills 
within my clinical practice. The appropriateness of my being commissioned to write a 
text on 'Musculoskeletal Injection Skills' in the absence of those personal skills is 
therefore a matter for debate and would certainly require some explanation and 
justification. In response to the challenge of my qualifications to write a textbook on 
injection therapy my starting point would be to steal a phrase from the Gestalt school: 
'the whole is greater than the sum of its parts'. 
Following the invitation to prepare the textbook from the publisher, Butterworth 
Heinemann, I needed to address the question within myself on what part I could play in 
its preparation, with consideration for the absence of the development of my personal 
skills in the application of injection techniques. My collaborative physiotherapy author 
and I had written the original textbook 'Orthopaedic Medicine - a Practical Approach' 
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as the sole authors. However we had sought the input of our teaching medical 
practitioner colleagues to read and evaluate the sections on injections both to ensure 
accuracy and to allow for inclusion of those small points that enhance the teaching 
value of any practical educational text. Those who had contributed to the text in this 
way were acknowledged, by agreement, within the appropriate section whilst not being 
listed as co-authors as such. 
Both my collaborative physiotherapy author and I have confidence in our teaching 
abilities and have a mandate to put our ideas in writing through past and present 
feedback following courses and lecture/demonstrations. Our partnership worked well 
in our collaborative publication mentioned above. The notion of confidence was an 
important point when we were commissioned to provide a companion to our original 
textbook that would dedicate itself to musculoskeletal injection skills. We were totally 
secure in the theory of injection therapy, but at the same time fully aware that the input 
of someone with the practical experience in the skill was crucial. We also believed that 
it was vital that a medical practitioner with experience of musculoskeletal injections 
should be included as a co-author of the text, even rather than an experienced injecting 
physiotherapist. I believe that, justifiably, we would have been exposed to criticism 
from both the medical and physiotherapy professions without that input and we agreed 
that we would not consider taking on the task without medical support. 
Dr Ian Davies had been the teaching medical practitioner (as a Fellow of the SOM) who 
had originally taken the injection therapy module, Module D, forwards. He had had the 
main responsibility for designing the module and its teaching materials from the outset. 
In that role he had also been able to observe physiotherapists as learners and had 
been able to take note of the queries they had had, and any special needs in terms of 
facilitating their learning. With his knowledge of the theory and practice of orthopaedic 
medicine and his background in anaesthetics he was the ideal collaborative author. 
My collaborative physiotherapy author and I had been part of the pilot student cohort 
on the original injection therapy module and I consider that that put us in a very strong 
position in being able to identify the module's strengths and shortcomings and the 
particular difficulties we es we has learners. From that perspective, I do not believe 
that it would have been appropriate for a medical practitioner (or medical practitioners) 
only to write a text to support the injection therapy module since they would have 
emerged from a different professional background and different issues might exist 
within their realm of experience in relation to the sociology of the professions. With 
consideration for the specific contributions of each of my co-authors and myself, I do 
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not believe that it would have been possible or desirable for the text to have been 
written by any one, or even two of us, but the inputs of all three of us combined to 
produce the 'whole' in the form of a credible text. 
Macdonald (1995) provides a useful introduction to the sociology of the professions 
that acted as a 'springboard' in increasing my awareness of factors that could impact 
on the ability for physiotherapists to put their injection therapy skills into practice. 
Reference to his text is also made within the paper that was produced from my 
research investigation (Section 5). Macdonald considers the attainment of autonomy 
within the medical profession itself and the way in which this has extended into 
'dominance' over 'kindred occupations'. He cites midwives who he describes as 
needing the sanction of the medical profession as one of the bases for their legitimacy, 
but not wanting to be dominated by it, acting as 'low status assistants'. The culture of 
physiotherapy has developed in that it originally achieved legitimacy in mainstream 
medical practice, particularly with respect to its core skill of massage, by forging a 
partnership with the medical profession. In the initial stages this demanded the 
surrender of autonomy and subservience to the medical profession, with parallels being 
drawn with the midwives mentioned above. With the continued development of the 
interdisciplinary partnership, each profession has come to acknowledge the skills and 
boundaries of ethical practice of the other, and independent practice has emerged. 
For the most part, the textbook 'Musculoskeletal Injection Skills was prepared in a 
similar way to 'Orthopaedic Medicine - a Practical Approach' with our roles combining 
towards the preparation of the final draft. Both my physiotherapy co-author and I had a 
clear plan in mind for the structure of the book, and our medical practitioner co-author 
was supportive of our ideas. It was not intended merely to draw out the relevant 
sections from our original textbook, and we set out to expand the introductory chapters 
to cover the theory of injection therapy with a particular emphasis on pharmacology. 
The remaining chapters of the book would take a regional approach to peripheral joint 
and soft tissue lesion injections but would be updated with relevant recent references. 
I believe that the 'lived experience' is valuable in allowing reflection on that experience 
andn from which to derive a theoretical framework. It was understood from 
the outset that those students who were attending the pilot injection module should 
provide feedback on the course content and teaching and assessment methods, to 
feed into the continued refinement and improvement of the module. The feedback was 
offered in group 'brainstorms', on a 'one-to-one basis' and retrospectively at education 
committee level. This spirit of evaluation was extremely useful from the SOM's 
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standpoint as well as from my personal point of view, in being able to identify the main 
points wanting of expansion to enhance the understanding of important concepts. The 
analysis directly informed the textbook and we aimed to be proactive in identifying the 
areas to highlight the questions to anticipate to be able to facilitate students' learning. 
This was true of the sectional approach to injections in discussing indications, 
contraindications and the spécifie techniques. It was particularly important in 
developing the theory chapters of the book. Pharmacology is not part of the 
undergraduate syllabus for physiotherapists and it was essential that thèse chapters 
should provide a comprehensive foundation for injection therapy to enable safe and 
effective practice. As teachers, it was an interesting exercise to set out to identify what 
we, as physiotherapists, need to know derived from what we do not know. 
Returning to the 'team' approach to writing the textbook, I believe that each co-author 
was vital for their contribution and that the end resuit, evidenced by the manuscript 
included in Section 4 (planned for publication in Autumn, 2001), is the richer for 
receiving the différent inputs, and more crédible as a core text for physiotherapists 
attending the modules to learn the skills of injection therapy. 
My collaborative physiotherapy author tended to perform most of the original literature 
searches and would then create a first thoughts draft as according to our decided 
scheme. It was accepted that my rôle was to scrutinise and expand on the original 
draft with respect to credibility, readability characteristics and gênerai clarity. I also had 
responsibility for the 'eut and paste' rôle of swapping chapters and sections within the 
drafts to create a logical flow through the material as it was presented. My 
collaborative médical practitioner author had a key rôle in checking the content for 
accuracy and in introducing his médical input, particularly with respect to medico-legal 
aspects, to enhance the credibility of the whole publication. My collaborative 
physiotherapy author and I have been teaching orthopaedic medicine for many years 
but since neither of us is currently developing our injection skills in clinical practice, our 
médical practitioner partners rôle was essential in this regard. 
Through the illness of one of my co-authors, the book's préparation had been delayed, 
but this enabled us to consider the developments within the injection therapy module to 
be able to reflect them within the textbook. The changes were not dramatic within 
themselves in terms of content, but the master's level of the module influenced the 
'essence' of the style of writing to a degree. 
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In my project plan, I had committed to hand the manuscript to the publisher, 
Butterworth Heinemann, by the end of October 2000, but, from our previous experience 
of preparing a manuscript, neither my colleagues nor myself were surprised or 
disappointed that the eventual handover date was moved to the end of November 
2000. I would say that we were relieved that it was delayed by such a comparatively 
short time. 
We worked well as a team in the preparation of the book. I mentioned that my 
colleague's illness for several months near the beginning of its development led to the 
book being placed 'on hold' throughout that period. The close collaborative nature of 
our partnership made it hard and undesirable to move on, and the publisher was most 
understanding. It was hard to eventually pick up on the original embryonic drafts, with 
the effect that much of the theory appeared to be seen 'as for the first time', and the 
renewal of enthusiasm was extremely difficult. However, throughout our previous 
combined projects, the challenge has always been to move things 'off one desk and 
onto the other's' and the impetus to achieve that soon led to a return to our previous 
pace of working. Certainly with our introduction to electronic communication since we 
had prepared our first textbook, the process of moving drafts between us was much 
easier and more straightforward than the cumbersome swapping of floppy discs and 
hard copy via 'snail mail' that had been employed previously. Nonetheless, with 
recognition of our considerable clinical, teaching, and family commitments, it was a 
great relief to hand over the manuscript at last. 
The attached manuscript (Section 4) may appear to be disappointingly bland. Clear 
guidelines are given to authors on the page layout and text style to be adopted! For 
ease of processing, highlighting and emphasis must be kept to a minimum and all 
laying out of the text is left to the publisher's design department. As the book develops, 
the authors' suggestions are taken into account and the production of the book is very 
much seen as a collaborative venture between the authors and the publisher. 
In early conversations with the publisher we had arranged to use the photographs that 
had been used in our previous textbook, 'Orthopaedic Medicine: a Practical Approach', 
to illustrate the techniques in the new text. ext. Rechniques had been included in 
the new book and an evaluation of the original textbook had demonstrated the need for 
supplementary photographs. 
We had worked with the pharmaceutical company 'Pfizer" in the past, to produce a 
small handbook on commonly used techniques for distribution to general practitioners. 
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A selection of the existing photographs had been used but using the considerable 
expertise within the design department appointed by the drug company, that had 
produced computer enhanced interpretive photographs and diagrams that were to a 
high specification in terms of quality and clarity in presenting the key points of the 
injections. We were aware that the original booklet was no longer in print but decided 
to ask the company if they would be prepared to sponsor our new publication through 
their educational grants, to enable us to tap into that expertise once more. Having 
submitted the manuscript, the preparation of the photographs and illustrations was the 
next important task towards publishing the book, and the draft page layouts would be 
delayed until that task was completed. 
Using the contacts established previously we arranged a meeting between the 
marketing department of the pharmaceutical company, the publisher and ourselves as 
the authors, and met at Pfizer's headquarters in Kent, where the initial meeting was 
very positive in the support and resources that would be offered. We were aware of 
the existing projects underway at Pfizer's in promoting new products and were 
prepared to wait for a final decision. However, a month or two passed when we were 
reluctant to apply inappropriate pressure for fear of forcing a refusal. Having tentatively 
arranged a follow up meeting, we were delighted to have the original offer confirmed, 
with the additional offer of sponsorship for colour in the book plus a sophisticated 'wiro' 
binding that will allow the book to open flat on a desk top, so enhancing its usefulness 
as a training guide in clinical practice. 
A date has been arranged for a completely new set of photographs to be taken that will 
be incorporated in the new textbook alongside interpretive drawings. My regret is that, 
with the production of the book being delayed in this way, I shall be unable to include 
some of the initial page proofs within this project presentation, that would have 
provided a further glimpse of the layout planning stage of the book towards its 
publication. An original draft of a proposed cover of the book is attached as a cover to 
the manuscript in Section 2, although this will be modified in terms of colours and 
layout in line with further discussions. 
LEVEL 5 DESCRIPTORS 
Cognitive 
The textbook itself isf is ion of my depth of knowledge of an inter-disciplinary 
nature and it is underpinned by recent research that required understanding of 
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research in its analysis, evaluation and synthesis into the text. Although the textbook is 
not exclusively intended for physiotherapists, its opening chapters required evaluation 
of gaps in undergraduate training of physiotherapists in related subject areas, 
particularly pharmacology, and the identification of knowledge that is needed to be able 
to develop safe and effective practice of injection therapy. The reporting of others' 
work is explicit in supporting the text with relevant references. 
Transferable skills 
The textbook was created to develop and improve practice skills in injection therapy. 
Reflection on my own practice and my collaborative authors' practice contributed to the 
text especially in the questions addressed towards increased understanding of the 
theory underpinning injection therapy and the facilitation of the application of the 
specific techniques. Autonomous study and working was essential towards the 
completion of the text whilst contributing to the author 'team' in the identification of 
problems and queries and the generation of solutions. Such problems arose within the 
creation of the content of the text but also in the process of developing a text for 
publication and the attendant problems accompanying that process. Throughout the 
development of the text ideas were presented and reviewed by SOM colleagues and 
student groups on the Society's Membership course modules, that supported the 
refinement of content and the style of presentation. Full use of critical communities 
was made in this way. The textbook will also be submitted for peer review following its 
publication. 
Operational context 
The production of this text was highly specialised in its subject area of musculoskeletal 
injections, and as innovative practice within physiotherapy it was a complex process to 
melt the demands of the medical and physiotherapy professions towards the creation 
of a comprehensive and useful text to both professions. 
I was aware of the contexts of this specific component of the project and also aware of 
its stakeholders, namely: 
• my co-authors as part of the collaborative team 
• students and readers of the text, from both the medical and physiotherapy 
professions, with an interest in developing their injection therapy skills 
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• injection therapy module leaders (not only the module leader of the SOM's 
module), as a core reader for the module 
• the SOM in support of its injection therapy module 
• orthopaedic medicine as a specialism 
• the medical and physiotherapy professions in support of this skill specialism. 
I was aware of my responsibilities to each of the stakeholders mentioned and shared 
autonomy in the textbook's production as part of the author team. The publisher also 
supported that autonomy wholeheartedly. Understanding of ethical principles 
underpinned the production of the text and the ethical boundaries of medicine and 
physiotherapy were respected, particularly with reference to prescribing issues and 
interprofessional communication. 
INVESTIGATION 
A copy of the paper drawn from the investigation and submitted for publication is 
included as Section 5 of this project presentation. 
1 deliberately took on the challenge to develop the injection therapy module because of 
my own personal experiences that had, on the whole, been negative with respect to my 
being able to successfully implement and develop my injection therapy skills. Since I 
had been teaching the theory and demonstrating the practice of injection therapy for 
over twelve years, it should have been a 'short hop* for me to be able to integrate and 
develop those skills within my own clinical practice. That was not the case, and it was 
my personal reflections that led me to identify the barriers, as I perceived them and that 
led me to investigate whether my experiences had common threads with the 
experiences of other physiotherapists. 
As I mention in the introduction to my paper, in common with other treatment 
techniques, competence does not necessarily imply confidence. The physiotherapist 
may not feel confident to administer injections, especially with the potential threat of the 
emergency situation of anaphylactic shock (a severe allergic reaction that could be 
fatal in outcome), or introduction of sepsis via this invasive technique. Potential 
problems could also exist with medical colleagues who might not support the 
physiotherapist in injecting their patients, their reasons including lack of confidence in 
the physiotherapist's abilities, particularly in coping with emergency procedures when 
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they have not had the expérience in professional practice, and threat to financial and 
professional monopoly. Without the prescription of drugs and supportive relationships 
with médical colleagues, physiotherapists would be barred from implementing their 
skills. My investigation started from a stance of curiosity, but then became most 
relevant in context of the potential for informing the development of an injection 
therapy module. 
I set out to investigate the facilitating factors and barriers to practice of physiotherapists 
in implementing their injection therapy skills. The paper is self explanatory in 
presenting the background, methodology and results of the investigation (Section 5). 
Political issues referred to earlier within this commentary, relating to physiotherapists 
injecting, are also expanded within the paper. 
My reflections on the performance of the investigation follow, and the reader is 
encouraged to consider them alongside the paper itself. 
In terms of those who volunteered to participate in the study there was a noticeable 
bias towards those who had successfully implemented their skills. On reflection, those 
physiotherapists who had been thwarted in this regard may have been less likely to 
respond, although this was not borne out totally by the sample. One participant had 
chosen not to develop her injection therapy skills in her clinical practice following 
qualification, and the other had been inhibited by local protocols that had debarred him 
from practising. The 'pilot' interviewée was selected on a 'first corne' basis in being the 
first subject to be interviewed having arranged interview dates at the convenience of 
the participants. 
I chose to visit the participants at their chosen venue, mainly to minimise any 
inconvenience on their part. Interviews were conducted in the interviewées' own 
homes, hospital departments or practices and I was fortunate in that, with considération 
for the variety of settings, ail of the interviews were conducted without interruption. I 
had set out to limit the interviews to one hour, to be mindful of taking the participants 
away from other commitments, but although this was adhered to, I was not aware of 
any time pressure and none of the interviewées put any pressure on me to finish 
through time constraints. 
I enjoyed the process of conducting the interviews. With the coopération of the 
interviewées, I was able to group the interviews broadly according to which area of the 
country they were based and I experienced a feeling of libération in pursuing my 
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interviewées through Kent, Leicestershire, Yorkshire, East Midlands and 
Worcestershire over three separate days. I have mentioned the variety of settings 
above and I was also delighted at the variety of clinical backgrounds of the 
interviewées, encompassing private, corporate and national health service practice, 
that gave a broad spectrum of expérience within the data collected. 
The interviews were unstructured but récurrent thèmes emerged in the direction that 
the conversations took, and I gradually became aware of this consistency as being 
derived from and pertinent to their expérience. I had mentioned to interviewées at the 
outset that I might be making notes, either to prompt me to explore avenues that were 
suggested within their conversation or to remind me of specific points that I would need 
for the purposes of triangulation, to be able to demonstrate the trustworthiness of my 
observations and conclusions. 
I believe I conducted the interviews fairly in only following those leads that were 
suggested within the conversation and also in picking up those eues to explore further 
avenues. In reading the literaturę I became a little confused with identifying the key 
points of linking the phenomenological approach with respect to the tenets of Husserl 
and Heidegger. Within my original proposai for my investigation I had noted the 
importance of bracketing my assumptions to avoid introducing bias into the interview 
on the basis of any preconeeived judgments I may have made from my existing 
expérience. I quoted Ashworth (1997) in that regard. However, an example of a 
debate underpinning my confusion appears in a response by Koch to Walters (1995) 
who pinpoints the distinctions between Husserlian and Heideggerian phenomenology. 
She describes that the 'notion of bracketing is central to Husserlian phenomenology' 
which is at odds with the phenomenology of Heidegger that would propound that 'the 
observer cannot separate themselves from the world' and that 'the interpreter inevitably 
brings certain background expectations and frames of meaning to bear in the act of 
understanding. These cannot be ignored, forgotten or bracketed'. I was certainly 
aware of my own assumptions prior to the start of the investigation, largely on the basis 
of my own expériences. 
The Module D of the Society's course was arranged over two weekends in the form of 
Modules D1 and D2. Within the intervening period of approximately four months there 
was a requirement for physiotherapists to undergo a period of clinical supervision, 
where ten speeified injections would need to be performed under clinical supervision. 
One of these would form the basis for the final case study assignment to be able to 
complète the assessment requirements of the module. In setting up the initial pilot 
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injection therapy module, the Society itself had set out to provide a network for support 
for students by compiling a director/ of medical practitioners who would be willing to 
provide supervisión in the inter-modular periods. 
I was fortúnate in that lan Davies, the Module D course principal, offered to support me 
through this phase and we arranged that I could visit him in his surgery where he would 
arrange for suitable patients to be 'clumped' together to allow me to perform the 
injections. This arrangement would consolídate and facilítate my clinical supervisión in 
that his surgery was based in Worksop, Nottinghamshire and I would be driving from 
my home in Woodford Green, Essex. It was very generous of him to provide the facility 
and to apportion time to the exercise that fell on his usual day off. 
We both noted a limitation of the arrangement in that the decisión to inject had arisen 
though his own clinical reasoning and in that sense, my role was rather that of 
technician in performing the injection. Also, he alone would be in the position to assess 
the outcome at follow up, since I would be far removed and the patients would return 
for their follow-up appointments on a less regulated basis. I performed seven injections 
on that day and was very grateful for the experience. I had not expected to feel so 
nervous before performing the injection. I fumbled ridiculously in gathering together the 
necessary items prior to performing the injection and felt 'cack handed' in assembling 
the syringe and needle. I had rehearsed the stages of the so-called 'no touch' or 
'aseptic' technique, to avoid introducing infection, several times before driving to 
Worksop - and had indeed taught it many times in the past - but nonetheless I faltered 
through the sequence when it carne to putting it into practice. 
I was aware of the possible side effects of injection, particularly noting the smaíl chance 
of anaphylactic shock, but felt totally secure in the environment in which I was 
performing the injections. In the event of such a happening, l would have been able to 
step back from the main responsibility, although being prepared to play a supportive 
role in the emergency procedures. This was another área that did not allow a role-play 
for, say, single-handed practice. 
Having completed my seven injections, I arranged to sit in with a local respected 
rheumatologist, who expressed delight at having an observer and was very keen to 
help with my progress through the module. He included me ed me assessment 
process and we discussed the cases ¡n terms of management. However, he 
apologised that he had no control over the conditions presenting themselves via GP 
referral to his clinic and in spite of several visits and being able to perform two or three 
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injections, they were not those required to complete my supervised 'set' and I was 
unable to complete the module. On reflection, I do believe that if I had been goíng 
through a relatively quiet period in terms of my activities both within my own practice 
and with the SOM, I would have travelled the length of the country to complete the set, 
and thus the module. 
I think that an added block to this was provided by the knowledge that within my local 
área there are medical practitioners who closely guard their right to inject and, although 
I have not so far put it to the test, I sense that there would be a resistance to my being 
able to develop my skills. The fact that physiotherapists are unable to prescribe is a 
bar to autonomy, and a major barrier to practice in that there is a reliance on the 
medical practitioner to prescribe the drugs required for injection. 
I would own to confidence issues within myself too. I enjoy the respect of my medical 
colleagues at a local level for the 'hands-on' work that I do, and I believe that I was 
resistant to not feeling totally 'at one' with a new skill, particularly with the knowledge of 
potential life-threatening consequences. I felt that I would find it hard to justify 
performing injections without medical support and back up, should 'the worst' happen. 
This was in spite of knowing the specific emergency routines to follow and being quite 
confident in the management of emergency procedures that 1 update on an annual 
basis. 
As part of my own continuing professional development plan, it is my intention to 
resurrect my interest in developing my skills of injection therapy after the completion of 
my doctórate, and I should anticípate that the expehence I have gained through 
completing my project will inform the process as I incorpórate the skills into my 
professional practice. 
As mentioned in the preceding paragraphs, I had encountered barriere to both training 
and practice. However, in relation to the interviews that I was proposing to conduct, I 
was also considering that facilitating factors might have been in place in allowing 
physiotherapists to apply their skills and I was not expecting other physiotherapists to 
duplícate my expehence as such. 
My recording equipment for the interviews was basic but effective and I heeded the 
advice of Easton et al (2000) to be aware of and to avoid common pitfalls in qualitative 
data coila collectil used a recorder that could be both battery and mains operated and 
carried spare batteries, as well as having a small hand held Dictaphone as a 'belt and 
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braces' back-up. I had originally considérée! the latter method as a first choice, since 
transcription would have been made easier with the use of a foot switch. However, 
when I had conducted a recording pilot using the Dictaphone, the recording was 
indistinct and several changes of tape would have been needed during each interview. 
No doubt more sophisticated Dictaphone equipment exists, but I did not have access to 
it. 
When it came to the point of transcribing the interviews I encountered several 
Problems. Initially I sought the help of my secretary to help with the task of 
transcribing. However, having checked the initial drafts it was clear that not only was a 
knowledge of the field necessary but I needed to be 'in touch' with the interviewée to be 
able to remind myself of the interview as a total expérience, and to check all those 
characteristics that are not identifiable in the written word: the laughter, pauses and 
inflections, that were particularly revealing of the physiotherapists' feelings and 
attitudes in their expérience and the gênerai atmosphère of the interview. When I then 
took the task over, I noted the 'ums' and ans' and rambling répétition that occurs in 
conversation, but I chose not to include that, since it appeared to be unnecessarily 
labour intensive and unwieldy, and not particularly helpful in enabling me to establish 
the trends necessary for the purposes of my study. Each transcript took between eight 
to ten hours to complète and although I had been forewarned of this by Bell (1993), it 
was nonetheless an unpleasant truism. 
The transcribing itself was interprétative, in that there was the décision at the outset of 
what to include and what to leave out. In performing the transcription myself it was 
helpful, and vital, to hear the tones and inflections and to annotate the typed transcript 
as a check that the actual meaning matched up with the interprétation of the written 
word. My own mutterings in steering the interview through were also very much part of 
the process and although they weren't included in the transcript, they should be 
acknowledged as an integral part of the conversations. I had made scant notes at the 
time of the interviews and thèse, with my personal reflections both at the time of the 
interview and afterwards also provided dues to support my impressions and 
subséquent interprinterpref the interview as a whole, in a form of triangulation to 
enhance the trustworthiness of the investigation. 
I found the interviews and préparation of the paper to be the most difficult component 
of the project. I conducted the interviews in November and December 2000, but, my 
attention was drawn to the préparation for the validation event for the MSc Orthopaedic 
Medicine at MU, to be held on 25January 2001, as well as to the revision of the 
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handbooks for the Society's Membership course that were needed for printing and 
distribution in the new year. I had already missed my intended January deadline for 
Submission of the paper when I began the earliest stages of interpreting the data in 
early February 2001. 
The professional peer reviewed journal I selected for submitting my paper is 
'Physiotherapy', the professional journal of the CSP that has a monthly circulation of 
35,000 worldwide. In accordance with the 'guidelines for authors' given within each 
issue, I had submitted a draft proposai and outline of my paper for considération by the 
journal's éditorial board. The response from the Scientific and Clinical Editor of 
'Physiotherapy' was most encouraging saying: 
7 think overall that it will make a most interesting contribution and as far as I am 
aware no-one has really looked at aspects of the introduction of a new 
technique in this way. ' 
However, at the same time I had feit a blow to my confidence in the methodological 
approach I had selected when she then went on to say: 
'From the perspective of whether your article will be publishable, rather than 
considering the value of your study per se I would suggest that you need to 
consider the number of informants involved. If your aim is to develop theory, 
i.e. to use a grounded theory approach, then you will need enough sources for 
your data to become saturated, and therefore enhance the dependability of any 
theoretical généralisations which you may be able to make as a resuit of your 
study. ' 
My study was based on phenomenology to explore the actual expérience of 
physiotherapists, but the implication was that I might be better to use a grounded 
theory approach in analysing the data, from which to produce theory and to develop 
insights to inform both injection therapy training programmes and the physiotherapy 
profession as a whole. At that stage, most of my background reading and groundwork 
towards my initial proposai had been concerned with phenomenology. I feit bleakly 
that I might have pursued a blind alley and was locked into the opinion of Wimpenny 
and Gass (2000) who explored the différences between the use of interviewing in 
phenomenology and grounded theory and noted that 'it is imperative that the means of 
collecting data should be.consistent with the underlying prescriptions of the specific 
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research approach selected' to avoid the 'muddling, slurring and blum'ng' of methods 
by combining éléments of each. 
I was reassured by the view of my adviser however, that the data I had collected could 
be a basis for différent interprétation using an alternative approach, as long as this was 
clarified at the outset. This could allow the préparation of a further paper that would 
develop the investigation still further in the manner suggested by the Scientific and 
Clinical Editor of 'Physiotherapy'. I decided to stay with my initial aims and viewed my 
investigation as the bottom step towards the génération of theory that could ultimately 
inform the profession on the facilitation of the intégration of this relatively new skill 
wtthin its scope of practice. 
I studied several textbooks as sources for ideas and approaches in data analysis with a 
particular focus on phenomenological data analysis. Miles and Huberman (1994) and 
Moustakas (1994) were particularly helpful, and Strauss and Corbin (1990), in 
presenting grounded theory procédures and techniques, enabled me to clarify my 
understanding of the important différences between the approaches. 
The actual writing of the paper presented a problem for me particularly in deciding what 
was essential to include by way of background information to contextualise the study. 
Finlay (1999) is adamant that 'phenomenology is committed to describing, not 
explaining, how and why meanings arise'. In describing catégories identified from the 
transcriptions and my recollections, I found it difficult to décide on the boundary 
between enough évidence in the form of quotation, and too much. Tarling and Crofts 
(1998) advise against looking for 'quotability' in the text and choosing the best quotes 
to illustrate the thème, suggesting that this might lead to an approach of making the 
data fit the quote. They suggest that it is better to choose the quote after 
catégorisation to avoid this, but I still encountered the problem in spite of heeding the 
advice. 
Finlay (1999) provides a further useful insight into the approach: 
'Phenomenological analysis remains both a logical procédure and an exercise 
in creativity where the researcher is simultaneously involved and analytically 
distant. The analysis is both intuitive and systematic; simultaneously subjective 
and objective. ' 
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The balance between being 'involved and distant' was also difficult to achieve, 
especially with référence to the debate between the Husserlian and Heideggerian 
interprétations of phenomenology as discussed above. 
I was excited by my findings and wanted to be able to présent the data in a style that 
was both interesting and relevant to practice. My initial drafts were at least 2,000 
words over the suggested limit of 4,000 for a research article and I reached an 'author's 
block* where I was unable to see where the paper could be edited without détriment to 
the central thèmes of the investigation and the overall structure. I was aware that input 
from my consultant would provide a jolt out of my inertia and so put the work aside to 
await his return from extended trans-global travel, whilst concentrating on the 
préparation of the required 'wrap around' reflective commentary. 
Interestingly, I had been working to the guidelines Writing for "Physiotherapy" 
published in the journal dated June 2000, that had stated the word limit for a research 
article as 4,000. In reading a later journal, December 2000, I skimmed the guidelines 
included in that issue and, with some relief, noticed that the word limit had been raised 
to 6,000 for a research article. I did review the article several times more to be more 
succinct in my literary style, but the 'goal posts' had nonetheless been moved in my 
favour. 
My consultante comments on his retum were as expected in being insightful and 
direct. I was as appréciative of his 'pedantic' (his word) literary and grammatical 
Otterings as I was of his comments that addressed the broader issues of my paper. I 
was inspired to complète the paper (Section 5) and it was submitted to 'Physiotherapy' 
on 3 April 2001 for peer review and considération for publication. An 
acknowledgement of its receipt was received on 7 April 2001, that is included for 
completeness at the end of Section 5. 
LEVEL 5 DESCRIPTORS 
Cognitive 
This component of the project relied on great depth of knowledge of the development 
of injection therapy as innovative practice and its relationship to physiotherapy and 
medicine. The investigation of the expérience of physiotherapists in implementing their 
injection therapy skills was a novel area for research and the methodological 
approaches adopted required review and refinement towards understanding and 
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implementation for the purposes of the research. The research area was complex and 
I believe that the investigation demonstrated that complexity and my ability to analyse 
and synthesise information in establishing the current status, as an initial step towards 
the génération of theory to inform injection training programmes. The investigation 
report provides évidence of my ability to evaluate the information obtained, with 
référence to the work of others. 
Transferable skills 
The investigation evolved through reflection on my own practice and relied on 
participants' reflection on their own expérience as a step towards establishing theory as 
a basis for training programmes in injection therapy. The interviews conducted 
demanded simultaneous analysis of other's self-appraisal and reflexive inquiry to lead 
towards improvement and refinement of training. 
The literature searches and conversations with colleagues to establish the background 
for the study were conducted with füll autonomy. I was fully aware of the political 
implications of the study in relation to the médical and physiotherapy professions and 
the ethical principles and boundaries of each. My reflection on the process of 
performing the investigation within this section has identified challenges I faced and my 
ability to isolate, assess and résolve problems has been demonstrated. 
The nature of the investigation relied on my ability to communicate effectively with 
participants and I believe that that communication was effective for the purposes of the 
study. Through the investigation I was able to demonstrate effective sélection, 
combination and use of research methods with füll appréciation of the limitations and 
possibilities of the methods adopted for my investigation towards the trustworthiness of 
the study. 
Operational context 
The expérience of physiotherapists in implementing their injection therapy skills was a 
new area of study and injection therapy is an extension of scope of practice into the 
domain of traditional médical practice. An awareness of the interdisciplinary 
relationship was necessary with understanding of the issues relating to the différent 
approaches to treatment and communication between the disciplines. 
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The research was conducted with awareness of ethical dilemmas particularly relating to 
ethical physiotherapy practice and prescribing issues in the implementation of injection 
therapy skills. Within the study l believe that I demonstrated a high level of 
responsibility for the participants who contributed to the study and for myself in 
conducting the investigation with autonomy but with full use and acknowledgement of 
the support ofothers, including my professional body. 
COMMENTARY 
As stated, my overall aim for the project was to develop and support the injection 
therapy module, and my objectives will be achieved through its successful launch and 
ongoing development. 
The project has internal cohérence but also forms a component of my whole doctoral 
programme. I have been involved at each step of the process towards the attainment 
of accredited and validated status for the Society's Membership course. My project, 
and the doctoral programme within which it sits, aims to be a cohérent démonstration 
of my abilities to opérate in satisfaction of the Level 5 descriptors in overseeing that 
process, and ultimately my authority as an orthopaedic medicine educator. 
To be able to consider myself as an authority in orthopaedic medicine I believe that it 
has been necessary for me to reflect on my past learning, as a step towards the 
achievement of learning to support me within that role. The project has allowed me to 
demónstrate that authority in that I have demonstrated knowledge of the tenets of 
orthopaedic medicine as embedded in my career in éducation, itself aligned within the 
SOM and the developments of its educational aims from hereon. 
Other modules are, or have been, in existence, but I have striven to take an holistic 
viewpoint of the module linking quality of présentation tightly to content and 
investigating potential barriers and facilitating factors to physiotherapists implementing 
their injection therapy skills, as a step towards informing training courses of stratégies 
to minimize the former and to exploit the latter. In this I have demonstrated my ability 
to analyse the complexities of the module that are covertly affecting its administration, 
to eventually be able to construct new approaches to module delivery. 
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In taking into account the opinions and criticism of the module I have demonstrated my 
ability to synthesise information and ideas towards the development of the injection 
therapy module that will be measured by future évaluations of the module as it 
continues within the MSc Orthopaedic Mediane framework. 
I am keen to absorb the feedback of my peers towards the development of the module 
and, importantly, towards my own personal and professional development. I have 
expounded on the political implications of the project through the évidence I have 
provided, and have embedded the project firmly in a variety of contexts. 
Throughout the planning stage of both the master's programme and the injection 
therapy module within that, there has been a chain of problems to solve in terms of the 
module's design and its supporting documentation. Deadlines have been the driver in 
forcing responses to the challenges set and solutions have been drawn from the 
depths of creativity both within myself and those colleagues that I have recruited to 
assist in this endeavour. 
The 'roundness' of my achievement I do believe has been through my ability to 
communicate with my peers and those that I have needed to call on for support to be 
able to move the development of the project on. I have been mindful of the research 
questions to pursue in support of the projects aims and have been careful to conduct 
that research ethically and with a focus on the trustworthiness of the data accumulated. 
I have been excited by the challenges presented by the research process and the new 
questions that have emerged. 
As a 'fiele! worker" within orthopaedic medicine with over 25 years' expérience I have 
had the opportunity to live through the change from prescriptive physiotherapy to that 
of autonomous practice and that has informed me of the political and professional 
contexts of injection therapy. The relationship between the médical and paramédical 
professions can be construetive and supportive but simultaneously fragile and 
vulnerable. The boundaries between professions have tended to become blurred and 
to explore those boundaries through extended practice can be a threat to the adjacent 
professions. An awareness and understanding of interdiseiplinary approaches is 
paramount in the promotion and development of interdiseiplinary professional practice 
towards enhanced patie patient mnt. 
I have been aware of my responsibility to all stakeholders in the development of the 
Society's injection therapy module. The Society itself, MU, the injection module 
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leader, the MSc Orthopaedic Medicine student (and the student of the module as a 
stand-alone module), medical and paramedical colleagues, colleagues in the 
orthopaedic medicine approach, the profession of physiotherapy and the patient, have 
all needed to be considered within my realm of responsibility. I have been mindful of 
their presence whilst supporting the autonomy of my profession linked to the 
development of an injection therapy module. 
I am aware of the ethical dilemmas that were likely to arise in my research and within 
my professional practice in relation to injection therapy, and was aware of the support 
of my professional body and peers should any unethical practice become apparent. 
My plans for my future role in orthopaedic medicine education would be to continue to 
collaborate as part of the SOM's education committee to be able to continue to develop 
and support the Society's courses and educational aims. The MSc Orthopaedic 
Medicine will form a significant component of that commitment over the next few years 
and, in terms of the project, the injection therapy model will also be a prime focus for 
evaluation and continued development. 
Several higher education establishments have expressed an interest in incorporating 
the Society's Membership course and injection therapy module into their existing post­
graduate programmes and I hope to have a significant role in forging additional 
partnerships for the Society. 
I believe that the tenets of orthopaedic medicine should be more strongly integrated 
into undergraduate education in the management of musculoskeletal lesions, and that 
is another area that I intend to explore in the future for the continued development and 
dissemination of the specialism of orthopaedic medicine. 
CONCLUSION 
The aim of my project was to develop and support an injection therapy module, 
specifically as an option module as part of the MSc Orthopaedic Medicine programme 
in the School of HeBES at Middlesex University. Within that context, this commentary 
has set out to reflect on the process of completing the three component parts of the 
project. Whilst this reflection has addressed each component separately, it has been 
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made explicit that the components were worked on simultaneously and each informed 
the other in the development of a cohérent project towards the satisfaction of my aim. 
I have been mindful of the Level 5 descripteurs throughout my entire doctoral 
programme and have endeavoured to demonstrate the capabilities that I possess in 
respect of the leaming outeomes as specified. I have demonstrated my knowledge 
within my research area, my ability to conduct research within a selected area of 
interest with justification for my chosen methodology, and then to analyse and discuss 
the data obtained. Within the pursuit of my project aim, I have encountered a variety of 
Problems and hurdles that have required the development of my skills in évaluation 
towards the génération of solutions to overcome obstacles, against a background of 
persévérance. The implementation of the stratégies so constructed has required the 
use of effective communication skills to be able to move the project forwards and thus 
achieve my aim. 
Injection therapy is innovative practice within the realm of physiotherapy and I have 
needed to be mindful of my own responsibilities and those of the Society in developing 
the injection therapy module. I have paid particular attention to professional ethics in 
moving the whole profession forwards to be able to integrate this new skill into its 
scope of practice, and also to the interdisciplinary issues as part of that process. 
I believe that the pursuit and completion of my project has enabled me to feel 
entrenched in the development of the injection therapy module, and to dérive fresh 
insights for taking that development on in relation to the module itself and its position 
within the MSc Orthopaedic Medicine programme. The project has allowed me to 
exercise autonomy in developing the module but with due récognition for the 
responsibility I hold in context of the students, the module's development team and the 
SOM itself, and in the wider scheme of the profession of physiotherapy and 
interdisciplinary relationships. The completion of my project has satisfied both my 
professional and personal interests, particularly in relation to my émergence as an 
authority in orthopaedic medicine éducation and to my commitment to the 
dissémination and continuing development of the specialism of orthopaedic medicine. 
Elaine Atkins MA MCSP 
20 April 2001 
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SECTION 2 
Appendix 1 
LEVEL 5 DESCRIPTORS 
Cognitive 
Knowledge: Evidence that the candidate has great depth of knowledge of 
an inter-disciplinary nature in a complex area and is working 
at current limits of theoretical and/or research understanding. 
Analysis: Can deal with complexity, lacunae and/or contradictions in 
the knowledge base and make confident sélection of tools for 
the job. 
Synthesis: Can autonomously synthesise information/ideas and create 
responses to problems that expand or redefine existing 
knowledge; can develop new approaches in new situations, 
through adding a new dimension to existing understanding or 
predicting an outcome that can be verified. 
Evaluation: Can independently evaluate/argue a position concerning 
alternative approaches; can accurately assess/report on own 
and others' work; can justify évaluations as constituting 
bases for improvement in practice. 
Transferable skills 
Self appraisal/reflection on 
practice: 
Evidence that the candidate has worked with 'critical 
communities' through whom a new or modified paradigm is 
being established. Habitually reflects on own and others' 
practice so that seif appraisal and reflexive inquiry become 
intertwined, thereby improving the candidate's own and 
others' action. 
Planning/management of 
learning: 
Is autonomous in study and use of resources; makes 
professional use of others in support of seif directed learning 
and is fully aware of the implications of the study. 
Problem solving: Can isolate, assess, and résolve problems of all degrees of 
predictability in an autonomous manner in work situations; 
can tackle unpredictable problems in novel ways 
Communication/présentation: Can engage in füll professional and académie 
communication with others in theirfield and place of work: 
can give papers/presentations to 'critical communities' for 
developmental purposes. 
Research capability: Can demonstrate effective sélection, combination and use of 
research methods; can show füll appréciation of their 
limitations and possibilities in achieving objectivity, reliability 
and validity appropriate to the area and.subject of study in 
the work situation; can contribute to the development of 
applied research methodology. 
Operational context 
Context: Complex, unpredictable, specialised work contexts requiring 
innovative study, which will involve exploring current limits of 
knowledge and, in particular, interdiseiplinary approaches 
and understanding. 
Responsibility: Autonomy within bounds of professional practice with high 
level of responsibility for self and others. 
Ethical understanding: Awareness of ethical dilemmas likely to arise in research, 
professional practice and work situations, ability to formulate 
solutions in dialogue with supehors, peers, clients, mentors 
and others. 
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BACKGROUND TO THE SOCIETY OF ORTHOPAEDIC MEDICINE 
Orthopaedic medicine is the examination, diagnosis and non-surgical treatment of disorders of 
the musculoskeletal system. The Society of Orthopaedic Medicine (SOM) is an organisation of 
medical practitioners and physiotherapists, established to promote the theory and practice of 
orthopaedic medicine. Courses in orthopaedic medicine contribute to the post-graduate 
education programme in both medicine and physiotherapy, and are run throughout the year at 
different venues both nationally and internationally. 
Orthopaedic medicine itself began in 1929 through the work of Dr James Cyriax at St Thomas' 
Hospital, London, and the Society was formed in 1979 to develop his philosophy. Charitable 
status has since been achieved by the Society. 
The Society continues to run courses, both nationally and internationally with a team of 
experienced teachers. Medical practitioners and physiotherapists come together to learn this 
approach and the Society continues to grow with a constantly increasing demand for courses. 
In 2000, 33 course modules were arranged, attended by 900 students, and the Society had over 
2,000 members. 
Since Dr Cyriax formulated the approach, it has undergone continual development and 
reappraisal in the light of current research. 
An academic journal is produced three times a year in conjunction with the British Institute of 
Musculoskeletal Medicine, the American Association of Orthopaedic Medicine and the Irish 
Society of Orthopaedic Medicine, and a Symposium and Conference are organised annually. 
These enable past students to maintain contact with the Society, so facilitating on-going 
education and communication. 
The course leading to full membership of the SOM achieved accreditation by the Joint 
Accreditation Panel of the Chartered Society of Physiotherapy and the University of Greenwich 
for 40 points at Level 3 in its PACE (Physiotherapy Access to Continuing Education) Scheme, 
which was based on the national Credit Accumulation and Transfer Scheme (CATS). In the 
light of changes within the 'PACE' scheme, courses were encouraged to explore partnerships 
with higher education institutions. The University of Greenwich reviewed the SOM Membership 
course in summer 1998, with an additional Injection Module for physiotherapists, and each was 
accredited at Level 3 being awarded 40 points and 10 points respectively. Also at this time, 
Leeds Metropolitan University took the Membership course as part of its MSc programme The 
Healthy Athlete', awarding it 15 points at masters level as part of that programme. 
In 2000 the course was developed and accredited by Middlesex University for 60 credits at 
Level 4/master's level. In January 2001, an MSC Orthopaedic Medicine programme was 
validated by Middlesex University with the SOM Membership course in its accredited form as 
the pre-requisite for entry to the programme. 
COURSE STRUCTURE 
The course is arranged in three modules: -
Module A - Cervical spine and upper limb 
Module B - Lumbar spine and lower limb 
Module C - Thoracic spine and Sacro-lliac joint. Revision of Modules A and B. 
Advanced techniques for the lumbar and cervical spine and less 
common neuromusculoskeletal conditions. 
Modules A and B can be attended in either order but must be completed before attending 
Module C. 
Modules A and B consist of 26 hours and Module C of 28 hours tuition each taking place over 
four days. The whole course will normally be completed between 12 and 24 months. 
COURSE PROGRAMME ORGANISATION 
The Education Committee of the SOM is a sub-committee of the main SOM Council and 
consists of the active Course Principals (see below). SOM teachers, or Fellows, may be 
medical practitioners or physiotherapists and each has completed the SOM's Fellowship 
Training Course proving competence in teaching orthopaedic medicine. 
The Education Committee forms the development and management team for the SOM course 
and is concerned with all the affairs of education in the Society. It reports to the SOM Council at 
each Council Meeting. 
An official Administrator has been appointed by the Society, who liaises with the Chair of the 
Education Committee who, through the Education Committee and the SOM Council bears 
responsibility for the annual course schedule, course module programmes, liaison with local 
organisers, appointing the teaching team for each course module and assimilating resources. 
The SOM runs a three-module course and the courses are run as satellite courses at a variety 
of venues and with a variety of course personnel. 
The Society is a limited company and a registered charity (Ch no 802164), and produces annual 
audited accounts. The Society Account finances the provision of resources and reimburses all 
expenses incurred. Research grants are available for suitable projects on application to the 
Society's appointed Research Officer. Funds are accrued through the provision of courses, 
membership fees and the Annual Symposium (shared with the British Institute of 
Musculoskeletal Medicine (BIMM), an organisation of medical practitioners with a special 
interest in musculoskeletal medicine). A copy of the most recent Accounts is obtainable from 
the Honorary Treasurer of the Society. 
The Education Committee supervises the continuous assessment procedure for the course. It 
meets twice a year as well as holding an annual review meeting in November, dedicated to 
educational policy. 
STAFFING 
There are 30 active teachers, or Fellows, in the Society and each has passed the Fellowship 
Examination to demonstrate competence in teaching the tenets of orthopaedic medicine. 
Several teachers have completed master's level courses, and have also attended educational 
courses independently to achieve an awareness of current educational theory, particularly with 
regard to a student centred approach to teaching and learning. 
One Course Principal has achieved a Certificate of Education and another has completed a 
Masters Degree in Post-Compulsory Education and Training. Her dissertation investigated the 
introduction of a student centred approach into the SOM course. 
The Education Committee actively encourages development in teaching and assessment 
methods and teachers are strongly recommended to achieve the City and Guilds Teaching 
Certificate in Adult and Further Education, (Course 7307) Stage 1, as a basic teaching 
qualification. 
STUDENTS 
The course is open to qualified medical practitioners and chartered physiotherapists, or those 
holding a qualification recognised by the Chartered Society of Physiotherapy, regardless of 
gender, age, disability or ethnic background. Previous experience in orthopaedic medicine is 
not essential and, for physiotherapists, there is no requirement for previous attendance at 
courses in manual therapy. It is recommended that students should preferably be working with 
musculoskeletal lesions during the intermodular learning period. No other criteria have been set 
in terms of current work placement since for some jobs in manual therapy, it is a pre-requisite 
that the physiotherapist has attended a SOM course. 
The most important requirement is an enthusiasm and commitment to orthopaedic medicine 
within the learning group. The course is designed to encourage and foster this interest. 
The SOM supports its students in on-going education and communication by providing the 
following: 
• A Membership List that is regionalised to offer students the support of other members of the 
SOM in their area 
• Access to a centralised collection of relevant papers, held by the SOM Course Organiser, 
and information relevant to orthopaedic medicine 
• A Journal of Orthopaedic Medicine (produced jointly with the British Institute of 
Musculoskeletal Medicine and the American Association of Orthopaedic Medicine) 
• Grants for research, available at the discretion of the SOM Council following the 
consideration of a written request detailing the focus of the study. Students awarded grants 
are expected to publish the results of their research in the Society's Journal, and to make 
the results available to other students and teachers of orthopaedic medicine. 
• An Annual conference with selected speakers, but with a focus on problem solving in an 
atmosphere of shared experience 
• An Annual Symposium, together with the British Institute of Musculoskeletal Medicine 
• Local group meetings with a specific interest in orthopaedic medicine through the specific 
interest group ACPOM (Association of Chartered Physiotherapists in Orthopaedic Medicine) 
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Source: 
WCPT (1995) Declarations of Principle and Position Statements. WCPT London 
Declarations of Principle 
EDUCATION 
Physiotherapy education is a continuum of learning beginning with admission to an 
accredited physical therapy school and ending with retirement from active practice. 
1. The goal of physical therapy education is the continuing development of 
physical therapists who are entitled, consistent with their education, to practice 
the profession without limitation. 
2. The curricula for physical therapy education should be relevant to the health 
and social needs of the relevant nation. 
3. The term 'accredited' is used in relation to physical therapy education to 
describe a programme which is regularly evaluated according to established 
educational standards. 
4. The first professional qualification should represent completion of a curriculum 
that qualifies the physical therapist for practice as an independent 
professional. 
5. An integral component of the curriculum for the first professional qualification 
is direct clinical experience under the supervision of appropriately qualified 
physical therapists. Clinical education will involve gradual access to 
responsibility as skill and experience grow. 
6. Life-long learning and professional development is the hallmark of a 
competent physical therapist, participation in continuing education contributing 
to the development and maintenance of quality practice. 
7. Physical therapists should be encouraged to undertake post-graduate 
education in physical therapy or related fields for advanced professional 
development. 
8. Physical therapists should be encouraged to undertake post-basic education 
in scientific methodology in order to contribute to a critical and researched-
based professional approach that may extend into daily practice. 
9. Basic physical therapy education should be conducted by physiotherapist (sic) 
teachers able to transfer knowledge and skills for the critical analysis of 
theories and methods of physical therapy. 
10. Where national physical therapy associations have adopted specialisation, the 
process of becoming recognised as a specialist should meet the academic 
and practice rigours of such a qualification. 
11.The goals, content, format and évaluation of the éducation programmes 
provided for physical therapists are the responsibility of the faculty but should 
involve the active participation of the national physical therapy association. 
(Approved at the 13th General Meeting of WCPT, June 1995) 
SPECIALISATION - Définitions and Guidelines 
1 Physical therapy spécialisation is the application of advanced clinical 
compétence by a physical therapist qualified in a defined area of practice 
within the field of activity recognised as physical therapy. 
2 Advanced clinical compétence is the démonstration of knowledge and 
skills beyond those required for entry to basic professional practice. 
3 A physical speciality is a prescribed area of physical therapy practice 
formally recognised by a Member Organisation within which it is possible 
for a physical therapist to develop and demonstrate higher levels of 
knowledge and skills. Spécialisation is not to be considered or implied to 
mean a limitation or restriction of practice. The field of activity recognised 
as physical therapy will remain open to ail appropriately qualified physical 
therapists both specialist and non-specialist practitioners working within 
their respective levels of compétence. 
4 A physical therapy specialist is a physical therapist who can demonstrate 
advanced clinical compétence in a physical therapy speciality by satisfying 
the requirements of suitable procédures for the formai récognition of 
his/her knowledge and skills by a member organisation or its accredited 
agent. 
5 The qualification of a physical therapy specialist will include a formai 
process for testing and acknowledging the appropriate advanced clinical 
knowledge and skills of the speciality. It is expected that the formai 
process will be fully documented. 
(Approved at the 13m General Meeting of WCPT, June 1995) 
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EXTRACT: 'Review of Previous Learning' Jan 2000 
THE SOCIETY OF ORTHOPAEDIC MEDICINE EDUCATION COMMITTEE 
The Education Committee of the SOM is a sub-committee of its main Council and, at 
the time of my appointment, it consisted of seven members, each of whom was an 
active teacher on the Society's educational course. The Education Committee is 
concerned with all the affairs of éducation in the Society but is answerable to Council, 
to which it must report at each Council Meeting. 
In the early nineties, the notion of continuing professional development was beginning 
to be formalised across the professions. The Chartered Society of Physiotherapy, the 
professional body of physiotherapy, was proactive in this process and, in partnership 
with the University of Greenwich, introduced a scheme entitled Physiotherapy Access 
to Continuing Education (PACE), which conformed to the existing national Credit 
Accumulation and Transfer Scheme (CATS). Physiotherapy is now an all gradúate 
profession, but originally the qualification was that of Diploma of the Chartered Society 
of Physiotherapy, with the transition of training courses to degree status being dräven 
through in the latter eighties. Apart from providing a System for accréditation of post-
graduate courses as a form of 'quality control', 'PACE' was also conceived to enable 
those physiotherapists who had qualified by diploma to Upgrade their qualification to a 
degree. Post-graduate course teams were invited to présent their courses for 
accréditation by the Joint Panel of the Chartered Society of Physiotherapy and the 
University of Greenwich. 
The course leading to füll membership of the SOM was originally presented to the Joint 
Panel for considération in 1991. I was part of the sub-group of three of the Education 
Committee that had been given responsibility for preparing the course documentation 
and being part of the team representing the SOM's educational course at the Chartered 
Society of Physiotherapy. The course was initiaily criticised for its mainly didactic style 
of teaching. It was true at the time that the course was mainly organised on the basis 
of transmission of knowledge from the teacher as 'expert' to the Student as 'novice', 
with the lectures being typically the main method of teaching and with comparatively 
little récognition of the leaming needs of the individual. 
There were several specific points within the documentation that were faulty in not 
giving sufficient information. The assessment procédures, being summative with tutor 
assessment only, did not conform to current educational theory and provided little 
formative information on Student progress. Certainly there was no self or peer 
component to the assessment procédures as well as being no démonstration of 
progression through the three modular course. 
With expérience and hindsight, I am able to reflect on the deficiencies and 
shortcomings of the course as they were given to us at the time. However, with the 
reminder that we were mainly clinically based physiotherapists with scant knowledge of 
educational theory, our reaction to the criticism was déjection and frustration at our 
ignorance. In spite of patient efforts made by the Chartered Society of Physiotherapy 
team to explain measures towards a more Student centred approach in the course, we 
simply did not have the background or expérience to get past the 'jargon', as we 
perceived it at the time. 
Having contacted the teams of other post-graduate courses that had been similarly 
rejected, there appeared to be a move to pay educationalists to 'tweak' the 
documentation and to advise on the implementation of changes suggested towards 
making courses more student-centred in their approach. The mood of the SOM 
however, was that we should take steps within our own body to drive the project 
through on a sound educational basis which we could ail understand. My colleague, 
the Society's Course Organiser, and I, with the support of Council, chose to be the 
prime movers in the latter task. Having sought advice on how we could make a start in 
gaining knowledge and expérience in teaching theory and practice, we were guided by 
the Chartered Society of Physiotherapy's Education Officer to attend the City and 
Guilds 7307 course towards gaining a Teaching Certificate in Adult and Further 
Education. 
CITY AND GUILDS 7307 - TEACHING CERTIFICATE IN ADULT AND 
FURTHER EDUCATION 
I completed the City and Guilds 7307 Course, Stages 1 and 2, through attendance at 
my local collège of further éducation, to gain the teaching certificate mentioned above. 
I found the expérience very rewarding in that the assignments were based on the 
Society of Orthopaedic Medicine course, and so were most pertinent, and the content 
and approach of the course gave valuable insights into educational theory. As a direct 
resuit of attending the course I was able to work with my colleague, who had also 
gained the certificate, to begin to implement a Student centred approach in the 
Society's course. In contrast to the didactic approach, I now understood that a student 
centred approach recognises the thoughts and feelings of the individual and includes 
them in the educational process. Carl Rogers (1902-87), a psychologist of the so-
called humanistic school, originated the terms 'active' or 'participatory' learning and I 
became interested in his ideas on éducation, which largely underpin the student 
centred approach. I appreciated that a key change was needed in the ethos of the 
Society's course to transfer responsibility for learning much more towards the student, 
with the teacher becoming more of a 'facilitator' in the learning process. As mentioned 
in my introduction to the review, I particularly identified with the notion that the student 
learns how to learn, with the implication that the process is ongoing (Rogers, 1983). 
I experienced a huge gain in confidence in using teaching methods and activities and 
devising assessment stratégies after attending the 7307' course. My colleague and I 
were able to collaborate on both the course design and documentation to implement 
the necessary changes towards gaining accréditation, and reported to the Education 
Committee to work closely as a team in this endeavour. 
In introducing a student centred approach in the SOM course it was necessary to 
explain the need for change and the essence of the changes to the 29 active teaching 
Fellows in the SOM's teaching body. A Teachers' Study Day was arranged which was 
attended by 25 teachers. I had had considerable expérience in managing change in 
my previous role as Physiotherapy Manager and in the running of my own practice and 
was prepared for some résistance since it was important to implement the changes 
fairly quickly, to be able to présent the course for accréditation by the looming target 
date. The structure of the day had been deliberately designed to be largely student 
centred in itself with respect to activities, assessment, feedback and évaluation. There 
was indeed massive résistance, with many of the more established teachers exhibiting 
dissension and opposition, and some owning to a feeling of threat. 
In the meantime, I was appointed to act as a Course Principal on the SOM courses, i.e. 
to be responsible for the organisation of the component modules, overseeing the 
management of the course programme, teaching team, the tutor groups, audio visual 
aids, course évaluation etc. At this stage the major implementation of a student 
centred approach was taking place with the introduction of a professional diary, inter-
modular case studies and a continuous assessment scheme that included éléments of 
self and peer assessment. 
The new thrust of the course was that 'the synthesis of thèse ( Le. the course 
objectives) will promote a reflective approach to problem solving in orthopaedic 
medicine, in line with current educational theory ' (Kolb 1984, Schon, 1983). 
The course was officially submitted for accréditation in 1994 and was awarded 40 
points at Level 3. I was one of two Education Committee members appointed to attend 
the Accréditation Meeting and admit to a feeling of triumph at playing such a major role 
in the development of the course and the préparation of its documentation. 
Références 
Kolb, D.A. (1984) Experiential Learning: Expérience as the Source of Learning and 
Development. New Jersey, Prentice Hall. 
Rogers, C. (1983) Freedom to Learn for the 80's. Ohio, Bell and Howell and Company. 
Schon, D.A.(1983) The Reflective Practitioner - How Professionals Think in Action. 
London, Temple Smith. 
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MSc Pathwav 
Module 1 
Introduction of professional 
development portfolio (PDP) 
Case study 1 
Module 2 
Continuer! develooment of PDP 
Case study 2 
Module 3 
Continued development of PDP 
Practical examination 
Unseen true/fal^e paper 
Membership of 
the Society of 
Orthopaedic 
Medicine 
Portfolio reflective essay with personal development plan 
Postgraduate Certificate in Orthopaedic 
Medicine 
(60 credit Doints Level 4} 
Methods of Critical Enquiry in Health Care 
Services (HPS 4006) 
2 optional Modules 
(Total of 60 credit points Level 4) 
Postgraduate Diploma in Orthopaedic 
Medicine 
Dissertation (IPH 4095) 
60 credit points at Level 4 
MSc in Orthopaedic Medicine 
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LEVEL DESCRIPTORS 
Learning at higher educational level develops certain abilities which make the individual 
a more effective work based learner and hence a more capable and insightful 
individual. Assessment criteria and the forms of assessment are directly related to the 
following abilities that are central to work based learning studies and independent 
learning: 
1. identification and appropriate use of sources of knowledge and évidence 
2. analysis, synthesis and évaluation of information and ideas 
3. application of learning 
4. sélection and justification of approaches to task 
5. action planning leading to effective and appropriate action 
6. effective use of resources 
7. effective communication 
8. working and learning with others 
9. self appraisal/reflection on practice 
10. ethical understanding 
These abilities are developed over the course of the module. They are mapped onto 
the Levels 1 to 4 framework of the Middlesex Académie Credit scheme. 
Level 1: Knowledge and straightforward compréhension predominate at this 
level. 
1. Identification and appropriate use of sources of knowledge and évidence will be 
within a very familiär context 
2. Analysis will often be partial, synthesis and évaluation of information of ideas is 
likely to be limited 
3. Application of learning is likely to be highly context specific 
4. Sélection and justification of approaches to task will often show little or no 
considération of alternative approaches 
5. Action planning leading to effective and appropriate action will tend to be in a 
prescribed context and probably not impact greatly upon others 
6. Effective use of resources will be limited to familiär context 
7. Effective communication but may be limited in context 
8. Working and learning with others will often be in a familiär context and not 
challenge or develop beliefs/practices of others 
9. Seif appraisal/reflection on practice will be evident but may not be fully developed 
10. Ethical understanding is likely to be context specific and may sometimes be limited 
to knowledge and application of a prescribed code 
Level 2: Application of knowledge and compréhension predominate at this level 
1. Identification and appropriate use of sources and knowledge and évidence may be 
within a familiär context but will be largely seif directed 
2. Analysis, synthesis and évaluation of information and ideas is likely to be partial but 
will be sufficient to indicate further areas for development 
3. Application of learning beyond a specific context 
4. Sélection and justification of approaches to task/problem will often be self-directed 
and involve récognition of a range of options from which a justified sélection is 
made 
5. Action planning leading to effective and appropriate action will tend to be in a 
prescribed context but may be wide ranging and may involve the work of others 
6. Effective use of resources will normally be limited to familiär context but will be 
largely seif directed 
7. Effective communication both in writing and orally 
8. Working and learning with others will often be in a familiär context and may 
challenge or develop practices of others 
9. Self appraisal/reflection on practice will lead to significant insights although thèse 
may not be fully developed 
10. Ethical understanding is likely to be context specific, where applicable prescribed 
codes will be understood and routinely applied 
Level 3: High level analysis and synthesis are the prédominant features of this 
level 
1. Identification and appropriate use of sources of knowledge and évidence will be 
wide ranging and critical 
2. Analysis, synthesis and évaluation of information and ideas will be sufficient to 
make judgements and dérive principles to guide further action 
3. Application of learning in a number of contexts 
4. Sélection and justification of approaches to task/problem will be self directed and 
involve récognition, articulation and critical évaluation of a wide range of options 
from which a justified sélection is made 
5. Action planning leading to effective and appropriate action is likely to be complex 
and impact upon the work of others 
6. Effective use of resources will be wide ranging 
7. Effective communication both in writing and orally will be clear, concise and 
persuasive 
8. Working and learning with others may span a range of contexts and is likely to 
challenge or develop the practices of others 
9. Self appraisal/reflection on practice will lead to significant insights impacting upon 
personal and professional development 
10. Ethical understanding will span a range of contexts, where applicable prescribed 
codes and their rationale will be fully understood and sensitively applied 
Level 4: Self directed research and development, depth of understanding and 
the création and articulation of knowledge of significance to others are the 
hallmarks of this level. 
1. Identification and appropriate use of sources of knowledge and évidence will be 
wide ranging, critical and often innovative 
2. Analysis, synthesis and évaluation of information and ideas will resuit in the 
création of knowledge of significance to others 
3. Application of learning will transcend specific contexts 
4. Sélection and justification of approaches to task/problem will be self-directed and 
involve récognition, articulation and critical évaluation of a range of options from 
which a justified sélection based upon a reasoned methodology is made 
5. Action planning leading to effective and appropriate action will be complex and is 
likely to impact upon the work of others 
6. Effective use of resources will be wide ranging and is likely to impact upon the work 
of others 
7. Effective communication both in writing and orally will be in an appropriate format to 
appeal to a particular target audience and will be clear, concise and persuasive 
8. Working and learning with others will span a range of contexts, often in a 
leadership rôle, and is likely to challenge or develop the practices and beliefs of 
others 
9. Self appraisal/reflection on practice will lead to significant insights which are likely 
to make a lasting impact upon personal and professional understanding 
10. Ethical understanding will span a range of contexts, where applicable prescribed 
codes and their rationale will be critically understood and sensitively applied 
SECTION 3 
MIDDLESEX 
UNIVERSITY 
STATEMENT OF COLLABORATIVE WORK 
During the past year Elaine Atkins and I have taken the lead in developing the MSc Orthopaedic 
Medicine, as a collaborative venture between Middlesex University and the Society of Orthopaedic 
Medicine. Elaine took the lead in developing a module in Theory and Practice of Injection Therapy -
IPH 4020, which was successfiilly validated as one of the clinical skills option modules within the 
programme. The development of this module involved a number of key tasks: 
• Restructuring the current course in line with University and School Policy 
• Developing appropriate level 4 aims and learning outcomes 
• Reviewing and revising the content of the current Society of Orthopaedic Medicine Injection 
Therapy Course with Society colleagues 
• Developing the teaching and learning strategy with the module leader 
• Developing the assessment strategy and constructing the assessment guidelines and marking 
criteria 
• Producing the Module Handbooks 
To date Elaine has successfiilly completed the first five tasks, and in relation to the production of the 
module handbook, has reviewed the current course manual and developed the additional sections to 
meet the School requirements for Module Handbooks. The production of the Handbook is now in the 
hands of the print designers, and Elaine will continue to oversee this until production is complète. 
Dr Kay Caldwell 
Postgraduate Programme Coordinator 
T H E Q U E E N ' S 
A N N I V E R S A R Y P R I Z E S 
1996 & 1998 
SOCIETY OF ORTHOPAEDIC MEDICINE 
MIDDLESEX UNIVERSITY 
SCHOOL OF HEALTH, BIOLOGICAL AND ENVIRONMENTAL 
SCIENCE 
IPH 4020 
THEORY AND PRACTICE OF INJECTION THERAPY 
2001/2002 
Module Handbook 
Module Leader 
Telephone 
E-mail 
Paul Hattam 
0114 267 8181 
paulhattam@taptonville.fsnet.co.uk 
PLEASE NOTE 
1. This Module Handbook should be read in conjunction with the University 
Catalogue, University Diary and Programme Handbook. Ail of thèse 
documents should be given to you at enrolment. A separate Course Manual 
will be issued to you on the first day of the Module. Ail spécifie 
administrative information relating to'the module will be sent to you directly 
by the Society of Orthopaedic Medicine Administrator, whose détails are 
given below. 
2. The material in this handbook is as accurate as possible at the date of 
publication. 
3. Your comments on any improvements are welcome - please put such 
comments in writing (with the name of the handbook) and h and them to the 
student office or Module Leader. 
; Amanda Sherwood 
Administrator, Society of Orthopaedic Medicine 
6 Court View Close 
Lower Almondsbury 
Bristol BS32 4DW 
Telephone/Fax 01454 610255 
E-mail AmandaShei,wood@coinpuserve.com 
Welcome 
Welcome to the Theoiy and Practice of Injection Therapy module, IPH 4020. 
We hope that you will find this module both relevant to your clinical practice and 
a stimulating component of your postgraduate programme. 
The value of this module lies in the commitment of all students to participate 
fiilly, and to be prepared to share their expériences with the whole group. 
Students are actively encouraged to engage in dialogue and discussion with their 
fellow students in an atmosphère of mutually supportive learning and 
development. 
Any comménts or suggestions for improvement to the structure and delivery of 
this module are wàrmly welcomed. 
Paul Hattam 
Module Leader IPH 4020 
CONTENTS 
Introduction to the module 
Module programme 
Assessment guidelines and criteria 
Core reading 
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1. The student voice 
2. Module évaluation form 
3. Key university publications 
4. Information on soldent support 
5. Equal opporoinities and the environment 
6. Abbreviations 
7. Campus soldent offices 
SOCIETY OF ORTHOPAEDIC MEDICINE 
MIDDLESEX UNIVERSITY 
SCHOOL OF HEALTH, BIOLOGICAL AND ENVIRONMENTAL SCIENCE 
THEORY AND PRACTICE OF INJECTION THERAPY 
IPH 4020 
INTRODUCTION TO THE MODULE 
Module Structure 
Code: 
Title: 
Level: 
Credit points: 
Pre-requisite: 
Teaching hours 
Teaching/Learning Strategies 
Total study hours: 
Module Leader 
Rationale and aims 
This module in injection skills is designed to develop cognitive and psychomotor 
skills-essential to the advancement of the chartered physiotherapist specialising in 
injection treatments for musculoskeletal lesions. The module aims to develop the 
knowledge of the chartered physiotherapist in the theory, application and practice of 
injection treatments in musculoskeletal disorders. It further aims to enhance 
constant critical reasoning and evaluation in the application of injection skills. It 
should be noted that this module is only open to Members of the Society of 
Orthopaedic Medicine who are currently practising. 
IPH 4020 
Theory and Practice of Injection Therapy 
4 
20 
Must be a Member of the Society of 
Orthopaedic Medicine 
24 
Lecture, Demonstration, Group work, 
Case Study, Tutorials 
180 
Paul Hattam 
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Learning outcomes 
On completion of this module students will be able to: -
• Demonstrate a high level of knowledge and understanding of the pharmacology 
of local anaesthetic and corticosteroid drugs in relation to orthopaedic medicine 
injections as well as the indications for and contraindications to injection 
techniques 
• Carry out an expert assessment of clients to determine drug selection and dosage 
• Demonstrate mastery of the handling skills required to administer injections 
appropriately and accurately 
• Critically evaluate the effects of treatment 
• Extrapolate and integrate the advanced knowledge and skills required to 
undertake independent practice in relation to orthopaedic medicine injection 
therapy 
Outline of content 
• Medico-legal aspects of mjection therapy 
• Principles of diagnosis and treatment 
• Absorption and elimination of drugs 
• Drug nomenclature and doses 
• Local anaesthetics 
• Corticosteroids 
• Basic equipment and safety 
• Aseptic technique 
• General injection techniques 
• Emergencies and complications 
• Record keeping and treatment protocols 
• Regional injection techniques 
• Supervised clinical practice 
Teaching and learning strategies 
This module will use a range of teaching/learning strategies including lectures, 
demonstrations, group work, case studies and tutorials. 
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MODULE PROGRAMME 
The Society of Orthopaedic Medicine's module 'Theory and Practice of Injection 
Therapy', IPH 4020, will be run at various locations across the UK. Each module 
will require a total of three days' attendance, split over two weekends, with guided 
study in between. 
Two modules are scheduled for the academic year 2001/2002, each of which is 
conducted over two units as shown below. 
October 1st and 2nd 2001, and Marchl8th 2002 
October 22nd and 23rd 2001, and April 22nd 2002. 
Unit 1 
Drawing up etc Practical demonstration, order of drawing up etc 
Clinical Pharmacology LA/CS/Adrenaline 
absorption/elimination 
pharmocokinetics 
Aseptic technique 
Needle proprioception Appreciating feel of different structures with a 
needle 
Side effects/Complications 
Injection Techniques: emphasis on the injections that demonstrate 'basic' techniques 
and that need to be practised in the inter-unit period as they are likely to be the ones 
used most frequently: 
Shoulder jomt - Subacromial bursa - acromioclavicular joint - 'tennis elbow' -
'golfer's elbow' - elbow joint - carpal tunnel - trochanteric bursa - knee joint -
tendon in a sheath (Dequervain's/Peronei) 
Unit 2 
Resuscitation techniques 
Other drugs injected Voltarol, sclerosant, etc 
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Medicolegal aspects 
Other techniques 
Prescriptions/Crown Report 
Historical perspective 
Information to patient 
Record Keeping 
4 
ASSESSMENT GUIDELINES AND CRITERIA 
Formative 
Clinical supervision of injection therapy techniques. 
Clinical supervision is a vital component of the module and essential to your 
development of confidence and competence in performing the application of 
injection therapy. It will be your responsibility to arrange for your own clinical 
supervision, although we shall be pleased to advise you m support of this. The 
following guidelines should help you to locate a suitable supervisor, or supervisors. 
Guidelines for organising clinical supervision 
Your supervisor should be medically qualified and have an interest and experience 
in the use of injections in the management of musculoskeletal conditions. 
It is important that your supervisor is aware of what will be required of them before 
agreeing to act in that role. 
The clinical situation in which you are being supervised should allow for you to 
assess patients to be able to reach a diagnosis and recommend that injection therapy 
is the treatment of choice, prior to discussion with the supervisor. It is accepted that 
injection therapy may not always be appropriate following those discussions m light 
of the collaborative clinical reasoning process. 
Throughout the module recommendations for drugs and dosages of injectable steroid 
and local anaesthetic will be given, to form the basis of the suggested approach to 
apply in clinical practice. These may vary from those usually applied by supervisors 
in their own clinical practice and then" cooperation is sought in this. The criteria for 
the assessment of your supervised injections are given below. The injections that 
you will be required to perform will be specified at the commencement of the 
module. An evaluation of each injection you administer should be included within 
your professional portfolio. 
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Criteria for assessing supervisée! injections 
INJECTION: 
Pass Fail 
Cardes out an expert assessment of clients to détermine drug 
sélection and dosage 
Demonstrates mastery of the handling skills required to 
administer injections appropriately and accurately 
Critically évaluâtes the effects of treatment 
SIGNATURE 
Summative 
Students will demonstrate achievement of the learriing outeomes by producing 
an assignment of 4,000 words in the form of a case study présentation of an 
injection treatment conducted. 
Guidelines for préparation of the case study 
Please read through the following guidelines before beginning your case study, 
including the 'criteria for marking the case study' on page 10. 
The case study should be presented using the headed sections set out below. A4 
paper should be used and the case study should be typed or hand written on one side 
of the paper and using double spacing. 
6 
1. Introduction 
This should give an outline of the content and the intentions of the case study. 
2. History (Subjective Examination) 
Mention relevant points of history relating to: 
Age, occupation, lifestyle (male/female) 
Site and spread of the pain and other symptoms 
Onset"àM"dùration"of thë pain and'öther symptoms 
Behaviour of the pain and other symptoms 
Other joint involvement 
Past médical history 
Médications 
Référence should be made to the significance of your subjective examination 
findings. 
3. Exammation (Objective Examination) 
Observation 
Inspection 
State at rest 
Logical examination by sélective tension 
Référence should be made to the significance of your objective examination 
findings. 
4. Clmical diagnosis 
The results of the examination should be carefully evaluated and a clinical diagnosis 
made. 
5. Treatment plan 
This should encompass your rationale for your selected treatment approach: 
Aims of treatment 
Modality of treatment 
Estimated duration of the treatment 
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Any discussions or exchange of ideas that you may have with colleagues. 
Guidelines for referencing are included at the end of this section on page 12 
6. Re-assessment 
Show which objective markers you used to re-assess the patient before each 
treatment session. 
lndicate how the treatment was progressed and explain the reasons for any changes 
or modifications to the treatment programme. 
7. Discussion'and'evaluation 
The discussion and évaluation portion of the case study is most important 
Reflect on the effectiveness of your treatment plan and discuss any changes you 
could have made to enhance treatment. How do you feel you managed the case? In 
conclusion, how has the theory and practice gained on the injection therapy module 
influenced your own abilities to apply injection therapy in clinical practice? 
It is important that your work shows clear analysis and reasoning throughout 
and that you justify your clinical décisions. 
The suggested word count for the essay is 4,000 words. The criteria for 
marking your case study are given on page 10. 
For the case study, you will be expected to provide évidence through referencing 
that you have read enough relevant literature to give you some awareness of the 
current knowledge on the subject area of your study, and to support your 
discussions. You will not be expected to conduct a full-scale literature search as 
such. You should back up your décisions with évidence (e.g. clinical papers and 
other références) wherever possible. 
The case study is designed to allow you to realise and provide évidence for your 
achievement of the learning outcomes of the module (page 2). Check that your 
study meets the following criteria before it is submitted: 
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CRITERIA FOR MARKING THE CASE STUDY 
Student's nu nie 
1-4 5-8 9-12 13-16 17-20 
-1 „ Ail relevant information of-
the history and 
examination is included, 
referring to applied 
functional anatomy. 
Relevant information of-the-
history and examination. 
referring to applied 
functional anatomy, is not 
included. 
2 An analysis is included of 
how the clinical diagnosis 
was reached. 
An analysis is not included 
of how the clinical 
diagnosis was reached. 
3 The aims of treatment are 
documented identifying 
any relevant theoretical 
information. 
The aims of treatment 
identifying any relevant 
theoretical information are 
not documented. 
4 Objective markers have 
been established to show 
how progress will be 
monitored. 
Objective markers to show 
how progress will be 
monitored have not been 
established. 
5 The relevant anatomy is 
included to demonstrate an 
accurate approach to 
treatment. 
• 
The relevant anatomy is to 
demonstrate an accurate 
approach to treatment is not 
included. 
6 Safe and effective 
treatment with évaluation 
of treatment application is 
clearly documented. 
Safe and effective treatment 
with évaluation of 
treatment application is not 
documented.. 
7 A critical évaluation of the 
outeome of the application 
of injection therapy is 
provided together with the 
development and 
progression of the 
treatment programme. 
A critical évaluation of the 
outeome of the application 
of injection therapy 
together with the 
development and 
progression of the treatment 
programme is not provided. 
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8 A self-evaluation is 
included of your clinical 
reasoning in performing 
orthopaedic medicine 
assessments and sélection 
of conditions suitable for 
treatment with injection 
therapy, relating to your 
expériences in preparing 
this case study. 
A self-evaluation of your 
clinical reasoning in 
performing orthopaedic 
medicine assessments and 
sélection of conditions 
suitable for treatment with 
injection therapy, relating 
to your expériences in 
preparing this case study is 
not included. 
9 An évaluation is made of 
your professional 
development relating to the 
intégration of injection 
therapy -into -your- clinical 
practice. Reflect on any 
change in your confidence 
and overall compétence. 
- -
An évaluation of your 
professional development 
relating to the intégration of 
injection therapy into your 
-clinical—practice,- -with 
reflection on any change in 
your confidence and overall 
compétence is not made. 
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REFERENCING 
There are several different methods of referencing that are all perfectly acceptable. 
The Society's preferred system is the ñame and date system (Harvard), rather than 
the numerical system, and a brief outüne of the former is given below. 
Please check that only references that appear in the text are listed in the References 
list. Other written work that you may have read without referring to may be 
included in a further reading list or bibliography if you wish. 
Within the text the references are usually contained within brackets giving just the 
authors súmame followed by a comma, and the year of publication e.g. (Twomey, 
1992). Two authors may be included within the brackets but if there are more than 
two authors the first is usually'listed followed by eí a! e.g. (Twomey and Taylor, 
1994)or(Kuslich etal, 1991). 
The reference list should give the ñames and initials of all authors unless there are 
more than four, when the first three are usually given followed by et al. 
For books: 
• Put the author's súmame followed by the forename or initials 
• Put the year of publication in brackets 
• Give the title of the book either underlined, in bold or in italics 
• Give the volume and/or edition 
• Mention the place of publication followed by the ñame of the publisher 
E.g.: Cyriax, J. (1982) Textbook of Orthopaedic Medicine. Vol 1, (8 , h Ed) 
Oxford: Bailliére Tindall. 
For journal articles or chapters in books: 
• Put the author's súmame and forename or initials 
• Put the year of publication in brackets 
• Give the title of the article or chapter, usually in plain script or inverted commas 
• Give the title of the joumal or book, usually in italics or underlined 
• Give the volume number, issue and page numbers in joumals 
E.g.: Coonrad, R.W., Hooper, W.R. (1973) Tennis elbow: its course, natural 
history, conservative and surgical management. Journal of Bone and Joini Surgery 
55-A 1177-1182. 
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APPENDIX 1 
THE STUDENT VOICE 
The University attaches great importance to the opinions of its students on the teaching and 
facilities provided for them. There are a number of formai and informai ways of collecting 
this information. 
Questionnaires 
Every two years, each student is asked to complète the Student Service Survey, on 
a range of services provided by the University: libraries, counselling, catering, 
childcare, transport etcr Response to this is analysed in May/June and dealt with by 
the relevant Heads of Services, Deans of School, and other staff. Feedback is also 
published in the North Circular. 
Feedback on Subjects and Programmes 
Each Curriculum Leader is expected to gather systematic feedback from students on 
their opinion of the way in which their programme is delivered. This can be 
collected by one or more methods: module questionnaires, group discussion, 
individual comment. This feedback is provided for annual monitoring surveys and 
periodic reviews of the Subject or Programmes. The action taken by the teaching 
team on the feedback is also monitored. 
Boards of Studies 
Each Subject or Programme is required to have a Board of Studies. This is a group 
of académie staff, and usually two student représentatives from each year of the 
Programme. They meet once a semester to discuss strengths or weaknesses of the 
programme, and to make recommendations for action to relevant staff. The student 
members represent their year, and are responsible for notifying the Board of issues, 
which have been brought to them by their fellow students. Boards of Studies 
reports are careflilly monitored for issues arising and action taken on them. MUSU 
run short training courses intending to become représentatives (see Student 
Information - last bullet point - above). 
Suggestions and Concems 
Students can, individually or by group, make suggestions or raise concerns relating 
to gênerai University facilities or aspects of a study programme. If there is no 
relevant staff member to contact, thèse can be left (in writing) with the Campus 
Student Office staff. 
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APPENDIX 2 
SCHOOL OF HEALTH, BIOLOGICAL AND ENVIRONMENTAL SCIENCES 
MODULE EVALUATION FORM 
To be completed by Student at end of Module 
Module Code and Title: Start Date: 
Please take the time to complète this form by ticking the boxes. Your opinions will help us to 
continually monitor and improve the qualify of the teaching and leaming you and others expérience 
whilst with Middlesex University. The results of your évaluation, and feedback as necessar>\ will be 
made available through the Boards of Studies at which von are represented. Further information 
about the School's Quality policies and procédures can be obtained from your module leader or the 
SchooFs Quality Co-ordinator. Please hand this form to your module leader. 
Strongly 
Agrée 
Agrée Disagree Strongly 
Disagree 
Dbes Not 
Apply 
Pre-module information was timely and useful 
Admissions/Student Office Staff were courteous 
and helpfi.il 
Module handbook was informative and easy to 
use 
Teaching facilities were appropriate and of a 
satisfactory standard 
Learning resources (library, computers etc.) were 
accessible, available and appropriate 
The teaching programme took place according to 
previously provided information. 
Teaching and leaming methods used/promoted 
were appropriate and effective 
Académie staff were accessible, approachable, 
and assisted me in achieving leaming outeomes. 
Learning outeomes were relevant to stated aims 
of module and were clear and explicit within 
teaching. 
Assessment was related to the leaming outeomes 
and used acceptable/appropriate methods 
Assessment information was clear, help ml and 
provided in good time 
The workload die module demanded of me was 
demanding whilst notbeing excessive 
The module was academically/ 
profession a lly challenging. 
I am aware of how the module fits into a longer-
term programme of study 
I have had access to student facilities 
(refreshments. student lounge etc.) during this 
module 
Overall, the module has met my expectations and 
needs. 
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General Comments: 
Thank you for taking the time to complete this form. Student evaluation 
summaries are presented to the Board of Studies for the Course or 
Subject area of your module. Your Student representative is invited to 
attend this meeting. 
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APPENDIX 3 
KEY UNIVERSITY PUBLICATIONS 
* The University Catalogue / Guide and Régulations Booklet 2000/2001 
Thèse include the University régulations on awards and assessment, and the full list 
of Subjects, Programmes and ail current modules. Ail students shouid refer to 
thèse publications and be familiar wilh the régulations relating to their programmes. 
* The University Handbook/Diary 2000/2001 
In addition to the diary section, this provides (in alphabetical order) a brief 
description of the main University structures, student services and names of key 
staff etc. 
The two publications above are re-issued at the beginning of each académie year, and each 
student shouid have a current copy.. 
* The North Circular 
Don't forget this useful weekly University paper, published every Wednesday/ 
Thursday during semesters, and in shortened form during the holidays. 
* The Internai Téléphone Directory 
This also gives staff grouped by School, Campus or Service area, and provides 
other useful information. 
STUDENT PUBLICATIONS AND OTHER INFORMATION 
AH produced by the Middlesex University Students Union (MUSU) 
* The Rough Guide for Students 2000/2001 
(produced by the Advisory Services of MUSU and the University) 
A useful guide on student life including: Out and about; Equal Opportunities; 
Money; Overseas Students; Legal Aid; Health 
* Freshers' Handbook 2000/2001 * The Clubs and Societies Handbook 2000/2001 
Information on student Sabbatical Officers for the Year, Campus Union Offices and 
staff, smdent societies and how to start a new society etc 
* The Planet 
lssued monthly: student news and articles of interest. 
* The Website 
MUSU updated information can be accessed on: 
WWW.mdx.ac.uk/www/musu/ 
* Planet FM (under developmcnt) 
MUSU mns short, accrediled, train ing courses for student reps. For information on 
thèse, ask vour Curriculum Leader or contact Selena Bolingbroke (6481) or Vickv 
Hallen (6754) 
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APPENDIX 4 
INFORMATION ON STUDENT SUPPORT 
Read the front section of the UNIVERSITY CATALOGUE for information on the following: 
Information and Learning Resource Service (ILRS) 
There is a section on Campus Computing Services, Language Centres and Libraries. Each 
Campus library has a number of factshcets dcsigncd to help with particular skills. 
(These will also be available shortly on the University Website.) 
Currently thcse are: 
1. Bibliography Humanities 
2. Bibliography Social Sciences 
3. Presentation of Thèses 
4. Essay Writing 
University library books can be checked. and réservations made, via the University 
computer .network-(Programme Manager - Corporate-Desktop)~under~the icon Horizon 
OPAC. 
Counselling, Health and Advice 
The Dean of Student on each major campus is responsible for the student support 
arrangements for the Campus. Health Campuses are co-ordinated from Highgate Hill 
Campus; Quicksilver place is covered from Cat Hill Campus; Ivy House and Bedford 
Campuses are covered from Trent Park Campus. 
Careers Advisory Service 
This service helps students lo plan their académie programme and personal development in 
relation to career goals, to become more aware of employment and study opportunities and 
to assist them to use their own study programme to take advantage of career opportunities. 
The Careers Service offers: 
* access to up-to-date information in the Careers Libraries at Enfïeld and Hendon on 
careers, employers, vacancies and postgraduale study 
* guidance from qualified Careers Advisers 
* help with job search procédures, interview technique and compiling a CV 
* opportunities to attend présentations from employers 
* student support from the time of enrolment to up to a year after the finish of study 
Students should: 
* make fuli use from an early stage of the careers information, careers présentation, 
planning and guidance resources available 
* recognise the importance of career planning and décision making from the 
beginning, and throughout their time at University. 
* Identify which careers services are available on their Campus by consulting the 
Campus Careers Advisory Service noticeboard. 
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APPENDIX 5 
Policies on Equal Opportunities and thc Environment 
The University has agreed and pubhshed a policy on each issue (Policy HRPS 8 and APS 5 
respectively). The University's Equal Opportunities Officer, Susanna Hancock, is based at Trent 
Park Campus (Ext 6873). 
The University's Environment Advisory Group is chaired by Professor Margaret House (ext 5398). 
Each major Campus has an Equal Opportunities and an Environmental representative. 
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ABB RE VI AT IONS APPENDIX 6 
These are the main abbreviations used across the University. 
AAM Académie Administration Manager 
ADPA Art, Design and Performing Arts (based at Cat Hill) 
APC Académie Planning Committee 
AP(E)L Accréditation of Prior (Experiential) Learning 
ASQC Académie Standards and Quality Committee 
CCSS Computing and Communication System Services 
CDOS Campus Dean of Studenls 
CFM Campus Facilities Manager 
CL Curriculum Leader 
CLD Centre for Leaming and Development 
CLRM Campus Leaming Resources Manager 
CS - .-(School.of)Computing-Science 
CSM Computer Support Manager 
CSO Campus Student Office 
CSS Corporate Student System (computerised datábase) 
DA (Campus) Data Administrator 
DCLQ Director of Curriculum Leaming & Quality 
DORA Director of Resources & Administration 
DOS Dean of Students 
DRPS Director of Research and Postgraduale Studies 
Edexcel Formerly operated as BTEC 
ENB English National Board (Nursing Studies) 
ES (School of) Engineering Systems 
FTE Füll time équivalent (method of counting part time studenls) 
HEBES School of Health Biologicnl and Environmental Sciences 
HETP (North London) Higher Education and Training Partnership 
HCS (School of) Humanities and Cultural Studies 
HNC/HND Higher National Certifícate/Diploma Run by Edexcel (formerly BTEC) 
ILRS Information and Learning Resource Services (includes Library and Computing) 
LLE (School of) Life long Leaming and Education 
MASN Maximum Allowable Student Numbers (HEFCE enrolment quota for each 
University) 
MDP Multidisciplinary Programme 
MSG Management Services Group (IT Systems Development and Training) 
MUBS Middlesex University Business School (based at Hendon) 
MUSU Middlesex University Student Union 
NCWBLP National Centre for Work Based Leaming Partnerships 
PDS Planning and Development Service (based at Trent Park) 
PVC Pro Vice-Chancellor 
QA Quality Assurance 
QAA Quality Assurance Agency for Higher Education 
QAAS Quality Assurance and Audit Service 
QTS Qualifîed Teacher Status (relating to a school teaching degree) 
RAP Review of Académie Provision 
RBL Resource-based learning 
RSP Review of Service Provision 
SAPC School Académie Planning Committee 
SASQC School Académie Standards and Quality Committee 
SS (School of) Social Science 
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VC Vice-Chancellor 
WBL Work Based Leaming 
APPENDIX 7 
MIDDLESEX UNIVERSITY CAMPUS STUDENT OFFICES 
2000/2001 
CAMPUS 
OFFICE LOCATION OPENING HOURS 
i 
NORTH MIDDLESEX Corridor B, North Middlesex Centre Mon - Fri 
10.00-3.00 
ROYAL FREE 
2nd Floor 
Mon - Fri 
10.00-3.00 
WHITTINCTON 
St Mary's Wing 
Mon - Fri 
8.45 - 11.30 
12.45-3.30 
CHASE FARM Réception, Block 4 Mon - Fri 
8.30 - 12.00 
ENFIELD 
Student Office 
Ground Floor 
Broadbent Building 
Mon-Fri 
9.30- 12.30 
1.30-3.30 
(Term Time) 
Postgraduate Office Mon -Thürs 
9.30-5.00 
Tues & Wed 
9.30-6.00 
F i i 
9.30-3.00 
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About the authors 
Monica Kesson Grad Dip Phys M C S P Cert Ed Cert FE 
Elaine Atkins MA Grad Dip Phys M C S P Cert FE 
lan Davies MB ChB 
Monica Kesson and Elaine Atkins are both physiotherapists in private practice 
who share a commitment to the development of the educational course of the 
Society of Orthopaedic Medicine. As educators they both have a gift for making 
the complicated elear and this was reflected in their previous collaborative best 
selling publication 'Orthopaedic Medicine - a Practical Approach' (1998). lan 
Davies is a gênerai practitioner and teacher of orthopaedic medicine, who also 
achieved an anaestnetic fellowship earlier in his médical career. He was the 
prime moverin developing the Society's Injection Module to provide 
comprehensive training for physiotherapists keen to develop their skills in this 
relatively new specialism within physiotherapy. Ail three authors support a multi-
disciplinary approach to primary care and extended scope of practice within 
professions. This has underpinned their détermination to produce a text that is 
relevant to both doctors and physiotherapists alike. 
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Foreword 
Dr Richard Ellis 
What's the difference between a bible and an encyclopaedia? To my mind a 
bible is a friendly companion that I constantly refer to, whereas an encyclopaedia 
is a mine of information that I never quite get round to looking up. So, a bible is 
something by my side, which keeps me on the straight and narrow, allowing me 
as far as possible to live a purposeful and rewarding life. 
"Musculoskeletal injection skills" is certainly a bible. It contains not only the 
primary information about how to position your patient and yourself for all the 
common musculoskeletal injections, but also answers those doubts and little 
ignorances which nag most of us who want to do the best for our patients. If 
you're starting from scratch, this book will keep you as free as possible from 
these nags. And in addition, when you dip into it in an (unusual) idle moment, or 
it opens at a page you hadn't intended, there are yet more pearls of information 
revealed. 
What a refreshing concept this book is, also. In the 'corporate structure' which 
medicine often seems to have, each division, such as 'pharmacology' and 
'musculoskeletal medicine' is liable to remain quite separate with its own 
textbook and jargon; as exactly may the disciplines, such as 'doctoring' and 
'physiotherapy'. Here we are dealing with a clinical task, with its basic evidence 
of efficacy, which the book takes apart into its essential aspects from basic 
sciences through to the clinical scenario and complications. The patient who is 
needing an injection wants it to be done by someone who has all the knowledge 
in this book: and the label on the operator's collar is not important. 
Of course extra background knowledge, as the book states, is of the greatest 
assistance on the diagnostic side, and familiarity with the applied anatomy and 
the function and dysfunction of the neuromusculoskeletal system is essential. 
You must have an understanding both of these areas and with the contents of 
this book if you are able to be an efficient and safe injector in orthopaedic 
medicine, whether you are physiotherapist, nurse or doctor. 
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Preface 
Musculoskeletal medicine and therapy have traditionally sat side be side, with 
both doctors and physiotherapists combining experience in the assessment and 
clinical diagnosis of musculoskeletal lesions and applying their different 
approaches and skills. 
.The role of Dr James Cyriax F R C P was pivotal in the development of 
orthopaedic medicine, arguably the bedrock of musculoskeletal medicine. The 
specialism developed from his background in orthopaedic surgery at St Thomas' 
Hospital, London, in 1929, where he was intrigued by conditions presenting in 
orthopaedic clinics with normal radiographic findings, where the lesion was 
clearly within the so-called 'soft tissues'. Putting surgery aside, he devoted his 
life's work to developing a system for examining the soft tissues towards 
establishing a clinical diagnosis, and from there to devising treatment techniques 
for the lesions diagnosed. Throughout his long professional life, he dedicated 
himself to the continued development of the specialism and, as well as 
techniques of mobilisation, manipulation and traction, injections were very much 
part of his treatment approach to the soft tissue lesions encountered within 
clinical practice. His approach was bi-disciplinary from the outset, drawing on the 
experience of doctors and physiotherapists and acknowledging the importance of 
co-operation and collaboration in the management of patients. Doctors and 
physiotherapists were taught alongside each other on his educational courses to 
acquire the theory and skills of assessment, manual techniques and injection 
therapy, even though the boundaries of scope of practice prevented 
physiotherapists from being able to put injection skills into practice. 
Musculoskeletal injections, therefore, traditionally remained firmly within the 
province of the physician. 
Physiotherapy is derived from a base of massage, remedial gymnastics and 
electrotherapy (Williams, 1986) and these have traditionally been considered to 
be the core skills of the profession, in determining scope of practice. 
The Chartered Society of Physiotherapy (CSP), the professional body of 
physiotherapy, is responsible for both the training and support of Chartered 
Physiotherapists whilst having a key role in deciding professional issues. A 
discussion document published in 'Physiotherapy' in 1988 ('Physiotherapy', 
August 1988, pp 356-358) emphasised the process of developing practice. It was 
clear in its guidelines for exploring developments in practice that the 'new 
modality, technique or philosophy' should be 'clearly based upon the core of 
physiotherapy'. This dictum had presented the stumbling block for the 
introduction of the use of injections which had been first considered in 1987 
('Physiotherapy', April 1990, pp 218-219), when the Professional Practice 
Committee of the C S P recommended that the giving of injections by 
physiotherapists, as an invasive technique, was not within the scope of 
physiotherapy practice. 
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It was also highlighted that the administration of drugs by physiotherapists was 
not consistent with Section 58(2)(b) of the Medicines Act 1968, where only 
registered medical practitioners, dentists and veterinary surgeons have the right 
to prescribe drugs, and that 'such a practice could cause conflict between 
physiotherapists and medical practitioners' ('Physiotherapy', April 1990, pp 218-
219). 
With the continued development of autonomy within physiotherapy came the 
extended role of the profession in orthopaedics and rheumatology, where 
orthopaedic and rheumatology 'assistants' or 'practitioners' were being created, 
whose role included the administration of local steroid injection, with consultant 
support but without direct intervention. This move towards greater autonomy was 
welcomed by both the medical and physiotherapy professions as a safe and 
cost-effective use of resources (Hourigan and Weatherley, 1994). 
Hockin and Bannister (1994) examined the extended role of a physiotherapist in 
an outpatient orthopaedic clinic and in analysing the treatments selected in 
patient management identified that 22% of patients had received local steroid 
injection. With the existence of such a fait accompli and the moves of continuing 
professional development in encouraging the process of developing practice 
towards skill specialism (Bergman, 1990), the C S P Professional Practice 
Committee was pressed to extend the scope of practice of physiotherapy to 
include injections in December 1995. The C S P produced guidelines for practice, 
which clearly enforced the need for proper post-graduate training. With respect to 
the Medicines Act it was pronounced that the doctor would be responsible for 
prescribing the drug but the physiotherapist would be responsible for 
administering the injection. 
In interpreting the term 'proper post-graduate training' a vehicle was required that 
would extend the physiotherapists' existing knowledge in injection therapy and 
allow the development of skills in the use of this modality. Even for 
physiotherapists who had been taught, and were experienced in, the application 
of the principles and practice of orthopaedic medicine and musculoskeletal 
therapy, it was apparent that further training was required to be able to achieve 
both the competence and confidence to inject. 
'Bolt on' courses in injection therapy have been developed that rely on a sound 
existing knowledge of functional anatomy and clinical diagnosis of soft tissue 
lesions, with an awareness of the basic tenets of injection therapy. There are 
particular implications for the process of clinical reasoning, now that the modality 
has come to form part of the armoury of the manual therapist and care in the 
selection of this invasive technique and issues of clinical safety have been 
emphasised within the training programmes. 
6 
Evidence based medicine has been a driver in consolidating the basis for 
selection of treatments applied in medicine and physiotherapy. In 1999, the 
Chartered Society of Physiotherapy endorsed 'A Clinical Guideline for the use of 
Injection Therapy by Physiotherapists' that was prepared by A C P O M , the 
Association of Chartered Physiotherapists in Orthopaedic Medicine, a clinical 
interest group of the Chartered Society of Physiotherapy. The guideline was 
rigorous in its approach to identifying evidence to support its recommendations 
for best practice in the application of injection therapy, and as well as being 
pertinent to physiotherapists intending to use the modality, it is also relevant to 
doctors who wortc in the field of musculoskeletal medicine and for general 
practitioners in primary care. At the time of writing, the guideline is undergoing a 
process of clinical audit to be able to monitor the extent to which it is being 
followed and to enhance reflection on the modality's effectiveness in clinical 
practice. 
The Crown Review of Prescribing, Supply and Administration of Medicines 
(1999) recommended that prescribing rights should be extended to 
physiotherapists, with appropriate legislation affecting physiotherapists, 
pharmacists and other health professionals awaiting Parliamentary discussion 
time ('Frontline', April 2000, p 7). The extended role of physiotherapy 
practitioners working in musculoskeletal clinics has already been demonstrated 
to be effective in the primary care setting, (Hattam and Smeatham, 1999) and the 
role will undoubtedly be enhanced still further by the introduction of prescribing 
rights, albeit limited at the outset. 
Injection therapy courses sit comfortably within masters programmes since they 
conform to the achievement of Level 4 (masters level) learning outcomes in 
allowing the demonstration of mastery in the application of a clinical skill within 
post-graduate education programmes. Clinical reasoning is paramount in the 
selection of intra-articular and intralesional injections as appropriate and 
efficacious treatment techniques. Subsequent evaluation and reflection on 
treatment outcomes promotes safe and effective practice. 
This text aims to support courses in injection therapy by addressing the theory 
underpinning the approach and the specific techniques presented on a regional 
basis. It will also be pertinent to those doctors who find themselves new to the 
specialism of musculoskeletal medicine, or will act as a refresher or corroborative 
reference to those who have existing experience. Physiotherapy 'grandfathers' 
who have been using the modality for many years, and who have now been able 
to own up to the skill, may also be included within the latter group. 
The adopted title 'Musculoskeletal Injection Skills' is intended to encompass 
those injections that may be appropriate for peripheral lesions encountered in 
sports and orthopaedic medicine, and is in line with the increasingly popular use 
of the terms musculoskeletal medicine and therapy within the respective 
professions. We have aimed for clarity and accuracy in presentation, whilst 
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acknowledging the need forcontinued'research to monitorthis developing 
therapy, and its place with respect to other available treatment modalities in both 
medicine and physiotherapy. 
Monica Kesson, Elaine Atkins and lan Davies 
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Section 1 Principles of Musculoskeletal Injections 
. Introduction to Section 1 
This section presents the theory underpinning the administration of intra-articular 
and intralesional injections for peripheral musculoskeletal lesions. The first two 
chapters provide an overview of basic pharmacology and the essential 
equipment required for administering injections. Safety precautions are 
highlighted with guidance on recognising and dealing with emergency situations. 
The third chapter describes injectable drugs for use in musculoskeletal injections 
with important note of their mechanism of action, effects and side effects. The 
section concludes with a chapter on general principles of injection therapy and 
lists the indications and contra-indications for injections, whilst explaining the 
application of general techniques, and providing notes on record keeping. A flow 
chart provides a background for the clinical decision making process. 
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1 Basic pharmacology - what do drugs do? 
Chapter summary 
This chapter presents the key points of pharmacology that are relevant to applied 
injection therapy. Pharmacology is introduced with an outline of how drugs are 
administered, absorbed, distributed, metabolised and eliminated. Drug 
nomenclature is then defined. 
The pharmacology presented in this chapter is basic, for which we make no 
apology. In preparing a text to enable both doctors and physiotherapists to 
enhance their injection skills, the authors were mindful of the lack of 
pharmacology within undergraduate physiotherapy training, at least until 
relatively recently when injections came within the scope of physiotherapy 
practice in 1995. 
All will agree that an understanding of pharmacology or, simplistically, how drugs 
work, is essential for the application of injection therapy. Doctors may choose to 
skip to Chapter 2, where the.theory presented in Chapter 1 will be assumed, and 
all should be equal from there on. 
A drug is a substance which modifies body function (Grundy, 1990; Kalant, 
1998). Pharmacology is the study of drugs and their action in the body. It can be 
subdivided into pharmacokinetics, the process whereby drugs are absorbed, 
distributed, metabolised and eliminated from the body or, simply, what the body 
does with the drug, and pharmacodynamics, the action of drugs on the cells, 
tissues and organs or, simply, what the drug does to the body (Grundy, 1990; 
Rang et al, 1995; Laurence et al, 1997). For a drug to be therapeutically useful it 
must act selectively on particular cells and tissues i.e. the target for the drug 
action. Individual classes of drugs bind to certain targets and individual targets 
recognise certain classes of drugs. However, a drug is not usually completely 
specific in its action and its effects on cells and tissues other than the target 
inevitably produce side effects (Rang et al, 1995). 
A: The pharmacokinetic process 
In order to produce its effects, a drug must be present in appropriate 
concentrations at the target tissue (Benet, 1996). As mentioned above, the 
pharmacokinetic process (what the body does with the drug) is the process 
whereby a drug is absorbed, distributed, metabolised and eliminated from the 
body. In order to go through these processes the drug must first cross the cell 
membrane. The cell membrane preserves and regulates the internal environment 
and consists of bilayers of lipid molecules with 'islands' of proteins (Laurence et 
al, 1997). 
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A variety of different mechanisms enable the drug to cross cell membranes within 
the tissues to facilitate its absorption. The drug's molecular size, its relative 
solubility in lipid and water, its ionisation and other properties, can all influence 
absorption (Kalant, 1998). There is a close correlation between the permeability 
of the cell membrane and the drug's solubility in lipid and water and for this 
reason, lipid solubility is an important determinate of the pharmacokinetic 
characteristics of a drug. The relative solubility determines whether the drug 
molecule will stay in the water phase or permeate the fatty cell membrane. 
Generally, a more lipid-soluble drug molecule is less water-soluble and a less 
lipid-soluble drug molecule is more water-soluble. Properties such as the rate of 
absorption, penetration into the tissues and duration of action can be predicted 
from knowledge of the drug's lipid-solubility (Rang et al 1995). 
B: Drug absorption 
In whatever form a drug is given, it will first pass into free solution at the site of 
administration. If administered by mouth, the dissolved drug is absorbed into the 
portal circulation (the visceral system which circulates via the liver). If 
administered by injection, inhalation or via the skin or mucous membranes, it is 
directly absorbed into the systemic circulation. Musculoskeletal injections are 
intended to directly affect the target tissue, but some systemic absorption is 
inevitable and is responsible for unwanted side effects (see Chapter 3). 
Absorption is the passage of the drug from its administration site into the plasma, 
which then transports it to its site of action or elimination (Rang et al, 1995). The 
more rapidly the drug is absorbed the more rapidly it is eliminated, and factors 
which affect its absorption therefore also affect its duration of action. Relatively 
insoluble drugs e.g. triamcinolone acetonide, have a longer period of action than 
relatively soluble drugs such as hydrocortisone. 
The drug may pass through some tissues and organs which are not affected by 
it, but act as reservoirs, affecting the drug's overall volume distribution and 
concentration in the plasma. Some drugs act as agonists (activators) binding to 
specific receptors on or in the target cells. A small number of drugs act as 
antagonists (causing no activation or acting as blockers), binding to a receptor 
without initiating change, but preventing other substances from gaining access to 
the receptor. 
B: Drug administration routes 
The main administration routes are: 
• Oral 
• Sublingual 
• Buccal 
12 
• Rectal 
• Topical - by application to the epithelial surfaces e.g. skin, cornea 
• Inhalation 
• Injection 
For the purposes of this text, administration by injection is the only route that 
concerns us. 
Injections are delivered: 
• Intravenously -
• Subcutaneously 
• Intramuscularly 
• Intralesionally and intra-articularly 
Intravenous injection gives direct access to the circulation and is the fastest 
route of delivery, producing high concentrations of the drug. It is initially delivered 
principally to organs of high blood flow such as the brain, liver, heart, lung, and 
kidney. It is an appropriate route for the administration of lidocaine to treat 
cardiac arrhythmias, but not for musculoskeletal injections where the high blood 
level produced can be dangerous. Musculoskeletal injections require local, not 
systemic effects. The rate at which the injection is given determines the levels of 
drug in the circulation, with a rapid intravenous injection producing the highest 
blood levels. The disadvantage of the intravenous route is that if the drug is 
delivered too quickly; the plasma concentration rises so rapidly that the normal 
mechanisms of distribution are outpaced and toxic side effects can occur 
(Laurence et al, 1997, BNF, 2000). 
Subcutaneous, intramuscular, intralesional or intra-articular injections 
produce a slower effect than the intravenous route, but generally a quicker effect 
than the oral route. The subcutaneous route tends to have relatively poor 
absorption and repeated injections into one site can cause fat atrophy 
(lipotrophy) (Laurence et al, 1997). Absorption may be more rapid by the 
intramuscular route, which is suitable particularly for irritant drugs and depot 
preparations (slow release drugs that may remain in the tissues for days, weeks 
or months). 
Clinical tip. Anatomical knowledge of the structures to be injected is paramount. 
A poorly placed injection into the subcutaneous tissues may cause fat atrophy 
(lipotrophy) e.g. as may be seen with injection at the tennis elbow site. 
Musculoskeletal injections are delivered to the exact site of the lesion, in order to 
produce their effects locally, but some of the drug may be absorbed into the 
general circulation. As mentioned above, complete specificity cannot be 
guaranteed, and knowledge of the side effects of the injected drugs is therefore 
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most important. The recognised side effects will be covered under the topics of 
local anaesthetics and corticosteroids (see Chapter 3). 
Clinical tip. Take care, a rapid, accidental intravenous injection of local 
anaesthetic can produce life threatening side effects. Therefore, when delivering 
an intralesional injection containing local anaesthetic, aspirate before delivery of 
the solution to ensure that placement of the needle is not within a blood vessel. 
The rate of absorption of the drug from the intralesional site will depend on: 
• The nature of the tissue injected 
• Local blood flow 
• The rate of diffusion through the tissues 
• The solubility of the preparation 
A high local blood flow produces more rapid absorption, but this will vary 
according to the tissue injected, as some are more vascular than others. The rate 
of diffusion is generally more rapid in inflamed tissues due to the increased blood 
flow in the area. The more soluble the preparation injected, the more rapidly it is 
absorbed. 
B: Drug distribution 
Distribution of the drug to its target occurs by passage across cell membranes 
and via the body fluids by: 
• Diffusion 
• Filtration 
• Carrier molecules 
Diffusion is the natural tendency of any substance to move from an area of high 
concentration to one of low concentration. Corticosteroids are transported across 
cell membranes by this method. Lipid-soluble substances diffuse more readily 
into cells and this is the most important way in which a drug enters the tissues to 
be distributed through them. Drugs show greater or lesser degrees of lipid-
solubility according to the structural properties of the molecule and the acidity or 
alkalinity of the environment (Laurence et al, 1997). Local anaesthetics are weak 
bases (i.e. alkaline) and are less soluble in lipids in an acid environment, such as 
within inflamed tissues. They therefore do not cross cell membranes easily and 
their activity becomes impaired. However, in an alkaline environment, local 
anaesthetics are comparatively more soluble in lipids, and cross the cell 
membrane more readily by diffusion. 
Filtration is the passage of small water-soluble molecules through aqueous 
channels in tight junctions between adjacent epithelial cells. Filtration plays a 
minor role in drug distribution and is mainly concerned with excretion of drugs by 
glomerular filtration (Laurence etal, 1997). 
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Carrier molecules are special protein molecules within the lipid bilayer, which 
act as 'ferry boats' allowing drug molecules, which are insufficiently lipid-soluble 
to penetrate lipid membranes on their own, to cross by active transportation 
against or with the concentration gradient (Rang et al, 1995; Laurence et al, 
1997). 
B: Drug metabolism 
Drugs affect the metabolic processes of the cell in a variety of ways, such as by 
blocking ion channels, e.g. the blocking action of local anaesthetics on the 
voltage-gated sodium channel, or by inhibiting the action of enzymes. Specific 
receptors (proteins) may exist within the cell to which a drug may become bound 
(Rang, etal, 1995). 
Most drugs are treated by the body as foreign substances (xenobiotics) and are 
metabolised by enzymes (Rang et al, 1995; Laurence et al, 1997). This process 
occurs mainly in the liver, but other tissues such as the kidney, gut mucosa, or 
lung may contribute. 
Metabolism occurs in two phases, involving different types of biochemical 
reaction (Rang et al, 1995; Laurence et al, 1997): 
• An initial 'phase I reaction', which changes the drug molecule by oxidation, 
reduction or hydrolysis, producing a derivative which may be more active or 
toxic than the original drug. In some cases the original drug (known as a pro­
drug) is inactive and the phase I metabolite is in fact the active drug 
• The subsequent 'phase II reaction', which usually terminates the drug's 
activity producing an inactive compound 
B: Excretion of drugs 
Once a drug is absorbed it must be eliminated from the body and this normally 
begins with a process of metabolic intervention. Most drugs are excreted as 
metabolites but a few are eliminated unchanged. 
One method of describing the rate of elimination is by the concept of the 'plasma 
half life' fa/?) of the drug, which is the time taken for the plasma concentration to 
fall by 50%. In reality this is an oversimplification, e.g. with a slowly absorbed 
drug such as the corticosteroid triamcinolone acetonide, absorption is still taking 
place as elimination occurs. The uneven distribution of some drugs throughout 
the fluid compartments and tissues of the body makes the concept an inaccurate 
measure. The plasma half-life is only one factor involved in the duration of action 
of a drug, e.g. dexamethasone has a longer half-life compared with 
triamcinolone, but the available preparation is shorter acting due to its greater 
solubility than the available preparations of triamcinolone. 
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As mentioned above, there are three main routes of elimination: 
• The main route is via the kidneys, where the drug and its metabolites leave 
the plasma by filtration through minute pores in the capillary walls of the 
glomerulus 
• The lungs, which deal with inhalational agents such as general anaesthetics 
• Some drugs and their metabolites are excreted in the bile by the liver, and 
ultimately eliminated in the faeces. Re-absorption is common in the gut, 
making this a relatively inefficient route of elimination, but 25% of 
corticosteroids are excreted in this way 
A: The pharmacodynamic process 
Pharmacodynamics is the action of drugs on the cells, tissues and organs of the 
body, or what the drug does to the body. Drugs act by altering the body's control 
systems. Most bind to a specialised constituent of the cell to alter its function, 
selectively changing the physiological or pathological system to which it 
contributes. Drugs may act on the cell membrane, or may affect the metabolic 
processes within and outside the cell (Laurence et al, 1997). Further information 
on the pharmacodynamic processes of injectable drugs used in musculoskeletal 
medicine will be covered in Chapter 3. 
A: Drug nomenclature 
Each drug has three names: 
A chemical name that is of no clinical interest but describes the compound for 
the chemist e.g. N-diethylaminoacetyl-2-6xylidine hydrochloride monohydrate 
which is the chemical name for lidocaine hydrochloride (Wood-Smith, Stewart 
and Vickers, 1968). 
A generic name or approved name chosen by the Nomenclature Committee of 
the British Pharmacopoeia Commission (Henry, 1991) e.g. lidocaine (now the 
internationally standardised name for lignocaine), or triamcinolone acetonide as a 
further example. 
A proprietary or trade name chosen by the manufacturer which may apply only 
to a specific formulation e.g. Xylocaine® (lidocaine manufactured by Astra 
Pharmaceuticals), Adcortyl® (triamcinolone acetonide suspension 10 mg/ml 
manufactured by E.R. Squibb & Sons), Kenalog® (triamcinolone acetonide 
suspension 40 mg/ml manufactured by E.R. Squibb & Sons). 
Since proprietary names differ internationally, generic prescribing is the preferred 
method for clarity, economy and convenience (Laurence et al, 1997). 
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Conclusion 
This chapter has been deliberate in its attempt to set out the basic pharmacology 
of how drugs work. From that starting point, the next step will be to consider the 
equipment needed and the safety precautions to be taken prior to performing an 
injection. These topics will form the basis of the following chapter. 
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2 Essential equipment, safety precautions, emergency situations 
Chapter summary 
This chapter provides details of the range of needle and syringe sizes commonly 
used for musculoskeletal injections. Emphasis is placed on precautions to be 
taken to ensure safety and to minimise the risk of infection. The potential side 
effects are listed with notes on how to recognise and deal with emergency 
situations. 
A: Basic equipment 
B: Drug containers 
Fig 2.1: Drawing or photo of drug containers 
Drugs for injection are usually supplied in either vials or ampoules. Vials have a 
rubber cap, which is designed to be penetrated by the needle and to self-seal 
afterwards. The cap may be covered by a hard plastic seal (e.g. Kenalog, 
Depomedrone) or by a metal seal Ampoules are normally of glass construction, 
with no separate stopper, and care needs to be taken when breaking off the top 
in order to prevent injury. The narrow neck of the ampoule may be scored during 
manufacture or a file may be used to weaken the neck to facilitate opening. 
Lidocaine and some other local anaesthetics may be contained in plastic 
ampoules such as Polyamps™ or Sure-amps™. Each usually comes with full 
instructions but generally the top of the ampoule twists off and the syringe taper 
then fits directly into the neck of the ampoule. 
Clinical tip: Caution should be exercised to prevent inflicting skin wounds if a 
glass ampoule should shatter on opening. An opening device should be used or 
the hands protected with a cloth or gloves. 
B: Syringes 
Fig 2.2: Drawing or photo of syringes 
Disposable syringes should be used. These are all manufactured with expiry 
dates clearly marked on the paper side of the wrapper. This wrapping is usually 
of 'peel apart' type, consisting of paper and clear plastic. 
Sizes 1, 2, 5, 10, 20, 30, 50 and 60 ml are available and generally speaking, the 
size is chosen to be appropriate for the amount of solution delivered. More 
pressure may be required when injecting the teno-osseous sites of tendons e.g. 
the common extensor tendon at the elbow (tennis elbow/enthesitis). This can be 
achieved by using a small piston to produce a higher pressure for a given force 
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and a 1 ml syringe is ideal for this. The effect of syringe size on injection 
pressure is illustrated below (Fig 2.3). 
Fig:2.3 Chart and graph - effect of syringe on injection pressure 
B: Needles 
Fig 2.4: Drawing or photo of needles 
Disposable needles should be used. These are packed in 'peel apart' paper and 
clear plastic with the needle protected by a rigid or semi-rigid plastic tube. All 
.should be clearly marked with the size and sterilisation and expiry dates on the 
paper side of the wrapper. The needles are available in a range of lengths and 
diameters but it is common practice to refer to the colour of the plastic hub, which 
denotes the diameter (or gauge) of the needle. 
The following table gives an indication of the needle sizes available; those 
highlighted in bold type denote the needles mores commonly used in 
musculoskeletal injections. 
Imperial size (") Metric size (mm) Hub colour 
Fine diameter 25G x 5/8" 0.5 x 16 mm Orange 
A i 2 5 G x 1" 0.5 x 25 mm Orange 
2 3 G x 1" 0.6 x 25 mm Blue 
2 3 G x VA" 0.6 x 30 mm Blue 
21G x VA" 0 .8x40 mm Green 
2 1 G x 2 " 0.8 x 50 mm Green 
Large diameter IQGxVA" 1.1 x 40 mm White 
(G - gauge) 
Each needle has an acute angle on the bevel (Fig 2.5) 
Fig 2.5: diagram to illustrate the bevel of the needle 
For some musculoskeletal injections, a spinal needle may be an appropriate 
choice (e.g. hip joint or psoas bursa injections) and although available in different 
lengths, these are generally longer than the standard hypodermic needles (e.g. 
20G x 314 in, 0.9 x 90 mm). Spinal needles have a wire stylet which remains 
present in the lumen of the needle during its insertion, to prevent the skin being 
taken in with the needle, and is withdrawn before connecting the syringe. This 
feature is important for spinal injections but is also pertinent when the needle is 
required for musculoskeletal injections, since that fragment of skin may be a 
means of carrying infection to the site of the lesion. 
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The needles and syringes referred to above are usually available from NHS 
supplies for general practitioners, or may be ordered from a pharmacy or medical 
supplier for physiotherapists. 
A: Disposal of equipment 
'Sharps' containers should be used for the disposal of syringes, needles and 
empty drug containers. These containers will be readily available in hospital or 
general practitioners' surgeries where a policy will be in place for the safe 
disposal of 'sharps'. In private clinics, advice should be sought from the local 
council's environmental health department, who can usually provide suitable 
containers and offer a disposal service. 
A: General safety precautions 
All doctors and physiotherapists wishing to practise injection therapy should 
undergo a course of immunisation against Hepatitis B. This involves three doses, 
the second being given one month after the first and the third six months after the 
original dose. An accelerated regime is possible should it be required (contact 
your general practitioner or practice nurse for further details). Antibody levels 
should be checked two to four months after completing the course, with 80-90% 
of people responding overall. Those aged over 40 are less likely to respond. As a 
general rule poor responders should receive a booster dose and non-responders 
should consider repeating the course. All responders should probably have a 
booster dose after five years (Salisbury and Begg, 1996). 
You should be aware of all safety policies within your place of work relating to 
protection against viruses (Hepatitis B, HIV). Doctors and physiotherapists 
working in private clinics may need to establish a policy for themselves. 
All equipment should be disposed of safely (see above). Clinical waste should be 
placed in appropriately marked plastic bags (usually yellow) and removed for 
subsequent incineration (seek advice from appropriate local environmental health 
department). Spilt blood or body fluids should be dealt with correctly using latex 
gloves and paper towels. If gloves are to be worn, latex is safer than polythene 
for protection against viruses (Korniewicz et al, 1989). The area of spillage 
should be cleaned with sodium hypochlorite solution e.g. Domestos™, rinsing 
any soiled linen in cold water and an appropriate disinfectant e.g. 1/10 solution of 
bleach. 
A: Needlestick injuries 
To prevent needlestick injuries, a used needle should never be re-sheathed. 
However, if an injury does occur, the recommended procedure is to encourage 
bleeding as much as possible and to wash with soap and water. Urgent medical 
advice may be obtained by telephone from the following sources as appropriate: 
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• Nearest Public Health Laboratory 
• C P H M (Consultant in Public Health Medicine) on call for the Local Health 
Board in Scotland 
• Hospital Control of Infection Officer 
• Occupational Health Services 
(Salisbury and Begg, 1996) 
Clinical tip: Remember - NEVER re-sheath a used needle 
A: 'No touch' technique 
A 'no touch', 'clean' technique is vitally important, particularly when using 
corticosteroid agents, since their immunosuppressive effect increases 
susceptibility to infection and makes infection more difficult to detect and treat 
(Schimmer and George, 1998). Particularly when injecting a joint, septic arthritis 
should be considered as a serious, but avoidable, complication. 
Possible sources of infection include: 
• Skin organisms carried in during the injection procedure or spread from other 
adjacent infections 
• Introduction via contaminated equipment or solutions 
• Haematogenous spread from distant infection such as septicaemia e.g. 
following dental procedures or the use of genito-urinary tract instrumentation 
such as during cystoscopy 
• Direct trauma may have produced infection into the local area, particularly in 
superficial bursae e.g. the pre-patellar or olecranon bursae (Hughes, 1996) 
A 'no touch' routine to minimise the risk of infection is suggested in Chapter 4. 
The recommended maximum dose for the local anaesthetic, lidocaine, is 200 mg, 
(see Chapter 3). It is advised that to avoid reaching toxic levels of local 
anaesthetic, those new to musculoskeletal injection therapy may prefer to use no 
more than 5ml of 1% lidocaine, or 15 ml of 0.5% lidocaine on one occasion. 
Local anaesthetics are relatively more toxic in more concentrated solutions and 
both figures given are deliberately below the maximum dose. These 
recommendations provide a wide safety margin to minimise the potential risk 
from accidental injection via a blood vessel directly into the bloodstream. 
In general, the patient receives one injection for each musculoskeletal lesion 
diagnosed. In one year it is advisable not to give more than two injections into 
any one anatomical structure except the glenohumeral joint where three may be 
necessary for the treatment of traumatic arthritis (frozen shoulder) (Kesson and 
Atkins, 1998). 
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Should the patient present with more than one lesion, two injections could be 
considered at one treatment session, but it is recommended that the total dose of 
corticosteroid does not exceed 60 mg as a maximum, to err on the side of 
caution. However, if there is any query for particular drugs, the manufacturer's 
recommendation on the data sheet should be checked. 
A: Complications and recognising and dealing with emergencies 
B: Infection 
It is not uncommon for patients undergoing corticosteroid injection to experience 
a post-injection flare of pain, which is treated by rest, ice and non-steroidal anti­
inflammatory drugs, or simple analgesia. However, this must be distinguished 
from the pain signifying infection, which is generally more severe and lasts 
beyond the approximate limit of 72.hours of a post-injection flare. As mentioned 
above, corticosteroids can mask signs of infection, which are heat, redness, 
swelling and loss of function. If a septic arthritis or infection following intralesional 
injection is suspected, the patient should be referred urgently to hospital where 
an initial aspiration to confirm diagnosis will be followed by intravenous antibiotic 
therapy (Hughes, 1996). 
B: Simple faint 
This presents as pallor, hypotension with bradycardia, occasional twitching 
movements and possible eye rolling. The normal management for such an event 
is to loosen tight clothing and to place the patient in a horizontal or lateral 
position with the feet raised. Most patients wake up as soon as they are 
horizontal but, if not, they should be moved into the recovery position to 
safeguard the airway and to prevent the risk of aspiration should vomiting occur. 
B: Allergy 
This can vary from simple urticaria to anaphylaxis (see below). Urticaria may be 
present as a minor irritation or 'nettle rash' in which the itching may be treated 
with an antihistamine e.g. Piriton®. A more severe urticaria may present as large 
wheals and possible facial and glossal swelling. Medical advice should be 
obtained for both situations but is urgent if facial or glossal swelling occurs. A 
rash other than that classified above may present as an allergic dermatitis for 
which the application of hydrocortisone cream may prove curative. 
B: Anaphylactic shock 
This is an extremely rare complication of injection, but it requires prompt action to 
treat the laryngeal oedema, bronchospasm, hypotension and associated 
tachycardia (BNF, 2000). An itchy sensation progressing rapidly to facial or 
glossal swelling, as mentioned for severe allergy above, may be an indication of 
impending anaphylactic shock. Should this event occur it should be treated as a 
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medical emergency, physiotherapists should obtain urgent medical advice, and 
the routine for Basic Life Support should be followed (Gabbott and Baskett, 1997; 
Handley, 1997; Resuscitation Guidelines for use in the United Kingdom, 1997). 
Following most regional anaesthetic procedures, maximum arterial plasma 
concentrations of anaesthetic develop within 10 to 25 minutes. For this reason 
careful monitoring for toxic effects is recommended during the first 30 minutes 
after injection (BNF, 2000). 
The C S P Clinical Guideline for the Use of Injection Therapy by Physiotherapists 
(1999) provides specific points for the management of anaphylactic shock, 
suggesting the following regime: 
• Stop delivery of the drug 
• Summon medical help 
• Administer adrenaline 
• Administer cardiopulmonary resuscitation 
Conclusion 
This chapter has provided details of the range of needle and syringe sizes 
commonly used for musculoskeletal injections. The precautions to be taken to 
ensure safety and to minimise the risk from infection have been highlighted. The 
potential side effects have been listed with important notes on how to recognise 
and deal with emergency situations. The following chapter will describe the drugs 
used in musculoskeletal injections, with note of their mechanism of action, effects 
and side effects. 
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3 Injectable drugs for musculoskeletal lesions 
Chapter summary 
This chapter sets out to provide an overview of the principal drugs used in 
musculoskeletal injections with note of their mechanism of action, effects, side 
effects and contra-indications. It contributes still further to the development of 
safe and effective practice in the administration of musculoskeletal injections. 
A: Corticosteroids 
Local corticosteroid injections are used to reduce inflammation and pain, allowing 
mobilisation. They are given intra-articulary to treat episodic disease flares 
(Hunter and Blyth, 1999) as in acute episodes of degenerative osteoarthrosis e.g. 
osteoarthrosis of the knee, inflammatory arthritis e.g. rheumatoid arthritis of the 
wrist, and occasionally traumatic arthritis e.g. traumatic arthritis of the elbow. 
Weitoft and Uddenfeldt (2000) suggested that the aspiration of synovial fluid 
before placement of an intra-articular injection of corticosteroid reduced the risk 
of relapse in patients with rheumatoid arthritis. Creamer (1999) reviewed the 
literature on the use of intra-articular corticosteroid injection in osteoarthritis and 
noted several studies which indicated significant benefit compared with placebo 
in the knee although the beneficial effects were short lived. 
Intralesional corticosteroid injections are given for tendinitis e.g. tennis elbow, 
tenosynovitis e.g. de Quervain's tenosynovitis where the injection is delivered 
between the tendon and its sheath, compression neuropathies e.g. carpal tunnel, 
and for some ligamentous lesions e.g. coronary ligaments at the knee. 
Corticosteroids are hormones that are produced in the body by the adrenal 
cortex. They are classified into two broad groups; mineralocorticoids and 
glucocorticoids. Although several individual corticosteroids have mixed actions, 
the main properties of the groups are listed below: 
• Mineralocorticoids (the main endogenous hormone is aldosterone) which 
influence water and electrolyte balance 
• Glucocorticoids (the main endogenous hormones are corticosterone and 
hydrocortisone (Cortisol) which influence carbohydrate and protein 
metabolism. As well as their metabolic effects they also have anti­
inflammatory, anti-allergenic and immunosuppressive actions (Rang et al, 
1995; Schimmerand George, 1998) 
A range of synthetic corticosteroids has been developed with the glucocorticoid 
and mineralocorticoid actions separated. However, it has not been possible to 
separate the wanted anti-inflammatory actions of the glucocorticoids from their 
other unwanted side effects (see side effects of corticosteroids, Chapter 3) (Rang 
et al, 1995). 
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The anti-inflammatory (glucocorticoid) effect of corticosteroid is only 
advantageous if the mineralocorticoid effect of the drug is low, with little effect on 
water and electrolyte balance. Prednisolone produces predominantly 
glucocorticoid effects and is the drug of choice for long term use by mouth. 
Cortisone and hydrocortisone are not suitable for long term use because their 
mineralocorticoid effects are high, resulting in fluid retention. However, 
hydrocortisone has less side effects and its moderate anti-inflammatory effect 
makes it useful for topical application for inflammatory skin conditions and for 
injection in musculoskeletal intralesional injections. Betamethasone and 
dexamethasone have insignificant mineralocorticoid effects and high 
glucocorticoid effects, making them suitable for administration in high doses 
where fluid retention is not wanted, e.g. cerebral oedema. 
Methylprednisolone and triamcinolone have anti-inflammatory and 
immunosuppressive effects but little or no mineralocorticoid effects, making them 
suitable for musculoskeletal injections. 
Glucocorticoids act intracellularly at the target tissue, binding to specific receptor 
proteins in the nucleus which become activated after interaction with the steroid. 
The steroid-receptor complex then binds to DNA and either initiates or prevents 
transcription of certain genes, although the mechanisms by which this 
modification of gene transcription occurs are not fully understood. The anti­
inflammatory effects of glucocoticoids are thought to occur through decreased 
generation of prostaglandins. The enzyme cyclo-oxygenase (COX-2) is 
responsible for producing the prostaglandins involved in inflammation. 
Exogenous glucocorticoids inhibit COX-2 by inhibiting transcription of the 
relevant gene, reducing prostaglandin generation in inflammatory cells. There is 
also evidence that glucocorticoids induce the anti-inflammatory mediator 
lipocortin (Grillet and Dequeker, 1990; Rang et al, 1995). Time is required for the 
changes in gene transcription and protein synthesis which is clinically significant 
in that most of the effects of corticosteroids are not immediate, there is generally 
a delay before the beneficial effects are seen (Schimmer and Parker, 1996). 
B: Anti-inflammatory effects of corticosteroid injection 
All aspects of the inflammatory response are depressed by corticosteroid, 
regardless of cause, from the early acute phase of pain, heat, redness and 
swelling to the later chronic phase in which proliferation and remodelling are 
affected. Excessive or 'useless' inflammation can benefit greatly from 
corticosteroid. However, it is generally accepted that corticosteroid is not an 
appropriate treatment for acute inflammation because of its potent effect on the 
protective aspects of the inflammatory response and on the delay it causes in 
fibre formation (Kerlan and Glousman, 1989; Nelson et al, 1995; Laurence et al, 
1997). In the chronic inflammatory phase the balance in collagen synthesis is 
disrupted and inflammation and proliferation continue side by side. Corticosteroid 
injection can be beneficial in this phase, providing its unwanted effects are 
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recognised, with particular note of the loss of tensile strength in the structure due 
to reduced production of collagen and glycosaminoglycans (Stefanich, 1986; 
Grillet and Dequeker, 1990; Mazanec, 1995; Rang et al, 1995). For this reason, 
relative rest from causative or overuse factors is most important following 
injection until the soft tissues are considered to have returned to their functionally 
normal strength, e.g. approximately two weeks following triamcinolone acetonide 
injection (Cameron, 1995, Drugs and Therapeutic Bulletin, 1995; C S P Guideline 
for the Use of Injection Therapy by Physiotherapists, 1999)(see below). 
Reduced inflammation and immunosuppression is mainly achieved by the action 
on blood vessels, inflammatory cells and inflammatory mediators, and involves 
the following processes (Rang et al, 1995; Schimmerand Parker, 1996): 
• Vasoconstriction of small blood vessels 
• Reduced fluid exudation 
• Reduced leucocyte infiltration 
• Reduced production of the inflammatory mediators, prostaglandins, 
histamine, kinins 
• Production of anti-inflammatory mediators, lipocortins 
• t Inhibition of the macrophage, delaying phagocytosis, fibroblast activity and 
ultimately repair 
• Reduction in the permeability of the synovial membrane; corticosteroid is 
taken up selectively by the synovium 
• Reduced migration of leucocytes 
• Reduced activity of mononuclear cells 
• Reduced proliferation of blood vessels 
• Reduced fibrosis 
The effect of corticosteroid injection on collagen synthesis in the proliferation and 
remodelling phases is disputed (Sandberg, 1964; Ehrlich and Hunt, 1968; Ehrlich 
et al, 1972; Kulick et al, 1984). Marks et al (1983) showed a significant delay in 
wound healing by the application of topical steroids. Long-term, large doses of 
the sustained-release form of methylprednisolone were found to suppress 
collagen synthesis (Cohen et al, 1977), whilst intermittent doses appeared to 
have no effect. Intralesional corticosteroid produces keloid regression by 
inhibition of fibroblast migration, decreased collagen synthesis and increased 
collagenase activity (Carrico et al, 1984). 
In basic terms, an intra-articular or intralesional corticosteroid injection reduces 
inflammation, alters collagen synthesis and relieves pain. The reduced 
inflammation and analgesic affect allows the patient to move the affected part 
more normally. Normal mechanical stress induces collagen fibre orientation and 
leads to a strong mobile repair (Steams, 19940a; Stearns, 1940b; Le Gros Clark, 
1965; Kesson and Atkins, 1998). The altered collagen synthesis may initially 
weaken collagen fibres and, as a general rule, the patient should be instructed to 
rest from causative or overusing factors until they are symptom and sign free. 
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B: Corticosteroids used in musculoskeletal injection techniques 
Preparations licensed for intra-articular and intralesional injections (compiled 
from information contained in manufacturer's data sheets): 
Generic name Trade name Strength of 
preparation 
Présentation 
Hydrocortisone acetate Hydrocortistab® 25 mg/ml 1 ml ampoules 
Prednisolone acetate Deltastab10 25 mg/ml 1 ml ampoules 
Methylprednisolone acetate Depo-medrone®" 40 mg/ml 1,2&3ml vials 
Triamcinolone acetonide Adcortyr 10 mg/ml 1 ml ampoules, 
5 ml vials 
Triamcinolone acetonide Kenalog 1 0 40 mg/ml 1 ml vials ** 
Triamcinolone hexacetonide Lederspan® 20 mg/ml 1 ml & 5 ml vials 
Betamethasone sodium phosphate Betnesol® 4 mg/ml 1 ml ampoules 
Dexamethasone sodium phosphate Organon® 5 mg/ml 2 ml vials &1 ml 
ampoules 
Dexamethasone sodium phosphate Decadron® 4 mg/ml *** 2 ml vials 
* also available as a combined preparation with lidocaine, containing 
methylprednisolone 4% and lidocaine 1% in 1 or 2 ml vials 
** also available in 1 and 2 ml pre-filled syringes, although these are mainly 
intended for systemic administration by deep intra-muscular injection, rather than 
intralesional use 
*** the quoted dose is actually expressed as the equivalent dose of 
dexamthasone phosphate 
B: Relative potency 
This is expressed in terms of hydrocortisone as the standard, administered 
systemically, which is said to have a relative potency of 1: 
Corticosteroid Relative potency 
Hydrocortisone 1 
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Prednisolone 4 
Methylprednisolone 5 
Triamcinolone 5 
Betamethasone 30 
Dexamtheasone 30 
B: Duration of action of the corticosteroids 
Relatively soluble Less prolonged 
Hydrocortisone 
Prednisolone acetate 
Betamthasone 
Dexamethasone 
Triamcinolone acetonide 
Methyprednisolone acetate 
Triamcinolone hexacetonide 
Relatively insoluble More prolonged 
Corticosteroids are categorized according to their duration of action, which varies 
inversely with the solubility of the drug in water. Preparations such as 
Dexamethasone and Betamethasone have relatively more potent anti­
inflammatory effects compared to the shorter acting preparations, such as 
Hydrocortisone, and equivalent doses will therefore vary. For example, 20 mg of 
Hydrocortisone is equivalent to 4 mg of Triamcinolone, 5 mg Prednisolone and 
0.75 mg of Dexamethasone (Kerlan and Glousman, 1989; Nelson, et a), 1995, 
BNF, 2000). The medium acting preparations, such as triamcinolone, fall into the 
middle range in terms of relative anti-inflammatory potency and equivalent dose. 
Hydrocortisone acetate is weak, relatively soluble and is usually absorbed within 
36 hours. Synthetic corticosteroids are more potent and less soluble and their 
anti-inflammatory effects are therefore more prolonged. Precise data on the 
duration of action is scant, but after peri-articular injection, methyprednisolone 
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acetate remains in the plasma for a mean of 16 days, triamcinolone 
hexacetonide takes 14-21 days to be absorbed from a joint and triamcinolone 
acetonide takes slightly less time (Cameron, 1995, Drugs and Therapeutic 
Bulletin, 1995). The duration of action of corticosteroids, once absorbed, is 
described by the 'plasma half life' of the drug (ti/2 i.e. the time taken for the 
plasma concentration to fall by 50% (see Chapter 1). 
The corticosteroid used as an example throughout the regional techniques in this 
book is triamcinolone acetonide (for other drugs and information see page 000 
and refer to current manufacturer's data sheets). The recommended dosage 
given in the regional section is intended as a guideline and is a conservative 
estimate. It is recommended that the clinician who judges that an injection of 
corticosteroid is the treatment of choice, makes a decision on dosage in line with 
the guidelines, but also takes into account the severity of the patient's condition, 
the relative size of the area to be injected and any response to previous injection. 
Fig 3.1 Dose/volume for Adcortyl® 
Fig 3.2 Dose/volume for Kenalog® 
In order to provide immediate pain relief and to allow confirmation of accurate 
diagnosis and appropriate treatment, the chosen corticosteroid is injected 
together with a local anaesthetic agent (Nelson et al, 1995; Saunders and 
Cameron, 1997; Kesson and Atkins, 1998). Lidocaine is generally the local 
anaesthetic of choice (see page 000). 
B: Side effects and complications of injected corticosteroids 
Side effects and complications of corticosteroids are generally related to large 
doses and/or prolonged systemic use. Systemic side effects of a 'one-off 
injection of corticosteroid are rare, but can occur. The potential benefits from the 
prudent use of local corticosteroid injections outweigh their adverse effects 
(Cooper and Kirwan, 1990). Kumar and Newman (1999) conducted a prospective 
study to investigate the possible complications associated with intra- and peri­
articular steroid injections and found the procedure to be safe with a very low 
complication rate, if performed while taking adequate precautions. In the section 
below, the more common side effects associated with local injection of 
corticosteroid are listed first, followed by the side effects most often associated 
with systemic use. 
C: Post injection flare 
This is a self limiting side effect occurring 6 to 12 hours after injection, once the 
local anaesthetic effect has worn off, and resolving in less than 72 hours. It is an 
acute inflammatory reaction considered to be associated with the precipitation of 
steroid crystals due to the paraben preservatives in the local anaesthetic. The 
induced synovitis in a joint causes typical symptoms of acute inflammation i.e. 
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pain, redness, heat and swelling, and similar effects can be induced in a soft 
tissue injection such as tennis elbow. A full explanation of the possible side 
effects should be given and the patient advised to take appropriate measures to 
reduce the inflammation, such as rest, ice and non-steroidal anti-inflammatory 
drugs, or simple analgesics. The symptoms may resemble a septic arthritis and if 
these symptoms do not abate in the expected time, appropriate action should be 
taken for this more serious complication (see Chapter 2, page 000) (Stefanich, 
1986; Grilletand Dequeker, 1990; Mezanec, 1995; Swain and Kaplan, 1995). 
C: Local soft tissue atrophy and pigmentary changes 
Fat atrophy (lipotrophy), skin atrophy, senile purpura (which occurs more 
commonly with long term systemic use of corticosteroids) and depigmentation 
have all been documented. These changes occur more readily with the longer 
acting, less soluble drugs such as the triamcinolone preparations and/or through 
repeated injection into the same site. Causes have also been associated with 
misplaced injections i.e. an injection given subcutaneously before the target 
tissue is reached and/or as a result of leakage of the solution back along the 
needle track. The changes are more likely to occur with superficial soft tissue 
injections such as tennis and golfer's elbow and can appear at the site six weeks 
to three months after the injection. (Ponec et al, 1977; Marks et al, 1983; Cooper 
and Kirwan, 1990; Grillet and Dequeker, 1990; Pfenninger, 1991; Swain and 
Kaplan, 1995). Due to the possible unsightly cosmetic appearance, this potential 
complication should be discussed with the patient before the injection is 
performed. 
C: Connective tissue (tendon) weakening 
A recognised effect of corticosteroid drugs is a change in the mechanical 
properties of connective tissue structures resulting in a loss of tensile strength 
due to reduced production of collagen and glycosaminoglycans. Following 
injection, the loss of tensile strength can last for up to two weeks and this 
highlights the importance of specific advice on relative rest following injection. 
Tendons in particular have a relatively poor blood supply and are prone to 
degeneration. Some are notoriously susceptible to rupture e.g. Achilles tendon, 
rotator cuff tendons, the long head of biceps and abductor pollicis longus and 
extensor pollicis brevis in their shared synovial sheath. It is difficult to find 
conclusive evidence that corticosteroid injection is directly responsible for tendon 
rupture, or whether the rupture is due to the degenerative disease process. 
(Kennedy and Baxter Willis, 1976; Kleinman and Gross, 1983; Mahler and 
Fritschy, 1992; Read and Motto, 1992). 
Measures can be taken to minimise the risk of rupture following corticosteroid 
injection. Advice on relative rest for up to two weeks is important, accurate 
diagnosis and treatment should avoid the necessity for repeated injections and 
attention should be paid to technique itself. 
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The injection should NEVER be delivered directly into the body of the tendon and 
this is particularly important for weight-bearing tendons and those susceptible to 
rupture (see above). Bathing the tendon with the corticosteroid solution (see 
Achilles tendon page 000) or introducing the solution between a tendon and its 
sheath (see de Quervains page 000) avoids direct injection into the tendon. 
The lesion commonly lies at the teno-osseous junction, where a peppering 
technique is used. Droplets of corticosteroid solution are delivered at the tendon-
bone interface covering the whole area of the lesion and avoiding delivery en 
masse into one small area (see tennis elbow page 000). 
Notification of tendon damage associated with quinolone antibiotics e.g. Ciproxin 
was delivered from the Committee on Safety of Medicines (1995). Inflammation 
and rupture of tendons is a rare complication of this association, but the elderly 
4and those treated concurrently with corticosteroids are considered to be at risk. 
C: Steroid arthropathy 
Although steroid arthropathy is a recognised side effect of repeated corticosteroid 
injections, particularly into weight-bearing joints, the evidence is inconclusive and 
based mainly on subprimate animal studies (mainly rabbits) and anecdotal case 
reports. Repeated intra-articular injections are thought to produce a Charcot*-
type arthropathy with destructive changes in the articular cartilage, although 
these changes are also seen with the natural progression of the underlying 
degenerative disease. Possible mechanisms for the development of steroid 
arthropathy include joint abuse following corticosteroid mediated analgesia, with 
a direct effect on the articular cartilage and ischaemic necrosis. (Stefanich, 1986; 
Cooper and Kirwan, 1990; Cameron 1995; Mazanec, 1995; Millard and 
Dillingham 1995). To minimise risk of steroid arthropathy, weight-bearing joints 
should not be injected more frequently than every 4-6 months. 
Foot note * A Charcot joint is a neurogenic joint where the joint is denervated by 
some disease process and suffers chronic damage as a result. 
C: Iatrogenic (clinician induced) septic arthritis 
This is a rare, but avoidable, complication of corticosteroid injection occurring in 
0.0001% of patients injected. The organism is typically Staphylococcus aureus 
and the route of infection may be contamination of the injected materials, 
penetration by skin organisms, haematogenous spread, infection such as 
respiratory or urogenital tract or re-activation of previous infection. (Grillet and 
Dequeker, 1990; Haslock et al, 1995; Hughes, 1996; Coombs and Bax 1996). 
The joint becomes red, hot, swollen and painful, but the anti-inflammatory and 
immunosuppressive properties of the injected corticosteroid may mask the 
condition and make it difficult to distinguish from a post injection flare. If 
symptoms linger after the expected time for post injection flare (48-72 hours) 
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sepsis should be suspected and treated accordingly. Corticosteroid injection into 
an already septic joint is contra-indicated, as it will aggravate the condition. If 
sepsis is suspected, aspiration of a swollen joint should be conducted to 
eliminate the presence of infection (see Chapter 2, page 000). 
Clinical tip: The complication of septic arthritis can be avoided by screening for 
current or previous infections, avoiding injection in the presence of skin sepsis 
and by using a 'no touch' technique. 
C: Suppression of the response to infection or injury 
The anti-inflammatory and immunosuppressive effects of corticosteroids affect 
the normal response to infection and injury, suppressing clinical signs. Wound' 
healing is also impaired and this would have implications for patients undergoing 
surgery soon after corticosteroid injection. Steroid warning cards held by patients 
on long term corticosteroid therapy include advice on avoiding contact with 
infectious disease, particularly chickenpox or shingles (BNF, 2000). 
C: Facial flushing 
Systemic absorption of corticosteroid may cause this benign, transient 
complication, occurring more readily with triamcinolone preparations in 
approximately one in 20 patents. Facial flushing can occur within a few minutes . 
of the injection and last for a few hours or up to one or two days. (Neustadt, 
1991; Nelson et al, 1995; BNF, 2000). 
C: Menstrual disturbance 
With larger injected doses (e.g. in excess of 40 m'g of triamcinolone acetonide) 
systemic absorption may cause menstrual irregularities and amenorrhoea (ABPI 
Compendium of Data Sheets and Summaries of Product Characteristics 1999-
2000; Saunders and Cameron, 1997; Kesson and Atkins, 1998). 
C: Hyperglycaemia 
Systemic absorption of the injected corticosteroid may produce a transient 
increase in blood glucose levels in diabetic patients (Mazanec, 1995). 
C: Suppression of the hypothalamic-pituitary-adrenal axis (HPA axis) 
Adrenal function is regulated through the HPA axis and suppression of this 
mechanism reduces the production of endogenous Cortisol. Although a'more 
recognised side effect of long term oral intake of corticosteroids, a single local 
corticosteroid injection can suppress the HPA axis for two to four days (Cooper 
and Kirwan, 1990; Mazanec, 1995, Nelson et al, -1995; BNF,,2000). In long term 
corticosteroid therapy withdrawal should be phased and patients should carry a 
warning card which indicates that the treatment should not be stopped abruptly. 
C: Iatrogenic Cushing's syndrome 
Cushing's syndrome is associated with prolonged use of glucocorticoid therapy, 
rather than 'one-off local injections. Alterations occur in fat distribution producing 
trunk obesity, 'buffalo (dowager's) hump'; moon face, muscle wasting and 
osteoporosis (Cooper and Kirwan, 1990, Rang et al, 1995). 
C: Osteoporosis 
Osteoporosis is a recognised side effect of long term use of oral corticosteroid 
therapy and depends on the dosage, duration of the therapy and the disease for 
which the drugs were prescribed (Cooper and Kirwan, 1990; Mazanec, 1995). 
Theoretically, repeated corticosteroid injections could also produce this effect, 
but this is unlikely to be significant in musculoskeletal injection therapy. 
C: Mood changes 
These are typically euphoria, but may be psychosis, agitation, depression and 
suicidal tendencies. The mood changes are reversible and more likely to occur in 
patients with pre-existing personality disorders (Cooper and Kirwan, 1990; BNF, 
2000). 
C: Anaphylaxis 
Mace et al (1997) document a rare case of anaphylactic shock after intra-articular 
injection of synthetic methylprednisolone acetate. 
B: Drug interactions 
The following drug interactions have been noted from the ABPI Compendium of 
Data Sheets and Summaries of Product Characteristics 1999-2000: 
Corticosteroids: 
• Antagonise the effect of hypoglycemic agents including insulin 
• Antagonise the action of anti-hypertensive agents and diuretics 
• Enhance the potassium lowering effect of acetazolamide (Diamox), loop 
diuretics (e.g. frusemide) and thiazides (e.g. bendrofluazide) 
Certain drugs (e.g. barbiturates, carbamazepine etc) enhance the metabolic 
clearance of corticosteroids, but this is not likely to be significant in injection 
therapy. 
A: Local anaesthetics 
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Local anaesthetic drugs produce a moderate to long lasting, reversible nerve 
block. With a few exceptions (see carpal tunnel page 000) corticosteroid 
injections are delivered together with local anaesthetic in musculoskeletal 
injections for the following reasons: 
• * • Therapeutic pain relief, to allow immediate re-assessment to confirm 
diagnosis 
' • To increase the volume effect of the injection in certain conditions e.g. bursitis 
The first known local anaesthetic was cocaine, extracted from coca leaves and 
used clinically for corneal anaesthesia in 1884, but its toxic effects were found to 
be excessive. The synthetic substitute procaine was discovered in 1905 and 
several other compounds were later developed (Rang et al, 1995). 
Chemically, local anaesthetics consist of an aromatic group linked by an ester or 
amide bond to a basic side-chain (Rang et al, 1995). The ester type, e.g. 
procaine, usually comprises generally less stable compounds, whilst the amide 
type e.g. lidocaine, bupivacaine, comprises generally more stable compounds 
which have a longer plasma half-life. 
B: Mechanism of action 
Local anaesthetics penetrate the nerve sheath and axon membrane and block 
initiation and propagation of the action potential by specifically plugging sodium , 
channels (Rang et al, 1995). Conduction is blocked more easily in the small 
diameter nerve fibres producing a reversible local nerve block. Not all fibres are 
equally susceptible to their action as seen below: 
• Small, myelinated axons(A6 fibres) most readily blocked 
• Non-myelinated axons (C fibres $ 
• Large myelinated axons (Ap fibres) least readily blocked 
Nociceptive and sympathetic conduction is blocked first, therefore, pain 
sensation is blocked more readily than other sensations such as touch and 
proprioception. Motor axons, which are large in diameter, are relatively resistant 
to the action of local anaesthetics but it is difficult to be totally selective to affect 
pain sensation only and a transient local paralysis may occur. 
The potency, toxicity, duration of action, stability and solubility of local 
anaesthetic drugs vary considerably and those suitable for use in 
musculoskeletal injections will now be discussed. 
B: Local anaesthetics used in musculoskeletal injection techniques 
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Generic name Trade name Dosage 
per ml 
Présentation 
Lidocaine hydrochloride 0.5% Non-proprietary 
0.5%* 
5mg/ml 10ml ampoule 
Lidocaine hydrochloride 1% Non-proprietary 
1%* 
10 mg/ml 2ml, 5ml,10 ml,20ml 
ampoules 
Lidocaine hydrochloride 2% Non-proprietary 
2%* 
20 mg/ml 2ml, 5ml ampoules 
Lidocaine hydrochloride 0.5% Xylocaine® 0.5% 
** 
5mg/ml 20 ml vial 
Lidocaine hydrochloride 1% Xylocaine® 1%** 10mg/ml 20 ml vial 
Lidocaine hydrochloride 2% Xylocaine® 2%** 20 mg/ml 20 ml vial 
Bupivacaine hydrochloride 0.25% Marcain® 
0.25%** 
2.5 mg/ml 10 ml Polyamp® 
Bupivacaine hydrochloride 0.5% Marcain® 0.5%** 5 mg/ml 10 ml Polyamp® 
* BNF No 39 March 2000 
** ABPI Compendium of Data Sheets and Summaries of Product Characteristics 
1999-2000 . 
B: Relative potency and duration of action 
Lidocaine Bupivacaine 
Rapid rate of onset Slow rate of onset 
Medium duration of action 
(plasma VA of 2 hours) 
Long duration of action 
(plasma t!4 of 3 hours) 
Maximum dose 200mg Maximum dose 150 mg 
Medium potency Four times as potent as lidocaine (Scott, 
1989) 
Risk: convulsions occur before cardiac arrest 
and give warning of impending serious toxicity 
Risk: irreversible cardiac arrest may occur 
without preceding convulsions 
B: Maximum doses 
The maximum doses recommended above are for infiltration, not via the 
intravenous route, and apply to a fit adult of average weight (BNF, 2000). 
Systemic toxicity is related to blood levels and these vary according to: 
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• Rate at which the drugs are absorbed and excreted 
• Potency 
• Patient's age, weight, physique, clinical condition 
• Degree of vascularity of the area to be injected 
• Duration of administration 
Maximum arterial plasma concentrations occur within 10-25 minutes and for this 
reason, patients should be carefully monitored for signs of toxic side effects for 
up to 30 minutes after administration of local anaesthetics (BNF, 2000). 
Fig 3.3 Maximum doses 
The maximum safe dose of lidocaine is possibly higher than the data sheet figure 
quoted which gives the recognised figures for the UK and Europe. In the USA the 
recommended maximum dose for lidocaine is 300mg (Scott, 1989; Palve et al, 
1995). 
B: Local anaesthetics combined with adrenaline 
Some preparations are combined with adrenaline, which acts as a . 
vasoconstrictor diminishing blood plasma levels and permitting a higher dose of 
local anaesthetic to be given (Scott, 1989; BNF, 2000). Although the effect of the 
local anaesthetic will be prolonged, possible additional complications include 
potential ischaemic damage, and the combined use of local anaesthetics with 
adrenaline is absolutely contra-indicated in the digits. Susceptibility to cardiac 
arrhythmias may also be increased. 
B: Side effects and complications of injected local anaesthetics 
Adhering to the maximum recommended doses (see above) should avoid serious 
side effects and complications of local anaesthetic drugs. Inadvertent intravenous 
injection is most likely to cause problems, and for this reason it is recommended 
that once the needle is judged to be within the target tissue, aspiration is 
conducted to ensure that there is no flow back of blood to indicate placement . 
within a blood vessel. Central nervous system toxicity tends to occur more readily 
with the ester-type local anaesthetics e.g. procaine, than with the amide-type e.g. 
lidocaine, bupivicaine (Rang et al, 1995, BNF, 2000). 
C: Central nervous system effects 
Local anaesthetics initially cause stimulation of the central nervous system, 
which may be seen as: 
• A feeling of inebriation and light headednëss 
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• Restlessness and tremor 
• Confusion 
• Extreme agitation 
Further increases of the drug leads to depression of the central nervous system, 
which may be seen as: 
• Sedation 
• Twitching 
• Convulsions 
• Respiratory depression which is potentially life threatening 
Clinical tip: Since procaine is more likely to cause central side effects, it has 
been replaced by lidocaine as the local anaesthetic of choice for musculoskeletal 
injections. 
C: Cardiovascular effects 
These are mainly: 
• Myocardial depression, which is due to the blocking of sodium channels in the 
cardiac muscle, reducing calcium stores and, in turn, reducing myocardial 
contraction, which could potentially lead to cardiac arrest. However, lidocaine 
is useful, in the appropriate clinical setting, for its antidysrhythmic effect 
• Vasodilatation, which is due partly to the drug's effect on the vascular smooth 
muscle and partly to sympathetic inhibition 
• Hypotension, as a result of myocardial depression and vasodilatation, can be 
sudden and life threatening 
C: Allergic reactions 
These are covered in greater detail in Chapter 2. The most common is an allergic 
dermatitis due to hypersensitivity. Rarely, an acute anaphylactic reaction can 
occur which is life threatening. 
B: Drug interactions 
Cimetidine (Tagamet®), an anti-ulcer drug, may delay the metabolism of 
lidocaine, but this is probably of little significance with the doses advocated (ABPI 
Compendium of Data Sheets and Summaries of Product Characteristics'!999-
2000). A metabolite of procaine (para amino benzoic acid) inhibits the action of 
sulphonamide antibiotics, but this is not relevant in this text since 
musculoskeletal injections in the presence of infection are contra-indicated (Rang 
etal, 1995). 
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Conclusion 
This chapter has given an overview of the principal drugs used in 
musculoskeletal injections with note of their mechanism of action, effects, side 
effects and possible complications. The following chapter will provide general 
injection principles and will complete the theory section that underpins the 
application of injection therapy. 
4 General injection principles 
Chapter summary 
This chapter provides the general principles of injection therapy by firstly 
addressing the absolute and relative contra-indications for the administration of 
injections. A discussion of general and specific techniques follows, with a 
guidance for a 'no touch' technique and notes on follow up management and 
advice to be given to the patient to enhance effectiveness. Key points of record 
keeping are listed and a suggested treatment regime is presented. A flow chart 
for the clinical decision making process towards the administration of an injection 
concludes the section. 
A: Contra-indications 
The reader is referred to the Chartered Society of Physiotherapy (CSP) Clinical 
Guideline for the Use of Injection Therapy by Physiotherapists (1999), that 
provides evidence for the following absolute and relative contra-indications to 
musculoskeletal injections: 
B: Absolute contra-indications 
• Infection in the joint 
• Local sepsis or any infective illness 
• Hypersensitivity/allergy to steroid or local anaesthetic 
• Adjacent osteomyelitis 
B: Relative contra-indications 
• Recent history of trauma 
• Anticoagulant therapy 
• Bleeding disorders 
• ' Poorly controlled diabetes 
• Prosthetic joint 
• Haemarthrosis 
• Psychogenic or anxious patient 
• Concurrent oral corticosteroid therapy 
The following should also be considered cautiously: 
• Pregnancy, especially in the first trimester (Silver, 1999), but the final risk 
benefit decision should be left to the doctor 
• Recent history of malignancy 
• Children and adolescents, may have an effect on skeletal growth and maturity 
(Nelson et al, 1995) 
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Musculoskeletal injections should only be delivered following a full assessment of 
the patient taking into account the history (subjective examination) and 
examination (objective examination) which lead to clinicaldiagnosis. If injection is 
judged to be the treatment of choice, the procedure, including benefits and risks, 
should be fully explained to the patient in order to obtain informed consent. The 
wishes of a patient to decline injection should be respected. The legal age for 
consent is 16. 
At the time of writing, physiotherapists do not have prescribing rights under the 
terms of the Medicines Act {1968). However, as a step in that direction, group 
protocols have been put into place in some areas that allow physiotherapists to 
prescribe named drugs without getting individual prescriptions from doctors. 
Injections conducted by physiotherapists should be with the agreement of the 
patient's doctor, who is responsible for prescribing the injectable drugs, but the 
physiotherapist remains responsible for administering the injection (CSP Clinical 
Guideline for the Use of Injection Therapy by Physiotherapists, 1999). 
The equipment required for injection should be assembled and checked. The 
area to be injected should be prepared taking into account the precise location of 
the target tissue, route of access to the lesion, avoidance of vulnerable structures 
such as nerves and blood vessels, and patient and operator comfort. The choice 
of needle will depend on the location and size of the target tissue, but in general 
terms this should be the finest needle that will reach the full extent of the lesion. 
The choice of syringe will depend on the volume of the injection to be delivered. 
The dose to be administered will depend on the nature and size of the lesion, the 
severity of the condition and any response to previous injection. The reader is 
recommend to use the example doses from the regional section, which are 
intended as a guide and tend towards the conservative. 
Using triamcinolone acetonide as an example of an injectable corticosteroid: 
Adcortyl 10 mg/ml 
Kenalog 40 mg/ml 
and lidocaine 1% as an example local anaesthetic 
Structure Corticosteroid 
dose 
Corticosteroid 
volume 
Local anaesthetic 
volume 
Total 
volume 
Small tendons 
E.g. tennis elbow 
10 mg 0.25 ml 
Kenalog 
0.75 ml 1% lidocaine 1 ml 
Large tendons 
E.g. adductor longus 
20 mg 0.5 ml Kenalog 1 ml 1% lidocaine 1.5 ml 
Small joints 
E.g. acriomioclavicular 
5-10 mg 0.25 ml 
Kenalog 
0.25 ml 1% lidocaine 0.5ml 
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Large joints Up to 40 mg 4 ml Adcortyl 1 ml 1% lidocaine 5 ml 
E.g. hip 
The following guidance for a no touch technique is suggested to minimise the risk 
of infection: 
A: Guidance suggested for a 'no touch' technique for musculoskeletal injections: 
• Any previous allergic reaction to injections should be noted, since this will 
contra-indicate continuing with the procedure 
• Check the drugs to be used, choose an appropriate sized needle and syringe. 
Note the expiry dates on the containers, needles and syringes 
• Consider the precise location of the anatomical structure to be injected and 
the possible route of access to the lesion. Position the patient with the lesion 
and injection site accessible, bearing in mind the patient comfort and that of 
the operator 
• Mark the injection site e.g. with the end of the needle sheath, retracted end of 
a ballpoint pen or fingernail or skin marker pen 
• Wash and dry hands preferably with surgical scrub or antiseptic soap 
• Clean the skin over the injection site with a suitable antiseptic e.g. 
chlorhexidine 0.5% in spirit or Mediswab™ (Cawley and Morris, 1992). Draw 
up the drug using single dose containers wherever possible 
• Disposable needles are inexpensive, therefore change the needle after 
drawing up the drug, in case of contamination 
• Deliver the injection using a 'no touch' technique. Neither the prepared 
injection site nor the needle should be touched. If withdrawing the needle to 
change to a different entry site, the needle should again be changed before 
the second insertion (e.g. injection of the Achilles tendon page 000) 
• Once the needle is judged to be within the target tissue, aspiration should be 
carried out to ensure that it is not placed within a blood vessel 
• Once the needle has been withdrawn, dispose of it and the syringe safely 
(see Chapter 2) 
• Apply a suitable dressing, e.g. sticking plaster, having ensured that the 
patient is not allergic to such materials 
An accurate knowledge of anatomy is vital. Needle entry should be made quickly 
through the skin using appropriate anatomical landmarks and guidelines to aim 
towards the target tissue (see Section 2). 
The sensation of resistance imparted as the needle passes through the different 
tissues varies and allows the clinician to judge where the needle is placed. 
Injections should never be given directly into the body of a tendon, which will be 
felt as a fairly solid resistance. At the teno-osseous junction where the solution is 
delivered at the bone-tendon interface, the bony sensation will be appreciated. It 
is important to be gentle as the needle point contacts bone, as this can be painful 
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for the patient. Injection into a tendon sheath (tenosynovitis) should have a 
sensation of little or no resistance and the sheath may be seen to fill and swell 
slightly. Injection into a joint capsule or bursa will be experienced as a loss of 
resistance to the needle, indicating placement in a space. The patient may be 
aware of the needle reaching the target tissue and report a provocation of their 
symptoms. For nerve entrapment syndromes (e.g. carpal tunnel) the solution is 
delivered to bathe the inflamed nerve. Any reports of paraesthesia indicate that 
the needle is in the nerve and must be immediately withdrawn. 
Once the needle is judged to be in the target tissue, the plunger should be drawn 
back slightly to check that placement is not within a blood vessel. If there is a 
back flow of blood, the needle should be withdrawn and firm pressure applied to 
the area before repositioning the needle and checking again before injecting. 
A joint injection should be checked for the presence of infection. Once in situ, the 
plunger should be drawn back slightly and the fluid drawn into the syringe 
inspected. If this is a clear, straw coloured solution it is normal, and the injection 
can proceed. If the withdrawn fluid is opalescent or cloudy, this indicates possible 
infection and the injection of corticosteroid should not proceed. Doctors may wish 
to aspirate the joint and send the fluid for culture. Physiotherapists should refer 
the patient back to the Doctor. 
A: Injection technique 
Accurate delivery to the target tissue is important to prevent soft tissue changes 
and subcutaneous leakage. The technique used to deliver the injection will 
depend on the structure: 
B: Peppering technique 
This is a technique used to inject at the teno-osseous junction. The aim is to 
deliver small droplets of corticosteroid solution over the whole extent of the 
lesion. These are delivered at the tendon-bone junction. The hard sensation of 
bone is experienced and the needle is withdrawn very slightly from the bone to 
deliver each droplet. This ensures that the droplets of solution are evenly 
distributed throughout the lesion, rather than a concentrated bolus at one 
location. The body of the tendon itself should not be injected. 
B: Bolus technique 
This technique is used to inject bursae, joints, tendon sheaths and other areas 
such as the carpal tunnel. The aim is to deliver the corticosteroid solution as a 
whole, with one continuous squeeze of the plunger, into the bursal or joint space, 
where there should be no resistance to the needle. 
A: Subsequent management 
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Once the injection has been delivered, the patient may rest for a few minutes 
before the positive objective findings are re-assessed. The use of local 
anaesthetic should temporarily abolish symptoms which allows the clinician to 
check diagnosis and accurate needle placement. Ideally, the patient should be 
kept under further observation for up to 30 minutes after the injection to monitor 
for any adverse reaction, particularly anaphylaxis (see Chapter 3) (CSP Clinical 
Guideline for the Use of Injection Therapy by Physiotherapists, 1999; BNF, 
2000). 
The patient should be instructed in the self-management of their condition. 
Relative rest from causative and aggravating factors is advised for up to two 
weeks following injection. The injection may form part of a rehabilitation 
programme and appropriate physiotherapy may be required once the injection 
has had its effects. The cause of overuse lesions must be established to prevent 
recurrence. 
The patient should be reviewed between one and two weeks after the injection. 
The injection can be repeated if the patient is partially improved, but not if the first 
injection failed to benefit the condition. It is recommended that no more than two 
corticosteroid injections be given into one structure per annum, except for the 
glenohumeral joint where a maximum of three injections may be necessary for 
the treatment of traumatic arthritis (frozen shoulder). Due to the risk of steroid 
arthropathy (see Chapter 3), weight-bearing joints should not be injected more 
frequently than every 4-6 months. 
As mentioned previously in Chapter 3, it is important to highlight the 
recommendation that if two structures require injection in one treatment session, 
the total dose of corticosteroid should not exceed 60 mg of triamcinolone 
acetonide (or the equivalent for other corticosteroid drugs). If a dose exceeding 
40 mg steroid is given, it may be advisable to issue a steroid card to the patient. 
In order to keep within the safety margins for local anaesthetic, it is 
recommended that no more than 5 ml of 1% lidocaine or 15 ml of 0.5% lidocaine 
be given on one occasion. These figures are well below the maximum 
recommended doses and deliberately err on the side of caution, whilst permitting 
effective treatment. 
A: Record keeping 
Detailed clinical records should always be maintained whatever the treatment of 
choice for the patient. When considering the use of a musculoskeletal injection, 
questions relating to the following need particular consideration: 
• Details of current medications, particularly anticoagulants, insulin or oral 
diabetic medication 
• Any significant medical conditions which may contra-indicate the injection, 
produce specific side effects or lead to the possibility of drug interactions 
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• Past allergic reactions particularly those relating to corticosteroids, local 
anaesthetics (e.g. following dental procedures) or sticking plaster 
• Past history of previous problems with joint or soft tissue injections. Recent or 
recurrent infections e.g. tuberculosis 
The injection site should be examined for evidence of local infection e.g. boils. 
Any such infection should be noted in the records and would constitute a contra­
indication to injection. 
The details of the drugs used should be noted: 
• Prescribing doctor 
• Name of the drug 
• Strength of the solution if relevant (e.g. lidocaine 0.5% or 1 %) 
• Dose given 
• Manufacturer* 
• Batch number* 
• Expiry date 
*This information is relevant if problems arise from a defective preparation in 
which case the manufacturer will be liable. Without this information, liability 
remains with the prescriber and injector. 
Any post injection advice to the patient should be noted and the date for follow up 
recorded. At the follow up appointment, findings on re-assessment should be 
noted. In particular any adverse reaction reported or observed should be 
recorded and physiotherapists should inform the patient's doctor. 
The general principles to be applied in the application of injection therapy are 
summarised in the following suggested treatment regime: 
A: Suggested treatment regime 
1. Take a full history and a perform a physical examination of the patient to 
reach a clinical diagnosis and to be able to formulate a treatment plan. 
2. Discuss the possible alternative treatment choices with the patient. 
3. Explain the procedure fully to the patient, including any risk and obtain 
informed consent (Gilberthorpe, 1996). Allow the patient time to consider the 
injection so that consent can be freely given; the legal age for consent is 16. 
4. If injection is the treatment of choice, the physiotherapist should liase with the 
patient's doctor to discuss the prescription for the drugs (at the time of writing 
the introduction of prescription rights for physiotherapists is under discussion). 
5. Prepare for the injection procedure; with strict adherence to the no touch 
technique described above. 
6. Deliver the injection. 
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7. Re-assess the patient where appropriate, approximately five minutes after the 
injection, using the positive findings on examination to assess the successful 
placement of the injection. 
8. Give advice on suitable relative rest and rehabilitation. 
9. It is recommended that the patient should be asked to remain at the 
surgery/practice for 30 minutes following the injection (see Chapter 3, page 
36) 
10. Make a follow-up appointment. 
11. Complete the patient's medical records. 
Conclusion 
This chapter has concluded Section 1 by presenting an overview of the general 
principles of administering musculoskeletal injections. Guidance for a 'no touch' 
technique has been included to minimise the risk of infection and the key points 
of record keeping and a suggested treatment regime draws the principles for the 
application of an injection together. The clinical decision making process to be 
applied in making the decision to injecMs presented as a flow chart (Fig 4.1), that 
guides the operator through by steps to the stage of administration of the 
injection, and beyond, to the advice on management to be given to the patient 
and the subsequent reassessment of treatment outcomes. Section 2, following, 
will provide information and suggestions for the application of specific injection 
techniques and will build on the theory developed within this and the preceding 
chapters. 
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The clinical décision making process 
No 
Continue chosen 
treatment plan 
Conduct a füll subjective (history) and objective 
(examination) examination of the patient 
Make a clinical diagnosis (hypothesis) 
Is injection judged to be the treatment of choice? 
Yes 
Are there any contra-indications to 
injection? 
Yes No 
Choose another 
treatment regime 
Has patient given 
informed consent? 
No Yes 
Discuss another 
treatment option 
Deliver the 
injection 
Re-assess immediately to 
confirm clinical diagnosis 
Provide post injection 
advice/regime 
Arrange follo46up 
assessment 
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SECTION 2 Practice of musculoskeletal injections - regional injection 
techniques 
Introduction to Section 2 
This section presents intra-articular and intralesional injection techniques for 
peripheral musculoskeletal lesions encountered within clinical practice. A 
regional approach is adopted, with the injections being categorised into those of 
the shoulder, elbow, wrist and hand, hip, knee, ankle and foot. For clarity, each of 
the injections described will be presented in a consistent format detailing 
indications, presentation, needle size, dosage, patient position, palpation of the 
site, technique of the injection and aftercare advice for the patient. The injection 
dosages are given as guidelines throughout, and the reader is encouraged to 
adapt and develop those suggested on the basis of clinical experience. 
Preparation of the skin for injection and the guidance suggested for a 'no touch' 
technique can be found in Section I, Chapter 4. 
Patient presentation of the various conditions is detailed according to an 
examination procedure using selective tension, devised by Dr James Cyriax 
(Cyriax and Cyriax, 1983; Cyriax, 1984; Kesson and Atkins, 1998). Lesions are 
described as capsular, in which the specific range of limited movement indicates 
an arthritis in the joint, non-capsular which may indicate a bursitis or ligamentous 
lesion, or contractile indicating tendinitis or muscle belly where pain is 
reproduced on the appropriate resisted testing. 
Throughout this section, triamcinolone acetonide is used as an example of an 
injectable steroid, but an equivalent dose of any other corticosteroid preparation 
may be substituted. The longer acting corticosteroid preparations have relatively 
more potent anti-inflammatory properties compared to the shorter acting 
preparations and for this reason equivalent doses will vary, e.g. 4 mg 
Triamcinolone is equivalent to 20 mg Hydrocortisone, 5 mg Prednisolone and 
0.75 mg of Dexamethasone, see Chapter 3, or refer to the relevant 
manufacturer's data sheet for further information (Kerlan and Giousman, 1989; 
Nelson, et al, 1995, BNF, 2000). Accuracy in the initial diagnosis and in needle 
placement is paramount and the tips for palpation and technique aim to facilitate 
and ensure the effectiveness of the injection. 
5. The shoulder 
A: Glenohumeral Joint 
B: Indication 
Capsulitis or 'frozen shoulder*. This may present as either primary or secondary 
frozen shoulder. Primary or idiopathic frozen shoulder is sometimes known as 
steroid sensitive or monarticular rheumatoid arthritis (Cyriax and Cyriax, 1983; 
Cyriax, 1984) and occurs without obvious causative trauma. The more common 
secondary frozen shoulder may be a progression from traumatic arthritis, or may 
be associated with other lesions including cervical spine disorders, thoracic 
immobility, surgery, neurological disease or systemic disease, such as diabetes 
mellitus (Anton, 1993; Grubbs, 1993; Stam, 1994). Changes in anatomical 
structures closely related to the glenohumeral joint, e.g. the subdeltoid bursa, 
rotator cuff tendons or the long head of biceps, may have a secondary effect on 
the joint capsule (Kesson and Atkins, 1998). 
B: Patient presentation 
The patient describes pain, gradually increasing over several weeks, which is 
usually felt in the deltoid region but may refer further into the area of the C5 
dermatome (the anterolateral aspect of the arm and forearm as far as the base of 
the thumb), depending on the irritability of the condition. There is stiffness and 
loss of functional movement, and the patient may be unable to sleep on the 
affected side, also indicating a high level of irritability. 
On examination, passive movements are limited in the capsular pattern, with a 
greater proportional loss of lateral rotation, less limitation of abduction and least 
limitation of medial rotation. The loss of medial rotation has the most functional 
significance for the patient and restricts such activities as reaching into the back 
pocket or doing up the bra. The overall limitation of passive movements reduces 
the range of active elevation and the restricted movements have an abnormal 
hard end-feel. 
B: Treatment by injection 
The aim of corticosteroid injection is to relieve inflammation and pain, allowing 
the range of functional movement to be restored. Cyriax and Cyriax (1983) and 
Cyriax (1984) suggested a course of corticosteroid injections given over 
increasing intervals. As a general rule one, two or a maximum of three injections 
may be needed for the symptoms to fully subside, depending on the irritability of 
the condition at assessment. Typical time intervals would be 10-14 days between 
the first and second injections and 3-4 weeks between the second and third, 
aiming to give the follow up injection before the effect of the previous one has 
completely worn off. 
54 
Dacre et a! (1989) compared the use of local injection, physiotherapy or the 
combination of the two to treat painful, stiff shoulders. Their results suggested 
that injection of corticosteroid plus local anaesthetic is as effective and less 
expensive than physiotherapy alone, or a combination of both treatments. In a 
systematic review of the literature, Van der Heijden et al (1996), found scarce 
evidence in favour of the efficacy of corticosteroid injections for shoulder lesions, 
and the methods of most studies were deemed to be of poor quality. 
Cameron (1995a) suggested that injections of corticosteroid are efficacious in 
treating frozen shoulder providing the patients selected fulfil the diagnostic 
criteria based on the Cyriax assessment and the patient presentation 
summarised above (for more detail see Kesson and Atkins, 1998). 
B: Needle size 
21Gx11/2 in (0.8x40mm) or2 in (0.8x50mm) green needle 
B: Dose 
20-30 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 2-3 ml Adcortyl®, 1 ml 1% lidocaine 
The evidence suggests that the corticosteroid is the most important component 
of the injection (Jacobs et al 1991). Some authorities advocate the use of much 
larger volumes of local anaesthetic to cause distension of the joint capsule (Gam 
et al, 1998). De Jong et al (1998) conducted a comparative study which showed 
that in the treatment of frozen shoulder, greater symptom relief was gained in a 
group of patients receiving 40 mg of triamcinolone acetonide, compared with a 
group receiving 10 mg. 
B: Patient position 
Place the patient in sitting or lying. A posterior approach is recommended. Rest 
the arm with the elbow in flexion across the front of the waist to position the 
shoulder into medial rotation, so opening out the posterior aspect of the joint. 
B: Palpation: 
Stand behind the patient and place the thumb of your 'non injecting' hand on the 
posterior angle of the acromion, with your index or middle finger placed anteriorly 
on the coracoid process. Mark a point approximately 1 cm below your thumb. 
B: Technique 
Insert the needle at the marked point and direct the needle forward aiming 
towards your finger placed on the coracoid process (Fig 5.1). Proceed steadily 
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through the different tissue layers and once you have felt either the needle 
piercing the slightly tougher joint capsule, or coming to rest against the 'sticky' 
articular surface of the humerus, deliver the injection as a bolus {Fig 5.2). If 
resistance is felt as the plunger is pressed, the needle tip maybe within the 
articular cartilage. Withdraw slightly and continue with the injection. 
Clinical tip: Note that the suprascapular artery and nerve pass through the 
suprascapular notch and posteriorly around the neck of the scapula. Avoid 
injecting into these structures by ensuring accuracy in palpation and the angle of 
needle entry. 
Alternative technique: An anterior approach can be used. Position the patient in 
sitting or lying and palpate the coracoid process. Insert the needle below and 
lateral to the coracoid process aiming towards the glenohumeral joint. Deliver by 
a bolus technique when there is no resistance to the injection. 
Clinical tip: Note that the axillary artery and brachial plexus lie medial to the 
coracoid process, deep to pectoralis minor, and the cephalic vein passes 
between the antero-medial border of deltoid and pectoralis major. 
B: Patient Advice 
The patient should be instructed to begin gentle mobilisation as early as pain 
relief allows. Injection, together with physiotherapeutic advice on an appropriate 
exercise regime, to include scapular stabilisation and normal movement patterns, 
is helpful. The loss of movement in the capsular pattern prevents normal 
scapulothoracic rhythm with the scapula moving abnormally early during 
glenohumeral movement. 
A: Subdeltoid bursa (synonymous with subacromial bursa) 
B: Indication 
Chronic subdeltoid bursitis and acute subdeltoid bursitis. Chronic subdeltoid 
bursitis is an extremely common cause of pain at the shoulder, but it may present 
a challenge to diagnosis through the muddled picture presented on examination 
(Kesson & Atkins, 1998). The close anatomical relationship this bursa has with 
surrounding structures means that it is common for lesions such as bursitis, 
tendinitis and capsulitis to co-exist at the shoulder. Congenital abnormalities of 
the acromion or degenerative changes in the acromioclavicular joint may reduce 
the subacromial space and surgery may be an option if the bursitis is resistant to 
treatment. 
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Acute subdeltoid bursitis is a completely separate entity from the common 
chronic subdeltoid bursitis, and has a characteristic onset, which is described 
below. 
B: Patient presentation 
Chronic subdeltoid bursitis is generally due to repeated impingement of the 
bursa. The patient complains of a gradual onset of low-grade aching over the 
deltoid area with increased pain on reaching movements with the arm at shoulder 
height, such as putting on a coat or car seat belt. They may have trouble 
sleeping on that side and may find pushing down through the arm painful since 
this action increases impingement of the bursa under the coraco-acromial arch. 
On examination a non-capsular pattern with a full range of active and passive 
movement is usually present. Full passive elevation may increase the symptoms, 
but the normal elastic end-feel exists. A painful arc may be present on active 
abduction indicating impingement of the inflamed bursa under the acromion. The 
application, or release, of resisted tests may compress the bursa and produce 
symptoms, hence the 'muddle' of signs mentioned above. A similar pattern of 
signs may be found with rotator cuff lesions, especially if more than one tendon is 
involved, for example, both supraspinatus and infraspinatus. 
Acute subdeltoid bursitis is a rarer condition and typically presents with a rapid 
onset of severe pain over several hours, the pain gradually referring through the 
extent of the C5 dermatome (the antero-lateral aspect of the arm and forearm as 
far as the base of the thumb). Sleep is disturbed by the acute nature of the pain 
leaving the patient looking tired and unwell. Voluntary muscle spasm ensures 
that the patient holds the arm in an antalgic, pain avoiding, posture to avoid the 
severe twinges of pain that are experienced on active movement. Acute 
subdeltoid busitis has a similar presentation to acute calcific tendinitis and it may 
be debated that both terms are describing the same underlying condition. 
On examination the patient will tolerate very little movement, particularly towards 
abduction. The condition is usually self limiting with the severe pain decreasing in 
approximately 7-10 days, but the condition may not settle completely for up to six 
weeks. 
B: Treatment by injection 
The treatment for chronic subdeltoid bursitis is an injection of a large volume of 
low dose local anaesthetic with an appropriate amount of corticosteroid. 
However, this is unlikely to have a lasting effect in itself, unless the mechanisms 
by which the bursa becomes inflamed are addressed (see below). 
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In acute subdeltoid bursitis a smaller overall volume of fluid is delivered to the 
already swollen bursa. This may initially increase the symptoms before the anti­
inflammatory effects of the corticosteroid lead to a reduction in the pain. 
B: Needle size 
21Gx11/2 in (0.8x40mm) green needle 
B: Dose 
C: Chronic subdeltoid bursitis: 
20 mg triamcinolone acetonide, 5 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 5 ml 0.5% or 1% lidocaine 
C: Acute subdeltoid bursitis: 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 1 ml 1% lidocaine 
B: Patient position 
Seat the patient with the arm resting pendant by the side. 
B: Palpation 
Palpate the lateral border of the acromion to locate the groove between the 
acromion and head of the humerus. The subdeltoid bursa caps the greater 
tuberosity and extends under the acromion as far as the acromioclavicular joint 
line; it is this subacromial portion of the bursa that you aim to inject. Mark a point 
approximately mid point of the acromion. 
B: Technique 
Insert the needle just below the mid point of the acromion angling it slightly 
upwards until it lies between the acromion and head of the humerus (Fig 5,3). 
Deliver the injection as a bolus when a loss of resistance is identified (Fig 5.4). In 
chronic bursitis, synovial folds and adhesions may prevent this bolus delivery and 
it may be necessary to deliver the injection by a horizontal peppering technique. 
Reproduction of the patient's pain as you inject is usually an indication of 
accuracy of positioning of the injection. 
Alternative techniques: (1) A posterior approach: the needle is inserted just below 
the posterior angle of the acromion (the posterior 'eye' of the shoulder in 
acupuncture) and angled forward. (2) An anterior approach: the needle is 
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inserted under the anterior edge of the acromion, lateral to the acriomioclavicular 
joint. 
B: Patient advice 
After the injection for either the chronic or acute conditions, the patient should be 
advised to rest from overuse activities. In the case of chronic subdeltoid bursitis, 
the cause of impingement should be identified. The restoration of normal muscle 
balance forces around the.shoulder is important to normal movement and 
prevents excessive superior translation of the humerus, which is a key factor in 
the development of 'impingement syndrome'. 
A: Acromioclavicular joint 
B: Indication 
Arthritis. Due to overuse or degeneration of the acromioclavicular joint, or strain 
following trauma. 
B: Patient presentation 
The patient complains of pain specifically localised to the acromioclavicular joint 
at the point of the shoulder. Usually the patient points to the pain with a single 
finger rather than using the whole hand. 
On examination of the glenohumeral joint, there is a non-capsular pattern of 
movement with pain felt at the end of range of all passive movements i.e. passive 
elevation, medial and lateral rotation. Diagnosis is confirmed by a positive 'scarf 
test' i.e. pain on combined passive, horizontal flexion and adduction. 
B: Treatment by injection 
Injection may be successful in minor sprains of the acromioclavicular joint or 
arthritis (Jacob and Sallay, 1997). Dislocation or recurrent subluxation of the joint 
may require surgical intervention. 
B: Needle size 
23G x 1 in (0.6x25 mm) blue needle or 25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 mg Kenalog®, 0.25 ml 1% lidocaine 
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B: Patient position 
Place the patient in sitting or half lying. 
B: Palpation 
Palpate for the superior aspect of the acromioclavicular joint line which will lie 
approximately 1-2 cm medial to the lateral border of the acromion. The clavicle 
tends to override the acromion and a bump or step may be felt. Gentle 
superior/inferior movement of the clavicle may aid the localisation of the joint line. 
B: Technique 
Insert the needle, angled interiorly and slightly medially, through the superior 
capsular ligament, and once in the joint deliver the injection as a bolus (Figs 5.5 
and 5.6). 
Clinical tip: This joint can be difficult to inject because it may be narrowed due to 
degenerative changes and surrounding osteophytes. An-articular disc dropping 
down into the joint space from the superior capsular ligament can also impede 
entry. Skill may be required in 'palpating' for the joint space with the needle, 
involving consideration for the angle of entry. The superior ligament can be 
injected using a peppering technique if entry into the joint is not possible. 
Alternative technique: An anterior approach can be used where the needle is 
inserted into the anterior "v" shaped notch between the clavicle and acromion, 
aiming backwards, in a horizontal line with the joint surfaces. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Rotator cuff tendons 
B: Indication 
A contractile lesion at the shoulder may involve one of the rotator cuff tendons, 
supraspinatus, infraspinatus or subscapularis. The lesion can vary from simple 
strain to degeneration involving full or partial thickness tears. The cause is 
usually overuse resulting in cumulative microtrauma of the tendon. Fatigue and 
degeneration may then result in muscle imbalance and abnormal movement 
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patterns. The head of the humerus is no longer effectively depressed by the 
action of the rotator cuff muscles, resulting in abnormal superior translation and 
further trauma to the tendons through impingement. 
B: Patient presentation 
The patient describes pain of gradual onset with single traumatic incidents being 
possible, but less common. Pain is felt over the deltoid area of the shoulder and 
is increased by activity, particularly involving the use of the hands above 
shoulder level. Chronic, long term lesions can lead to involvement of the other 
closely related anatomical structures, i.e. the subdeltoid bursa and/or the joint 
capsule. 
On examination, an uncomplicated tendinitis presents with pain on the 
appropriate resisted test and possibly pain on the opposite passive movement. 
However, the principal signs are: 
• supraspinatus: pain on resisted abduction 
• infraspinatus: pain on resisted lateral rotation 
• subscapularis: pain on resisted medial rotation 
Localising signs may exist which help to locate the exact site of the lesion. In the 
case of supraspinatus and infraspinatus, the presence of a painful arc 
incriminates the teno-osseous junction of the tendon. In subscapularis, a painful 
arc incriminates the upper fibres, and a positive 'scarf test (combined, passive 
horizontal flexion and adduction of the shoulder) incriminates the lower fibres. 
Ultimately palpation of the identified structure will reveal the exact site of the 
lesion. 
B: Treatment by injection 
Injection of simple tendinitis can be curative provided that the exact site of the 
lesion is located. Establishing and eliminating the cause of the problem is also 
important. Complicated cases can be more resistant to treatment, especially if 
partial or full thickness tears exist, and the patient may require surgical 
investigation. Ultrasound scanning can be useful in identifying the exact 
pathology present. More chronic lesions may lead to secondary capsulitis, in 
which case the joint itself may require injection as described for capsulitis or 
'frozen shoulder" above. 
Clinical tip. Some authorities disagree with injecting individual rotator cuff 
tendons. Degenerative tears of these tendons are relatively common and there 
are some reported cases of tendon rupture following corticosteroid injection (see 
Kesson & Atkins, 1998, Chapter 3). An 'umbrella' injection under the acromion 
may effectively bathe these lesions, as described for the injection of subdeltoid 
bursitis (page 000). 
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A: Supraspinatus 
B: Needle size 
25G x 5/8 in (0.5x16 mm) orange needle or 23G x 1 in (0.6x25 nim) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting supported at an angle of approximately 45 degrees. 
Medially rotate the shoulder and extend the arm behind the back to expose the 
superior facet of the greater tuberosity, anteriorly. 
B: Palpation 
Supraspinatus inserts into the superior facet of the greater tuberosity. Palpate the 
anterior border of the acromion and the superior facet on the greater tuberosity. 
The tendon of supraspinatus runs forward between these two bony points and is 
approximately as wide as the patient's index finger. Locate the exact site of the 
lesion by palpation for tenderness along the tendon. Mark a point approximately 
mid point of the tender site. 
Clinical tip: To locate supraspinatus and infraspinatus (see below), the greater 
tuberosity provides a useful bony landmark. The greater tuberosity lies in line 
with the lateral epicondyle at the elbow and this may be used as a point of 
reference if locating the greater tuberosity proves difficult. 
B: Technique 
Insert the needle perpendicular to the teno-osseous junction and deliver the 
injection by a peppering technique (Figs 5.7 and 5.8). 
A: Infraspinatus 
B: Needle size 
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23G x 1 in (0.6x25 mm) or 23G x 11/4 in (0.6x30 mm) blue needle or 21G x 11/2 
in (0.8x40 mm) green needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Place the patient into prone lying, propped up on the elbows; or side lying with 
the painful side uppermost. In both positions place the shoulder joint into 
adduction and lateral rotation to expose the middle facet of the greater tuberosity 
posteriorly. 
B: Palpation 
Infraspinatus inserts into the middle facet of the greater tuberosity. Palpate the 
posterior angle of the acromion and locate the greater tuberosity. The tendon of 
infraspinatus runs parallel to the spine of the scapula, inserting into the greater 
tuberosity just below the acromion. It is approximately two fingers wide. Locate 
the exact site of the lesion by palpating for tenderness along the tendon and 
mark this point. 
B: Technique 
Insert the needle perpendicular to the tendon and deliver the injection by a 
peppering technique, being sure to cover the whole extent of the lesion (Figs 5.9 
and 5.10). 
A: Subscapularis 
B: Needle size 
23G x 1 in (0.6x25 mm) or 23G x 11/4 in (0.6x30 mm).blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
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Seat the patient with the arm in the anatomical position and supported on their 
lap. 
B: Palpation 
Subscapularis inserts into the lesser tuberosity and it is approximately three 
fingers wide, although the thin membranous tendon is not easy to feel. Palpate 
for the coracoid process and move laterally and slightly down, or identify the 
bicipital groove and move medially. Both methods will locate the lesser 
tuberosity. Locate the exact site of the lesion by palpation for tenderness along 
the tendon. Mark a point approximately mid point of the tender site. 
B: Technique 
Deliver the injection by a peppering technique being sure to cover the full extent 
of the lesion (Figs 5.11 and 5.12). 
Injection of the rotator cuff tendons is just one treatment option and another is 
transverse friction massage by a physiotherapist. Whatever the choice of 
treatment, the cause of the overuse activity and/or reason for impingement must 
be addressed to prevent recurrence. 
B: Patient advice 
The patient should be instructed to rest from aggravating activities for a period of 
up to two weeks following the injection. 
A: Long head of biceps in the bicipital groove (intertubercular sulcus) 
B: Indication 
Tenosynovitis, which may affect the tendon in the bicipital groove. The long head 
of biceps originates within the capsule of the glenohumeral joint and exits the 
joint behind the transverse humeral ligament taking with it an extension of 
synovial lining into the bicipital groove. 
B: Patient presentation 
Pain is felt in the anterior shoulder region usually associated with a history of 
overuse. On examination resisted elbow flexion and resisted supination 
reproduce the pain felt at the shoulder. 
B: Treatment by injection 
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Tenosynovitis involves inflammation of the double layered synovial sheath rather 
than the tendon itself, and adhesions may form between the two layers of the 
sheath, interfering with function (Cyriax, 1982). An accurately placed injection of 
corticosteroid may be curative. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) or 23G x 11/4 in (0.6 x 30 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the arm supported in the anatomical position. 
B: Palpation 
In the anatomical position the bicipital groove faces forward, lying between the 
greater and lesser tuberosities of the humerus. If in doubt, locate the coracoid 
process, move down and laterally onto the lesser tuberosity. Lateral to this is the 
bicipital groove. Mark the area of tenderness, as located by palpation. 
B: Technique 
Insert the needle parallel and close to the bicipital groove approaching from 
above downwards (Fig 5.13). The injection is delivered as a bolus into the 
synovial sheath of the tendon, not into the body of the tendon (Fig 5.14). 
B: Patient advice 
Advise a period of relative rest from aggravating factors for a period of up to two 
weeks. 
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6. The elbow 
A: Elbow joint 
B: Indication 
Arthritis at the elbow joint which may be degenerative, traumatic or inflammatory. 
Inflammatory arthritis, such as rheumatoid, is probably the most common 
condition to be injected. 
B: Patient presentation 
Pain is felt over the elbow and, depending on the severity, may be referred into 
the forearm. If traumatic in origin the possibility of fracture will need to be 
excluded. 
On examination there will be a capsular pattern of more limitation of flexion than 
extension, with the flexion having an abnormal hard end-feel. The superior radio­
ulnar joint may be involved, since it shares a common capsule with the elbow 
joint proper. The capsular pattern at the superior radio-ulnar joint is pain felt at 
the end of range of both rotations. 
B: Treatment by injection 
Despite the complicated anatomical structure of the elbow joint, a bolus injection 
via the radiohumeral articulation is the easiest intra-articular route. The 
corticosteroid injection will reduce pain and inflammation, allowing some recovery 
of the range of movement. 
B: Needle size 
25G x 5/8 in (0.5x16 mm) orange needle for the lateral approach 
23G x 1 in (0.6 x 25 mm) or 23G x 11/4 in (0.6 x 30 mm) blue needle for the 
posterior approach 
B: Dose 
20 mg triamcinolone acetonide, 1ml local anaesthetic 
e.g. 2ml Adcortyl®, 1ml 1% lidocaine 
B: Patient position 
Seat the patient with the forearm supported into mid pronation with the elbow at 
approximately 45 degrees of flexion. 
B: Palpation 
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Palpate the head of the radius and locate the radiohumeral joint line on the . 
posterolateral aspect. Mark a point at the approximate mid point of the joint line. 
B: Technique 
Insert the needle to lie between the head of the radius and the capitulum (Figs 
6.1 and 6.2). Deliver the injection as a bolus. 
Alternative technique: Position the patient with the elbow flexed to 70 degrees. 
Locate the depression between the olecranon and lateral epicondyle on the 
posterolateral aspect of the elbow joint. Direct the needle forward and slightly 
downward and deliver the injection as a bolus. 
B: Patient advice 
The patient should be advised to maintain a period of relative rest for 
approximately two weeks following the injection. 
A : Olecranon bursitis 
B: Indication 
Olecranon bursitis (student's elbow). This is inflammation of the subcutaneous 
bursa which is positioned between the upper end of the posterior aspect of the 
ulna and the skin. Bursitis may be idiopathic, related to trauma, repetitive injury, 
gout or arthritis, such as rheumatoid (Kumar and Clark, 1994). Superficial bursitis 
such as this may have an infective origin since it is vulnerable to unrecognised 
perforating injuries. Diagnosis of this is important before proceeding with the 
injection. 
B: Patient presentation 
Pain is felt over the posterior aspect of the elbow and swelling is both visible and 
palpable. 
On examination there are usually no clinical findings and the condition is 
diagnosed by the obvious swelling over the olecranon. 
B: Treatment by injection 
Injection can be curative, but aspiration to check for the presence of infection is 
important before proceeding. Clear aspirate is normal; cloudy aspirate indicates 
possible infection, but bacteriological confirmation may be required. 
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B: Needle size 
21G x 11/2 in (0.8x40 mm) green needle 
B: Dose 
10 mg triamcinolone acetonide, 1ml local anaesthetic 
e.g. 1ml Adcortyl®, 1ml 1% lidocaine 
B: Patient position 
Seat the patient with the elbow supported in a degree of flexion. 
B: Palpation 
Palpate the obvious swollen bursa and mark a convenient point for inserting the 
needle. 
B: Technique 
Insert the needle into the bursa (Figs 6.3 and 6.4). Aspirate first to check for the 
presence of infection and if clear, the injection can be delivered as a bolus. 
B: Patient advice 
The patient should be advised to avoid further trauma to the bursa. 
A: Tennis elbow (lateral epicondylitis) 
B: Indication 
Tennis elbow is strain of the wrist extensor muscles at their origin (enthesis) from 
the anterior aspect of the lateral epicondyle. The tendon most commonly involved 
is extensor carpi radialis brevis. Repeated gripping actions may produce traction 
of fibres at the common extensor origin leading to microtrauma and inflammation 
(Foley, 1993). Micro- and macroscopic tears lead to the development of fibrous 
scar tissue and contracture, eventually resulting in degenerative foci and 
calcification (Coonrad and Hooper, 1973; Ernst, 1992; Gellman, 1992; Noteboom 
et al, 1994). Initial changes in the tendon would seem to be inflammatory and 
therefore true tendinitis. In chronic long term lesions the degenerative changes of 
tendinosis may be more pronounced making the condition more difficult to deal 
with. Early treatment, whatever the choice, may prevent the development of 
chronic lesions and ease pain (Hay et al,1999). 
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B: Patient presentation 
The patient complains of a gradual increase in pain on the lateral aspect of the 
elbow, which may radiate into the forearm and sometimes into the dorsum of the 
wrist and hand. Repeated gripping actions aggravate the symptoms and a twinge 
of pain is often experienced, when the grip will feel weak. 
On examination, resisted wrist extension with the elbow extended provokes the 
symptoms. The exact site of the lesion is located by palpation. 
B: Treatment by injection 
There are several possible sites for the lesion, which will be determined by 
palpation. Involvement of the origin of the common extensor tendon, mainly 
extensor carpi radialis brevis at the anterior facet of the lateral epicondyle is the 
most common, and is the site that may best respond to injection. However, 
alternative treatment techniques will be discussed below. 
Corticosteroid injection aims to reduce the inflammation and pain. Once pain is 
reduced, normal movement will encourage alignment of fibres and reduce 
scarring. Given that the condition can progress to being mainly degenerative, 
treatment, particularly by corticosteroid injection, would seem to be most 
efficacious in the early inflammatory phase where good results have been shown 
in the short term (Price et al, 1991; Haker and Lundeberg, 1993; Sdlvebom et al, 
1995; Assendelft et al, 1996; Verhaar et al, 1996). 
Price et al (1991) reported a more rapid relief of pain and a reduced need for 
repeated injections with 10mg triamcinolone over25mg hydrocortisone or 
lidocaine alone in the short term. Injection of 20 mg triamcinolone produced 
similar results to 10 mg with the higher dosage more likely to produce skin 
atrophy. The results of their study were not statistically significant. 
B: Needle size 
25G x 5/8 in (0.5x16 mm) orange needle 
• B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
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Seat the patient with the forearm supported in full supination, the elbow flexed to 
approximately 90 degrees. This positions the tendon to run directly forwards from 
the anterior facet of the lateral epicondyle. 
B: Palpation 
Palpate the lateral epicondyle of the humerus. Roll onto the anterior surface and 
palpate the insertion of the tendon, which should be tender, compared with the 
other side. Mark a point at the mid point of the tender site. 
B: Technique 
Insert the needle from an anterior direction, perpendicular to the facet, and 
deliver the injection by a peppering technique (Figs 6.5 and 6.6). Ensure that the 
injection is delivered to the target tissue and not superficially, which could lead to 
the complication of local soft tissue atrophy and/or pigmentary changes. 
The teno-osseous junction is just one possible site of the lesion, albeit the most 
common (Cyriax, 1982; Cyriax and Cyriax, 1983). The other possible sites are 
the origin of extensor carpi radialis longus from the lower third of the lateral 
supracondylar ridge, the body of the tendon lying over the head of the radius and 
the muscle belly. All traditionally respond to physiotherapeutic measures. 
Techniques such as deep transverse friction massage and Mill's manipulation, 
electrotherapy and acupuncture, to name a few, are other possible treatment 
approaches for the common extensor origin site (Cyriax and Cyriax, 1983; 
Cyriax, 1984; Kesson and Atkins, 1998). 
B: Patient advice 
The patient should be advised to maintain a period of relative rest for 
approximately two weeks following the injection. Addressing the cause of the 
problem is probably the most important issue. Sporting advice may be 
appropriate in terms of looking at training regimes and grip size. Workstations 
may need adjusting and breaks from repetitive activities should be strongly 
encouraged. Counterforce braces (clasps, bandages or strapping) may be 
helpful. 
Clinical tip: A branch of the radial nerve, the posterior interosseous nerve, 
passes between the two heads of the supinator muscle at the elbow. Entrapment 
of the nerve may be a factor in the resistant tennis elbow. Full assessment to 
address all causes is essential. 
A: Golfers elbow (medial epicondylitis) 
B: Indication 
Golfer's elbow describes a strain of the wrist flexor muscles at their origin from 
the anterior aspect of the medial epicondyle. The aetiology and disease process 
is similar to that of tennis elbow (see page 000) although Golfer's elbow is not as 
commonly encountered. The principal site of the lesion is at the teno-osseous 
junction (enthesis) of the common flexor tendon but, less commonly, the lesion 
may be seen a little further distally in the musculotendinous junction. 
B: Patient presentation 
The patient complains of a gradual onset of medial elbow pain, often well 
localised to the medial epicondyle, although symptoms may be referred more 
distally. Onset is associated with overuse activities and the symptoms are 
provoked by use. 
On examination resisted testing of the wrist flexors with the elbow placed in 
extension is positive, and palpation will locate the exact site of the lesion. 
B: Treatment by injection 
Like tennis elbow, early injection can be curative, but the reason for the onset 
must be determined and the aggravating actions avoided to prevent recurrence. 
It is the teno-osseous site which responds well to injection (Cyriax and Cyriax, 
1983). 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle or 23G x 1 in (0.6 x 25 mm) blue 
needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Place the patient in sitting with the elbow extended over a pillow and in 
supination. 
B: Palpation 
Palpate the medial epicondyle of the humerus and move round onto its anterior 
aspect to palpate the origin of the common flexor tendon, Identifying the area of 
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maximum tenderness, compared with the other side. Mark a point approximately 
at the mid-point of the tender site. 
B: Technique 
Insert the needle perpendicular to the anterior facet of the medial epicondyle and 
deliver the injection by a peppering technique (Figs 6.7 and 6.8). 
Clinical tip: The ulnar nerve lies posterior to the medial epicondyle of the 
humerus but the suggested approach should prevent injection into the nerve 
itself. Stahl and Kaufman (1997) describe an accidental injury to the ulnar nerve 
following injection for medial epicondylitis in a patient with undetected recurrent 
dislocation of the ulnar nerve. 
B: Patient advice 
The patient is advised to rest from aggravating factors for up to two weeks. 
As with tennis elbow, it is most important to address the cause of the lesion. 
The teno-osseous junction (enthesis) is one site for Golfer's elbow, and 
physiotherapeutic modalities such as deep friction massage and electrotherapy 
are alternative techniques for treating this lesion. A lesion may exist at the 
musculotendinous junction, but this traditionally responds to physiotherapeutic 
modalities alone e.g. transverse friction massage (Cyriax and Cyriax, 1983; 
Cyriax, 1984; Kesson and Atkins, 1998). 
A: Biceps tendon insertion at the radial tuberosity 
B: Indication 
Strain at the insertion of the biceps tendon at the radial tuberosity. This usually 
arises from overuse and may be difficult to differentially diagnose from 
inflammation of the subtendinous bursa at this site. 
B: Patient presentation 
The patient complains of pain localised to the elbow. 
On examination of the elbow joint, resisted elbow flexion and resisted supination 
reproduce the patient's pain. Involvement of the subtendinous bursa may be 
indicated by a muddle of signs e.g. pain on resisted elbow flexion, passive elbow 
extension and passive pronation, all of which squeeze the inflamed bursa. 
B: Treatment by injection 
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Since a lesion in either the tendon or the bursa lies deeply, injection of 
corticosteroid is the treatment of choice. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in prone lying with the arm at the side resting in the 
anatomical position. Fix the humerus to avoid changing the position of the 
glenohumeral joint and carefully pronate the extended forearm. This rotates the 
forearm to bring the radial tuberosity to lie posteriorly. 
B: Palpation 
Locate the radial tuberosity, which is lying between the radius and ulna 
approximately 2 cm distal to the radiohumeral joint line. Mark the principal point 
of tenderness. 
B: Technique 
Insert the needle between the radius and ulna, at the point of maximum 
tenderness, until the resistance of the tendinous insertion is felt (Figs 6.9 and 
6.10). Deliver the injection by a peppering technique to cover both the insertion of 
the tendon and the subtendinous bursa. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. As with all overuse lesions, eliminating the causative factors will 
prevent recurrence. 
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7. The wrist and hand 
A: Inferior (distal) radio-ulnar joint 
B: Indication 
Arthritis. This joint is most commonly affected by rheumatoid arthritis, although 
degenerative and traumatic arthritis may also cause symptoms. 
B: Patient presentation 
The patient complains of pain felt in the lower forearm. 
On examination a capsular pattern is present, with pain reproduced at the end of 
both extremes of passive pronation and supination. Limitation of these 
movements is not usually found, except in advanced cases of arthritis. 
B: Treatment by injection 
A bolus injection of corticosteroid aims to reduce inflammation and pain. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the forearm supported in pronation. 
B: Palpation 
On the dorsal surface, the inferior radio-ulnar joint lies approximately 1.5 cm from 
the ulnar styloid process. The joint can be glided passively to confirm its position. 
Mark a point over the mid point of the joint line. 
B: Technique 
Insert the needle via the dorsal surface of the inferior radio-ulnar joint line, 
angling it if necessary to allow for the curvature of the articular surfaces (Figs 7.1 
and 7.2). Deliver the injection as a bolus once the needle is intracapsular. 
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B: Patient advice 
The patient is advised to maintain a period of relative rest for up to two weeks 
following the injection. 
A: Wrist joint 
B: Indication 
Arthritis. Inflammatory arthritis such as rheumatoid arthritis can affect the wrist 
joint. If the lesion is due to trauma, fracture of one of the carpal bones, usually 
the scaphoid, should be excluded. 
B: Patient presentation 
The patient presents with pain felt locally at the wrist. There may be a history of 
trauma, or if due to inflammatory arthritis, the patient may have other joint 
involvement. 
On examination the joint may be swollen, and heat and synovial thickening may 
be palpated at the wrist. Assessment by selective tension will reveal a capsular 
pattern of equal limitation of flexion and extension. 
B: Treatment by injection 
The aim of treatment by corticosteroid injection is to reduce inflammation and 
pain. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle. 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 1 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the forearm supported in pronation. 
B: Palpation 
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Palpate the radiocarpal joint line on the dorsal surface of the wrist, select and 
mark a point on either side of the extensor carpi radialis brevis tendon. 
B: Technique 
Insert the needle into the joint at angled slightly proximally to allow for the 
curvature of the articular surfaces (Figs 7.3 and 7.4). The proximal carpal bones 
are slightly convex; the lower end of the radius is concave. Deliver the injection 
by a bolus technique once intracapsular. J 
Alternative techniques: (1) In the wrist affected by rheumatoid arthritis, it may not 
be possible to introduce the needle into the joint capsule. Palpate for the areas of 
tenderness around the wrist and use two or three separate needle insertions to 
pepper the areas of synovial thickening (changing the needle for each insertion). 
This technique may be painful for the patient. (2) Palpate the radio-ulnar joint line 
and insert the needle immediately distal to the ulnar styloid process; deliver the 
injection by a bolus technique. 
B: Patient advice 
The patient is advised to maintain a period of relative rest for up to two weeks 
following the injection. If pain is severe, a supporting splint may be worn. 
A: Trapezio-first metacarpal joint (first carpometacarpal joint) 
B: Indication 
Arthritis. This may be inflammatory arthritis but, more commonly, it results from 
an overuse activity that precipitates a traumatic arthritis in an already degenerate 
joint. 
B: Patient presentation 
The patient complains of pain felt locally at the base of the thumb which is 
aggravated by activities that involve compression of the joint e.g. writing, 
gripping. The condition commonly affects middle-aged women (Livengood, 
1992). 
On examination the capsular pattern of limited extension at the trapezio-first 
metacarpal joint is present. 
B: Treatment by injection 
Injection may be successful for inflammatory, degenerative or traumatic arthritis 
of this joint. In the symptomatic degenerate joint, physiotherapeutic modalities 
such as mobilisation and transverse friction massage to the capsular ligaments 
can give good symptomatic relief (Cyriax and Cyriax, 1983; Cyriax, 1984; Kesson 
and Atkins, 1998). 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the forearm supported. 
B: Palpation 
Identify the first metacarpal Run your thumb down this bone to its proximal end in 
the anatomical snuffbox and locate the joint line. The patient may be able to help 
identification and facilitate the injection by applying a little distraction to the joint. 
Mark the mid point of the joint line. 
B: Technique 
Insert the needle perpendicularly into the joint and deliver the injection as a bolus 
once the needle is intracapsular (Figs 7.5 and 7.6). 
Alternative technique: Position the thumb in extension and adduction, identify the 
joint line anteriorly on the palmar surface, through the thenar eminence. Insert 
the needle into the joint and deliver the injection by a bolus. This approach may 
be useful if the patient has had longstanding symptoms and some wasting of the 
thenar muscles. 
Clinical tip: Osteophytes around the degenerate joint may impede the injection 
via either of the approaches given. The gentle distraction of the joint facilitates 
the needle insertion into the joint space. 
B: Patient advice 
Advise the patient to maintain a period of relative rest from the aggravating 
factors for up to two weeks. 
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A: Metacarpophalangeal joints and the interphalangeal joints 
B: Indication 
Arthritis. Degenerative, inflammatory or traumatic arthritis may affect these joints. 
B: Patient presentation 
The patient will be able to localise the symptom of pain to the particular joint(s) 
involved. 
On examination, the capsular pattern of limitation of movement will confirm the 
diagnosis. For the metacarpophalangeal joints the capsular pattern is limitation of 
radial deviation and extension, whilst the interphalangeal joints demonstrate an 
equal limitation of flexion and extension. 
B: Treatment by injection 
Corticosteroid injection aims to reduce the inflammation and give effective pain 
relief. 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
5-10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the hand supported comfortably. 
B: Palpation 
Locate the symptomatic joint by palpation and identify the joint line. Mark a point 
on the dorsolateral aspect of the joint line. 
B: Technique 
Insert the needle into the relevant joint via a dorsolateral approach, avoiding the 
dorsal digital expansion (Figs 7.7, 7.8, 7.9 and 7.10). Once intracapsular, the 
injection can be delivered as a bolus. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Radial and ulnar collateral ligaments 
B: Indication 
Ligamentous sprain. A single traumatic incident or repetitive microtrauma through 
overuse may sprain these ligaments. 
B: Patient presentation 
The patient complains of pain well localised to the wrist joint. 
On examination, a non-capsular pattern of pain on passive ulnar deviation will be 
positive in a sprain of the radial collateral ligament, whilst passive radial deviation 
will be positive in a sprain of the ulnar collateral ligament. 
B: Treatment by injection 
A corticosteroid injection may be curative or, alternatively, physiotherapeutic 
methods including mobilisation by transverse friction massage may be used. 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1% lidocaine 
B: Patient position 
Position the patient comfortably in sitting with the hand supported. 
B: Palpation 
Palpate for the area of tenderness over the ligament and mark this point. 
B: Technique 
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Insert the needle perpendicular to the ligament (Figs 7.11, 7.12, 7.13 and 7.14) 
and deliver the injection to the affected area by peppering technique. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Carpal tunnel 
B: Indication 
Compression of the median nerve in the carpal tunnel. The median nerve passes 
through a fibro-osseous tunnel formed by the overlying flexor retinaculum and the 
underlying carpal bones. This is a restricted space, being occupied by the 
superficial and deep flexor tendons to the digits as well as the median nerve and 
vessels. Any reduction in the space causes compression of the median nerve 
and produces symptoms (see below). Intrinsic factors such as inflammation and 
swelling, or extrinsic factors such as trauma or repetitive occupational and leisure 
activities may be the reason for the condition. It is more common in women 
between the ages of 40-60 (Norris, 1993; Kumar and Clark, 1994) and the 
syndrome may also be associated with diabetes, myxoedema, pregnancy and 
rheumatoid arthritis. In advanced cases, the muscles of the thenar eminence 
may become weak, particularly abductor pollicis brevis, which causes the first 
metacarpal to fall back into the same plane as the other metacarpals. 
B: Patient presentation 
The history generally substantiates the diagnosis. The patient complains of 
aching and burning 'pain' with tingling or numbness of the fingertips. 
Paraesthesia is reported on the palmar aspect of the radial three and a half 
digits. Smith and Wemick, 1994, reported 70% of patients feeling numbness at 
night and 40% complaining of pain radiating proximally into the lower forearm 
with paraesthesia felt simultaneously in the fingers. The patient may be woken at 
night by the symptoms and gain relief by shaking or rubbing the hands (Cailliet, 
1990). 
On examination, wasting of the thenar eminence may be observed and 
weakness experienced in advanced cases. Traditionally TinePs test, tapping over 
the flexor retinaculum and Phalen's test, the application of sustained 
compression to the median nerve by maintaining the wrist in a position of flexion, 
are used to elicit the reported paraesthesia and to diagnose carpal tunnel 
syndrome (Hoppenfeld, 1976; Otto and Wehbe 1986; Cailliet 1990; Vargas 
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Busquets, 1994). However, false-positive and false-negative results are not 
uncommon. 
B: Treatment by injection 
Injection of corticosteroid into the carpal tunnel may reduce the inflammation and 
swelling associated with the compressed nerve and reduce or eliminate the 
symptoms for the patient. The more advanced cases, with muscle weakness and 
wasting, should be referred on surgical opinion. 
B: Needle size 
23G x 1 in (0.6x25mm) or 23G x 11/4 in (0.6 x 30 mm) blue needle 
B: Dose " 
20 mg triamcinolone acetonide 
e.g. 0.5 ml Kenalog® 
The injection is not particularly painful for the patient and a small volume of 
concentrated corticosteroid is advised; the addition of local anaesthetic serves no 
purpose here and its addition would increase the volume of the injection • 
unnecessarily. 
B: Patient position 
Position the patient in sitting with the wrist supported in extension and the 
forearm supinated. 
Palpation 
Observe the three skin creases, which are generally visible on the palmar aspect 
of the tower forearm. Note the position of palmaris longus, which gives an 
approximate position of the underlying median nerve. 
Clinical tip: If palmaris longus is absent, ask the patient to oppose the thumb 
and little finger. The mid-line crease produced between the thenar and 
hypothenar eminences gives the approximate position of the median nerve in the 
carpal tunnel. 
Mark a point between the middle and distal wrist creases, to the ulnar side of 
palmaris longus (or the middle crease as identified above). 
B: Technique 
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Insert the needle between the middle and distal wrist creases, to the ulnar side of 
the palmaris longus tendon which ensures that you do not make contact with the 
median nerve (Fig 7.15). Angle the needle approximately parallel with the 
direction of the flexor tendons in the carpal tunnel. Advance the needle between 
the flexor tendons until you judge it to rest beyond the distal wrist crease and 
therefore within the carpal tunnel (Fig 7.16). Deliver the injection as a bolus. 
Clinical tip: If you grip the syringe gently, the needle will glide into the carpal 
tunnel parallel to the tendons. As you position the needle for injection, check with 
the patient that they are not experiencing paraesthesia, to avoid injecting into the 
nerve itself. 
Alternative techniques: (1) Position the patient with the forearm supinated and 
insert the needle V* inch distal to the distal wrist crease aiming down and towards 
the wrist joint Once under the flexor retinaculum, inject as a bolus. (2) Position 
the patient with the wrist in a degree of extension and the forearm supinated. 
Insert the needle just proximal to the distal wrist crease immediately to the radial 
side of palmaris longus (if palmaris longus is absent, see above). Advance the 
needle between the flexor tendons until you judge it to rest within the carpal 
tunnel. Deliver the injection as a bolus. 
B: Patient advice 
It is most important to ascertain the cause of this lesion and to eliminate these 
factors to prevent recurrence. The patient should maintain a period of relative 
rest for up to two weeks following the injection and avoid all aggravating factors. 
A wrist-supporting splint may be helpful. 
Carpal tunnel syndrome may be part of a wider scenario and it may be necessary 
to eliminate causes in the cervical spine and those involving adverse neural 
tension (pathoneurodynamics). 
Clinical tip: the use of corticosteroid injection for carpal tunnel syndrome in 
pregnancy is not recommended. 
A: Trigger finger or trigger thumb 
B: Indication 
A 'catching' or 'triggering' phenomenon of a flexor tendon in its sheath. The 
superficial and deep flexor tendons pass through osseo-aponeurotic canals, 
which are formed by the phalanges, their joints and the digital fibrous sheaths. 
Midway between the proximal and intermediate phalanges is a stronger 
thickening of transverse fibres known as an annular pulley (Williams et al, 1989). 
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These pulleys prevent bowstringing of the tendons and enhance tendon 
efficiency. The flexor tendons receive maximum stress at the pulley level with the 
metacarpophalangeal joint and nodules form in longstanding conditions (Otto and 
Wehbe, 1986; Lloyd Davies, 1998). 
B: Patient presentation 
The patient complains of a localised, painful, snapping sensation as a flexor 
tendon catches in a thickened area of its sheath on flexion, and is suddenly 
released during forced extension (Smith and Wernick, 1994; Murphy et al, 1995). 
There may be little to find on examination, but an area of thickening may be 
observed or there may be a palpable nodule. 
B: Treatment by injection 
Injection of corticosteroid may be curative and aims to restore painless, smooth 
movement at the finger (Murphy et al, 1995). 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1 % lidocaine 
B: Patient position 
Position the patient in sitting with the hand supported. 
B: Palpation 
Palpate the symptomatic digit for the area of pain and thickening. Mark the mid­
point. 
B: Technique 
Insert the needle into the thickened nodule of the affected tendon on the palmar 
surface, this is usually just distal to the mid-palmar flexor crease (Figs 7.17 and 
7.18). Angle the needle approximately 45° distally or proximally with the bevel of 
the needle parallel to the tendon. Avoid injecting into the tendon itself by. 
withdrawing back from the tendon slightly until a loss of resistance is 
appreciated. 
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B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: De Quervain's tenosynovitis 
B: Indication 
Inflammation of the shared synovial sheath of abductor pollicis longus and 
extensor pollicis brevis in the first extensor compartment at the wrist. The 
condition may be complicated by thickening and scarring of the sheath and 
occasionally a ganglion may be associated with the chronic condition (Tan et al, 
1994; Klug, 1995). 
B: Patient presentation 
The onset can be due to trauma, but overuse more commonly causes a gradual 
onset of pain felt on the radial side of the wrist. The radial styloid area may feel 
tender to palpation. An audible crepitus may be present on movements of the 
thumb. 
On examination, a localised, thickened area over the tendons may be observed. 
Symptoms will be reproduced on testing resisted abduction and extension of the 
thumb. Passive movements may also be painful as the tendons move through 
the thickened, inflamed sheath. Finkelstein's test (flexion of the thumb across the 
palm with ulnar deviation at the wrist increasing the angulation of the tendon) 
produces the pain and is said to be pathognomic of de Quervain's tenosynovitis 
(Otto and Wehbe, 1986; Shea et al, 1991; Livengood, 1992; Elliott 1992; Rettig, 
1994). 
B: Treatment by injection 
An injection of corticosteroid aims to reduce inflammation, swelling and pain. If 
the condition is resistant to treatment by injection, physiotherapeutic modalities 
may be considered or the patient may need a surgical opinion. 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75ml local anaesthetic 
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e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the wrist supported. Hold the thumb in a degree 
of flexion and the wrist in ulnar deviation and slight extension. 
B: Palpation 
Locate the triangular 'gap' between abductor pollicis longus and extensor pollicis 
brevis tendons at the base of the first metacarpal. Mark this point. 
B: Technique 
Insert the needle between and parallel to the two tendons, delivering the injection 
as a bolus, into the common sheath (Figs 7.19 and 7.20). 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. As the lesion is due to overuse activities, the causative factors 
should be addressed to prevent recurrence. 
A: Wrist extensor and flexor tendon lesions 
B: Indication 
Tenosynovitis or tendinitis. Tenosynovitis may affect the tendons as they cross 
the wrist and hand protected by their synovial sheaths. Tendinitis may be present 
at the teno-osseous junction, i.e. the point of insertion of the tendon into the 
bone. 
B: Patient presentation 
These are most frequently overuse lesions, with the patient complaining of a 
gradual onset of pain which is well localised. 
On examination a resisted test, appropriate for the individual tendon, will be 
positive. In the case of tenosynovitis, the opposite passive movement may also 
be painful as the tendon is pushed or pulled through its inflamed sheath. 
B: Treatment by injection 
Injection of corticosteroid solution aims to reduce inflammation and relieve pain. 
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B: Needle size 
25G x5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient in sitting with the hand supported. 
B: Palpation 
Locate the area of tenderness and mark the central point. 
B: Technique 
At the teno-osseous junction deliver the injection by a peppering technique. For 
tenosynovitis the injection is delivered as a bolus between the tendon and its 
sheath. 
A: Extensor carpi radialis longus and brevis 
Pain is reproduced on resisted wrist extension and resisted radial deviation. 
Extensor carpi radialis longus inserts into the radial side of the base of the 
second metacarpal and extensor carpi radialis brevis into the radial side of the 
base of the third metacarpal At the teno-osseous site the injection can be 
delivered by a peppering technique(Figs 7.21 and 7.22). A lesion involving the 
common sheath of these tendons is not common, but if present, injection is 
delivered between the tendon and its sheath by a bolus technique (Figs 7.23 and 
7.24). 
A: Extensor carpi ulnaris 
Pain is reproduced on resisted wrist extension and resisted ulnar deviation. The 
tendon inserts into the base of the fifth metacarpal where an injection may be 
delivered using a peppering technique. If the lesion is tenosynovitis, either as the 
tendon crosses the wrist or in the groove between the head of the ulna and the 
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ulnar styloid process, the injection is delivered between the tendon and its sheath 
using a bolus technique (Figs 7.25 and 7.26). 
A: Flexor carpi ulnaris 
Pain is reproduced on resisted wrist flexion and resisted ulnar deviation. The 
tendon may be affected at its teno-osseous junction either proximal or distal to 
the pisiform. Injection is delivered by a peppering technique to the area found to 
be tender to palpation (Figs 7.27 and 7.28). 
Clinical tip: the ulnar artery and nerve pass into the hand lateral to the pisiform 
bone. 
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8. The hip 
A: Hip joint 
B: Indication 
Arthritis. Most commonly for acute episodes of degenerative arthritis but may 
also be indicated in inflammatory arthritis or possibly traumatic arthritis. Primary 
degenerative osteoarthrosis is common and is said to occur in 50% of the 
population over the age of 60 (Kumar and Clark, 1994). Men and women are 
equally affected (Dieppe, 1995). 
B: Patient presentation 
The patient complains of a gradual onset of pain and loss of mobility. The pain 
may be felt in the area of the L3 dermatome, i.e. the upper buttock, groin, or 
referred into the medial aspect and front of the thigh and leg as far as the medial 
malleolus. The more distally the pain is felt, the more irritable the lesion. Pain 
may be associated with activity and/or rest. X-ray changes are not a good 
indicator of the symptoms as joint changes may be seen long before symptoms 
present and vice versa. 
On examination a capsular pattern of limited movement exists, limited medial 
rotation, flexion, abduction and extension. The limited movements will have lost 
their normal elastic end-feel and will feel hard at the end of range. 
B: Treatment by injection 
Osteoarthrosis progresses with periods of exacerbation and remission (Dieppe, 
1995). A corticosteroid injection may give symptomatic relief and improve 
function for the patient. It may postpone the need for surgical,intervention. As 
mentioned above, inflammatory arthritis such as rheumatoid arthritis, may also 
benefit from an intra-articular injection. 
B: Needle size 
20G x 31/2 in (0.9 x 90 mm) spinal needle 
B: Dose 
40 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 4 ml Adcortyl®, 1 ml 1% lidocaine 
Some authorities recommend the use of much larger volumes of local 
anaesthetic to cause distension of the hip joint capsule. 
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B: Patient position 
Position the patient in side lying with the painful leg uppermost, supported in 
neutral by a pillow. 
B: Palpation 
Palpate the greater trochanter (the large quadrangular, bony prominence on the 
lateral aspect of the upper femur), approximately one hand's breadth below the 
iliac crest. Grasp the greater trochanter with thumb, index and middle fingers, lift 
the leg passively into abduction to relax the iliotibial tract and feel the dip above 
the top of the greater trochanter with your index finger. Mark this point and 
replace the leg into the neutral position. 
B: Technique 
Insert the needle at the point marked and aim vertically down toward the neck of 
the femur, until contact is made with bone (Figs 8.1 and 8.2). Since the fibrous 
capsule of the hip joint surrounds the neck of the femur, the needle will be 
intracapsular once this contact is made. Deliver the injection as a bolus. 
Clinical tip: Since septic arthritis of the hip is a very serious complication, a no 
touch technique is absolutely essential to prevent infection. Some authorities 
advocate injecting the hip joint under surgical conditions. 
Clinical tip: There is some controversy concerning repeated steroid injections 
into weight-bearing joints and the associated risk of developing steroid 
arthropathy (Parikh et al, 1993; Cameron 1995b). To minimise risk of steroid 
arthropathy, it is recommended that weight-bearing joints should not be injected 
more frequently than every 4-6 months. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. Since Chakravarty and Pharoah (1994) showed that 24 hours of 
complete bed rest following injection of the knee joint for rheumatoid arthritis 
produced more prolonged benefit, it may also be appropriate to apply this regime 
to the hip joint. 
A: Psoas bursa (synonymous with iliopsoas bursa) 
B: Indication 
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Psoas bursitis. Repetitive minor trauma or a single traumatic incident may be the 
cause of the lesion, but the bursa's communication with the hip joint means that 
the condition may be associated with hip joint pathology such as rheumatoid 
arthritis (Armstrong and Saxton, 1972; Meaney et al, 1992). 
B: Patient presentation 
The patient may complain of a gradual onset of pain felt in the groin or referred 
into the L3 dermatome (the upper buttock, the medial aspect and front of the 
thigh and leg as far as the medial malleolus). 
On examination a non-capsular pattern exists with a 'muddle' of signs 
characteristic of bursitis i.e. possibly pain on passive lateral rotation, passive 
extension and resisted flexion of the hip. Diagnosis is confirmed by combined 
passive flexion and adduction of the hip, which compresses the bursa against the 
front of the hip joint. 
B: Treatment by injection 
The treatment of choice for psoas bursitis is an injection of a large volume of low 
dose local anaesthetic together with an appropriate amount of corticosteroid. The 
injection aims to reduce inflammation and to relieve pain. 
B: Needle size 
20G x 31/2 in (0.9 x 90 mm) spinal needle 
B: Dose 
20 mg triamcinolone acetonide, 8 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 8 ml 0.5% lidocaine 
B: Patient position 
Position the patient in supine lying with the groin area exposed. 
B: Palpation 
The psoas bursa is a large bursa measuring approximately 5-7 cm in length and 
2-4 cm in width, in its normal collapsed state (Underwood et al, 1988; Toohey et 
al, 1990; Flanagan et al, 1995). It lies between the musculotendinous junction of 
the iliopsoas muscle and the front of the capsule of the hip joint, protecting the 
tendon as it winds around the front of the hip joint, to its insertion into the lesser 
trochanter. 
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Establishing the position of the bursa for injection is complicated, since it is also 
associated anteriorly with the neurovascular bundle in the femoral triangle which 
must be avoided. Locate and mark the femoral pulse, just distal to the mid-point 
of the inguinal ligament. The psoas bursa lies deep to the artery. To avoid the 
neurovascular bundle, move laterally 5 cm and 5 cm distally and mark this point. 
Technique 
Insert the needle at the marked point and angle it deeply, medially and proximally 
towards the bursa, to be deep to the neurovascular bundle (the initial point of 
palpation recommended above, located by the femoral pulse) (Figs 8.3 and 8.4). 
On making contact with bone, the needle is now at the front of the hip joint and 
should be withdrawn slightly so that it is positioned within the psoas bursa. If 
there is no resistance to the injection, inject using a bolus technique. Resistance 
to the injection may indicate that the bursa is multiloculated with well-defined 
walls, and it may also contain debris. In this case, deliver the injection by 
peppering technique, covering the area of the lesion determined by tenderness to 
palpation (Meaney et al, 1992, Cyriax and Cyriax, 1983, Kesson and Atkins, 
1998). Kerry et al (2000) describe a collaborative approach to diagnosis and 
treatment of iliopsoas bursitis with corticosteroid injection, ultrasonography and 
physiotherapy. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following the injection. The causative factors should be ascertained and avoided 
to prevent recurrence. 
A: Trochanteric bursa 
B: Indication 
Trochanteric bursitis. Repetitive overuse is the usual cause, although the 
condition may be associated with tight lateral structures at the hip, such as the 
iliotibial band, or with lumbar, sacro-iliac or hip joint pathology (Shbeeb et al, 
1996). 
B: Patient presentation 
The patient presents with a gradual onset of pain felt in the lateral thigh. 
On examination there may be little to find by way of physical findings, apart from 
tenderness to palpation over the greater trochanter. Resisted hip abduction 
and/or passive lateral rotation may provoke the symptoms (Rasmussen and 
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Fano, 1985; Shbeeb et al, 1996). There may be some muscle tightness on 
testing for range of joint movement or leg length inequality as a precipitating 
factor. 
B: Treatment by injection 
Providing the causative factors are also addressed, injection of corticosteroid 
may be curative and is therefore the treatment of choice (Schapira et al, 1986). 
Shbeeb et al (1996) conducted an observational study of 75 patients with 
trochanteric bursitis with an injection of either 6, 12 or 24 mg betamethasone. 
Their results indicated that most patients improved with a single injection, those 
that received the highest dose of corticosteroid reported longer term 
improvement. 
B: Needle size 
21G x 11/2 in (0.8 x 40 mm) or 21G x 2 in (0.8 x 50 mm) green needle 
B: Dose 
20 mg triamcinolone acetonide, 1-3 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 1-3 ml 1% lidocaine 
B: Patient position 
Position the patient in supported side lying. 
B: Palpation 
The trochanteric bursa caps the greater trochanter separating the overlying 
gluteus maximus muscle from the bone as it passes to its insertion into the 
iliotibila tract and upper femur. The position is similar to the way in which the 
subdeltoid bursa caps the greater tuberosity of the humerus. Locate the large, 
quadrangular greater trochanter and palpate for an area of tenderness over its 
superolateral aspect. Mark this point within the tender area. 
B: Technique 
Insert the needle into the centre of the tender area, over the superolateral aspect 
of the greater trochanter, until the needle rests between the insertion of gluteus 
maximus into the iliotibial tract, and the underlying greater trochanter (Figs 8.5 
and 8.6). This usually reproduces the patient's pain. Deliver the injection by a 
bolus technique if no resistance is felt, or if this is not possible a peppering 
technique, aiming to cover the full extent of the tender area within the bursa. 
B: Patient advice 
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Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
Causative factors should be addressed to prevent recurrence. It may be 
appropriate to introduce a regime of stretching techniques for the iliotibial tract. 
A: Origin of the hamstrings at the ischial tuberosity 
B: Indication 
Hamstring tendinitis (enthesitis). The hamstring muscles are commonly strained 
during sporting activities. As two joint muscles they act to extend the hip and flex 
the knee and are relatively weak in comparison to the quadriceps (Sutton, 1984). 
The ballistic action of sprinting commonly leads to acute lesions in the muscle 
bellies, whilst overuse activities are more likely to produce strain of the common 
origin at the ischial tuberosity. 
B: Patient presentation 
The patient complains of a gradual onset of pain in the lower buttock area, 
localised to the ischial tuberosity. 
On examination pain is reproduced on testing resisted knee flexion and on 
passively testing the straight leg raise. 
B: Treatment by injection 
Injection into the common origin of the hamstrings at the ischial tuberosity may 
be curative for chronic strain. Alternative treatment modalities may be considered 
such as mobilisation by deep transverse friction massage and electrotherapy. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle (or larger if more appropriate for the 
patient) 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1 ml 1% lidocaine 
B: Patient position 
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Position the patient in prone lying over the side edge of a plinth with the hip and 
knee flexed to a right angle. The knee should be supported on a stool. As an 
alternative position, the patient may be placed in side-lying with the painful side 
uppermost and hips flexed to 90 degrees,. 
B: Palpation 
The positions described above expose the ischial tuberosity from under the 
gluteus maximus muscle. Locate the area of tenderness in the tendon, commonly 
found at its teno-osseous junction on the ischial tuberosity and mark this point. 
B: Technique 
Insert the needle perpendicular to the tendon and ischial tuberosity and deliver 
the injection by a peppering technique (Figs 8.7 and 8.8). 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following injection. It is important to establish an appropriate training regime for 
full rehabilitation of the hamstrings and the causative factors of any overuse 
injury should be addressed. 
A: Origin of adductor longus 
B: Indication 
Strain of the adductor longus tendon, commonly known as 'rider's strain'. 
Overuse of the adductors, e.g. whilst working a horse, may produce chronic 
tendinitis. A single traumatic incident, in which the tendon is overstretched, may 
be the cause of an acute lesion. 
B: Patient presentation 
The patient complains of pain localised to the groin area or referred to the medial 
aspect of the thigh. 
On examination the symptoms will be reproduced by resisted adduction and on 
stretching, by passive abduction. 
B: Treatment by injection 
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An injection at the teno-osseous junction of the origin of adductor longus with the 
body of the pubis (the enthesis) may be curative. Alternative physiotherapeutic 
modalities may also be considered. 
B: Needle size 
23G x 11/4 in (0.6 x 30 mm) blue needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1ml 1% lidocaine 
B: Patient position 
Position the patient in supine lying on a plinth with the leg supported in a degree 
of abduction and lateral rotation. 
B: Palpation 
Locate the area of tenderness at the teno-osseous junction on the body of the 
pubis, in the angle between the crest and the symphysis pubis. Mark this area. 
B: Technique 
Insert the needle just distal to the teno-osseous junction angling obliquely 
upwards toward the body of the pubis (Figs 8.9 and 8.10). Deliver the injection by 
a peppering technique, covering the full extent of the lesion as identified by 
palpation. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following the injection. Once the symptoms and signs have subsided, a full 
rehabilitation programme can be followed including stretching if necessary. 
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9. The knee 
A: Knee joint 
B: Indication 
Arthritis. Arthritis of the knee joint may be due to an acute episode of 
degenerative osteoarthrosis or inflammatory arthritis. Traumatic arthritis is 
usually a secondary response to a ligamentous lesion at the knee and should be 
treated as such (see Kesson and Atkins, 1998). 
B: Patient presentation 
The patient may complain of a gradual or sudden onset of pain and swelling at 
the knee. The pain may be anterior and/or posterior since the knee lies within the 
L3,4 and S1,2 dermatomes. Symptoms are generally aggravated by weight-
bearing activities and the knee may be stiff after rest. 
On examination swelling and synovial thickening may usually be palpated. A 
capsular pattern of greater limitation of flexion than extension is present and 
flexion has a harder than normal end-feel. 
B: Needle size 
21G x 11/2 in (0.8 x 40 mm) green needle 
B: Dose 
30 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 3 ml Adcortyl®, 1ml 1% lidocaine 
B: Treatment by injection 
An infra-articular injection of corticosteroid may be beneficial in the treatment of 
symptomatic osteoarthrosis or inflammatory arthritis (Dieppe et al, 1980). The 
possible mechanical causes of traumatic arthritis (e.g. ligamentous lesion) should 
be addressed directly. 
B: Patient position 
Position the patient in half lying and support the knee in the extended position. 
B: Palpation 
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Palpate the patella and glide it medially, pressing down on the lateral border to lift 
the medial edge. Mark a point at the approximate mid point of the medial border 
of the patellar. 
B: Technique 
Insert the needle at the mid point of the medial border of the patella, angling 
laterally and slightly posteriorly to allow for the convex shape of the posterior 
surface of the patella (Figs 9.1 and 9.2). Once intracapsular, and when there is 
no resistance to the injection, deliver by a bolus technique. 
Alternative techniques: (1) Glide the patella laterally. Insert the needle at the mid 
point of the lateral border of the patella, aiming medially and slightly posteriorly 
with the needle parallel to the articular surface of the patella. Deliver by a bolus 
technique. (2) If a visible effusion is present, the needle may be inserted into the 
suprapatellar pouch and intra-articular placement confirmed by initial aspiration 
before injecting as a bolus. (3) Position the patient in supine or half lying with the 
knee flexed. Insert the needle below the apex of the patella on either the medial 
or the lateral side of the patellar tendon (in acupuncture, the "eyes" of the knee) 
and once intracapsular, deliver as a bolus. 
Clinical tip: There is some controversy concerning repeated steroid injections 
into weight-bearing joints and the associated risk of developing steroid 
arthropathy (Parikh et al, 1993; Cameron 1995b). To minimise risk of steroid 
arthropathy, it is recommended that weight-bearing joints should not be injected 
more frequently than every 4-6 months. 
B: Patient advice 
Advise the patent to maintain a period of relative rest for up to two weeks after 
the injection. Chakravarty and Pharoah (1994) showed that 24 hours of complete 
bed rest following injection of the knee joint for rheumatoid arthritis produced 
more prolonged benefit. 
A: Bakers cyst 
This is a fluctuant swelling which appears on the posterior aspect of the knee 
Joint line. It is associated with pathology in the knee Joint such as degenerative or 
inflammatory arthritis and treatment should be directed at the knee Joint itself. 
A: Bursitis associated with the patella 
B: Indication 
Prepatellar bursitis (housemaid's knee) and superficial infrapatellar bursitis 
(clergyman's knee). These are usually associated with friction between the 
patella or patellar tendon and the skin. Since these are subcutaneous bursae 
they are vulnerable to unrecognised perforating injuries, therefore it is important 
that the patient is screened for possible infection before injecting with 
corticosteroid. 
B: Patient presentation 
The patient complains of a gradual onset of aching pain felt superficial to the 
patella or patellar tendon, depending on which bursa is involved. 
On examination there are usually no clinical findings and the condition is 
diagnosed by the obvious swelling over the patella. 
B: Needle size 
21G x 11/2 in (0 .8x40 mm) green needle 
B: Dose 
10 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 1 ml Adcortyl®, 1ml 1% lidocaine 
B: Treatment by injection 
An injection into the bursa can be curative. 
B: Patient position 
Position the patient in half lying and support the knee in the extended position. 
B: Palpation 
Palpate the tender, swollen area of the bursa on the anterior aspect of the patella 
or patellar tendon and mark a central point convenient for the injection. 
B: Technique 
Insert the needle at the mid point of the tender area and inject as a bolus when 
the bursa is identified by a loss of resistance to the needle insertion (Figs 9.3 and 
9.4). 
B: Patient advice 
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The patient should be advised to avoid further trauma to the bursa. 
A: Pes anserine bursa 
B: Indication 
Bursitis, that is commonly due to overuse (Hutson, 1990) This bursa is located on 
the medial aspect of the knee deep to the pes anserine complex of the tendons 
of semitendinosus, gracilis and semimembranosus. 
B: Patient presentation 
The patient may complain of a gradual onset of aching pain felt on the medial 
aspect of the knee. 
On examination, passive movements and resisted tests are generally negative, 
but swelling and tenderness to palpation are present on" the anteromedial aspect 
of the tibia just below the joint line. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle or 25G x 5/8 in (0.5 x 16 mm) orange 
needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1ml 1% lidocaine 
B: Treatment by injection 
An injection into the bursa can be curative. 
B: Patient position 
Position the patient in half lying and support the knee in the extended position. 
B: Palpation 
Palpate the tender, swollen area of the bursa on the medial aspect of the tibia 
and mark a central point convenient for the injection. 
B: Technique 
99 
Insert the needle at the mid point of the tender area and inject as a bolus when 
the bursa is identified by a loss of resistance to the needle insertion (Figs 9.5 and 
9.6). 
B: Patient advice 
The patient should be advised to avoid further trauma to the bursa. 
A: Coronary ligaments 
B: Indication 
Sprain of the coronary ligaments. A rotational or hyperextension injury at the 
knee can affect the coronary ligaments. The coronary (meniscotibial) ligaments 
attach the menisci to the upper surface of the tibia. The longer lateral coronary 
ligaments are less commonly involved, but the shorter medial coronary ligaments 
are vulnerable to sprain especially in association with medial meniscal damage. 
Discussion here is of the more commonly affected medial coronary ligaments, 
but if the lateral coronary ligaments were involved, the same principles would 
apply. 
Patient presentation 
The patient complains of pain on the medial aspect of the knee possibly related 
to a rotational or hyperextension injury. On examination there is a non-capsular 
pattern of pain on passive lateral rotation of the knee. 
B: Treatment by injection 
This lesion responds very well to physiotherapeutic modalities, transverse friction 
massage in particular (Cyriax and Cyriax, 1983; Cyriax, 1984; Kesson and 
Atkins, 1998). In more chronic cases an injection may also be curative and is an 
alternative treatment to physiotherapy. 
B: Needle size 
23G x 1 in (0.6x25mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
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B: Patient position 
Position the patient in lying with the knee flexed and laterally rotated to expose 
the medial tibial condyle. 
B: Palpation 
Palpate the superior surface of the medial tibial plateau for the area of 
tenderness in the medial coronary ligaments. Mark the area of tenderness. 
B: Technique 
Insert the needle tangentiale to the meniscus and deliver the injection by 
peppering technique along the affected area of the ligament (Figs 9.7 and 9.8). 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Infrapatellar tendon 
B: Indication 
Infrapatellar tendinitis ('jumper's knee'). The condition may be due to repetitive 
overuse, particularly arising from activities that involve a jumping action, resulting 
in microfailure and fraying of the tendon fibres with areas of focal degeneration 
(Curwin and Stanish, 1984). 
B: Patient presentation 
The patient complains of a gradual onset of anterior knee pain, usually localised 
to the inferior pole of the patella. 
On examination the pain is reproduced at the front of the knee by resisted knee 
extension. 
B: Treatment by injection 
An injection into the teno-osseous junction of the infrapatellar tendon may be 
curative, but the cause of the lesion should also be addressed to prevent 
recurrence. 
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B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1 ml 1% lidocaine 
B: Patient position 
Position the patient in half lying with the knee supported in extension. 
B: Palpation 
Tilt the inferior pole (apex) of the patella upward by applying downward pressure 
over the superior pole (base) with the web space between your index finger and 
thumb. Palpate the teno-osseous junction of the infrapatellar tendon and mark 
the area of tenderness. 
B: Technique 
Insert the needle just distal to the inferior pole of the patella angling upward to 
make contact with the bone at the teno-osseous junction of the tendon (Figs 9.9 
and 9.10). Fanning outwards from this mid position, deliver the injection by 
peppering technique, depositing two parallel rows of droplets of solution along 
the affected part of the teno-osseous junction. 
Clinical tip: To avoid weakening of the collagen fibre content of this weight-
bearing tendon the injection is NOT delivered into the body of the tendon but at 
the teno-osseous junction. 
B: Patient advice 
Advise the patient to maintain a period of relative rest from all aggravating and 
overuse factors for up to two weeks following the injection. 
Alternative treatments for infrapatellar tendinitis may include physiotherapeutic 
modalities such as mobilisation by transverse friction massage Cyriax and 
Cyriax, 1983; Cyriax, 1984; Kesson and Atkins, 1998). The condition may be due 
to maltracking mechanisms of the patella and this may need to be addressed by 
corrective taping techniques and specific exercises. 
A: Suprapatellar tendon 
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B: Indication 
Suprapatellar tendinitis. This is not as common as infrapatellar tendinitis, but the 
cause, disease process and management, are the same (see above). 
B: Patient presentation 
The patient complains of a gradual onset of pain felt at the superior pole (base) 
of the patella. 
On examination the pain is reproduced at the front of the knee by resisted knee 
extension. 
B: Treatment by injection 
An injection into the teno-osseous junction of the suprapatellar tendon may be 
curative, but the cause of the lesion should also be addressed to prevent 
recurrence. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1 ml 1% lidocaine 
B: Patient position 
Position the patient in half lying with the knee supported in extension. 
B: Palpation 
Tilt the superior pole (base) of the patella upward by applying downward 
pressure over the inferior pole (apex) with the web space between your index 
finger and thumb. Palpate the teno-osseous junction of the suprapatellar tendon 
and mark the area of tenderness. 
B: Technique 
Insert the needle just proximal to the superior pole of the patella angling 
downward to make contact with the bone at the teno-osseous junction of the-
tendon (Figs 9.11 and 9.12). Fanning outwards from this mid position, deliver the 
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injection by a peppering technique, depositing two parallel rows of droplets of 
solution along the affected part of the teno-osseous junction. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
Alternatively, treatment for suprapatellar tendinitis may be by physiotherapeutic 
modalities including mobilisation by transverse friction massage (Cyriax and 
Cyriax, 1983; Cyriax, 1984; Kesson and Atkins, 1998). The condition may be due 
to maltracking mechanisms of the patella and this may need to be addressed by 
corrective taping techniques and specific exercises. 
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10. The ankle and foot 
A: Ankle (talocrural) joint 
B: Indication 
Arthritis. This may be an acute episode of degenerative osteoarthrosis, 
inflammatory arthritis, such as rheumatoid arthritis, or traumatic arthritis 
associated with fracture or ligamentous injury. Degenerative osteoarthrosis in this 
joint is not common unless there has been a precipitating cause such as fracture, 
instability or postural overuse. 
B: Patient presentation 
The patient complains of pain and swelling located locally around the ankle joint. 
On examination a capsular pattern of limited movement will be evident, with a 
greater limitation of plantarflexion than dorsiflexion. Plantarflexion will exhibit an 
abnormal hard end-feel. 
B: Treatment by injection 
An intra-articular injection may reduce the pain and swelling, allowing an 
increase in the range of mobility at the ankle joint. 
B: Needle size 
23G x 1 in (0.6 x 25 mm) blue needle or 21G x 11/2 in (0.8 x 40 mm) Green 
needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 2 ml Adcortyl®, 1ml 1% lidocaine 
B: Patient position 
Position the patient in half lying with the knee flexed and the foot flat on the 
plinth. This places the ankle in a degree of plantarflexion, which opens the 
anterior aspect of the joint. 
B: Palpation 
Palpate the anterior ankle joint line to locate a suitable entry point into the ankle 
joint. Generally this will be between the tendons of tibialis anterior and extensor 
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hallucis longus, but a point of entry may also be made at the upper, inner aspect 
of either malleolus. Mark the selected point of entry on the joint line. 
Clinical tip: The dorsalis pedis artery and deep peroneal nerve lie just lateral to 
the extensor hallucis longus tendon at the ankle joint. These structures should be 
avoided when selecting the point for needle insertion. 
B: Technique 
Insert the needle at the point marked anteriorly and angle the needle upward to 
run parallel to the upper surface of the talus, which Is slightly convex (Figs 10.1 
and 10.2). Once the needle is intracapsular, deliver the injection as a bolus. 
Clinical tip: There is some controversy concerning repeated steroid injections 
into weight-bearing joints and the associated" risk of developing steroid 
arthropathy (Parikh et al, 1993; Cameron 1995b). To minimise risk of steroid 
arthropathy, it is recommended that weight-bearing joints should not be injected 
more frequently than every 4-6 months. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Subtalar (talocalcaneal) joint. 
B: Indication 
Arthritis. This can affect the subtalar joint, the commonest form being 
inflammatory rheumatoid arthritis. 
B: Patient presentation 
The patient complains of pain and swelling in the ankle region. 
On examination a capsular pattern of limited movement is present i.e. limitation 
of supination, in advanced cases the foot fixes in pronation. 
. B: Treatment by injection 
Corticosteroid injection may alleviate the symptoms. 
B: Needle size 
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23G x 1 in (0.6 x 25 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 1 ml Adcortyl®, 1 ml 1% lidocaine 
B: Patient position 
Position the patient in half lying with the lower leg supported. 
B: Palpation 
Locate the subtalar joint by palpating the sustentaculum tali of the calcaneum 
which lies approximately one thumb's width directly below the medial malleolus. 
Just above this bony, horizontal ridge lies the subtalar joint line. This joint is wider 
posteriorly and more easily entered there. 
B: Technique 
The anatomy of the subtalar joint is complicated as the joint is divided into two 
compartments by an interosseous ligament. Insert the needle into the point 
marked (see above) and first angle it posteriorly, to deliver approximately half of 
the corticosteroid solution into the posterior compartment as a bolus (Figs 10.3 
and 10.4). Withdrawing the needle slightly, re-position it anteriorly and deliver the 
remainder of the solution into the anterior compartment (Figs 10.5 and 10.6), also 
as a bolus. 
Clinical tip: The posterior tibial artery and tibial nerve lie below and behind the 
sustantaculum tali. Locate the tibial artery pulse by palpation. Avoid these 
structures by accurately selecting the needle insertion point as indicated and by 
angling the needle as described above and below. 
Alternative technique: Insert the needle laterally via the sinus tarsi which is 
located by palpation antero-inferiorly to the lateral malleolus. Deliver by a bolus 
technique. 
Clinical tip: There is some controversy concerning repeated steroid injections 
into weight-bearing joints and the associated risk of developing steroid 
arthropathy (Parikh et al, 1993; Cameron 1995b). To minimise risk of steroid 
arthropathy, it is recommended that weight-bearing joints should not be injected 
more frequently than every 4-6 months. 
B: Patient advice 
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Advise the patient to maintain a period of relative rest for up to two weeks -
following the injection. 
A: Midtarsal (transverse tarsal) joints 
B: Indication 
Arthritis. This may be acute episodes of degenerative osteoarthritis, inflammatory 
arthritis or traumatic arthritis. 
B: Patient presentation 
The patient complains of pain and swelling felt over the mid-foot region. 
On examination the capsular pattern of limited movement will be present with 
limitation of adduction and supination. In advanced cases the foot fixes in 
abduction and pronation. 
B: Treatment by injection 
Symptomatic relief can be gained from an intra-articular injection of 
corticosteroid. 
B: Needle size 
23G x 1 in (0,6 x 25 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.5 ml local anaesthetic 
e.g. 1 ml Adcortyl®, 0.5 ml 1% lidocaine 
B: Patient position 
Position the patient comfortably supported in half lying. 
B: Palpation 
The midtarsal complex consists of the calcaneocuboid joint laterally and the 
talocalcaneonavicular joint medially. Palpate the joints to identify the site of the 
lesion. The calcaneocuboid joint is located approximately one thumb's width 
behind and above the base of the fifth metatarsal The talocalcaneonavicular joint 
is located by passively everting the foot and palpating along the talus in front of 
108 
the medial malleolus until the joint line is felt. Mark a convenient point over this 
joint. 
B: Technique 
Insert the needle perpendicular to the joint line and once intracapsular deliver the 
injection as a bolus (Figs 10.7 and 10.8). 
Clinical tip: The dorsalis pedis artery and deep peroneal nerve lie on the dorsum 
of the foot lateral to the extensor hallucis longus tendon. Locate the dorsalis 
pedis pulse by palpation and avoid injecting into the artery or nerve by 
considering their positions in the foot. 
B: Patient advice 
Advise the patient to maintain a period or relative rest for up to two weeks after 
the injection. 
A: First metatarsophalangeal joint 
B: Indication 
Arthritis. This may be an acute episode of degenerative osteoarthrosis, 
inflammatory arthritis or traumatic arthritis. 
B: Patient presentation 
The patient complains of pain, and often swelling, located locally over the big toe. 
On examination a capsular pattern of limited movement will be present with gross 
loss of extension and some loss of flexion. The loss of extension can hamper 
function since is required for the toe-off phase of gait. 
B: Treatment by injection 
An injection of corticosteroid can give good symptomatic relief and allow 
mobilisation to restore the range of movement. 
B: Needle size 
25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
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10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1% lidocaine 
B: Patient position 
Position the patient in half lying with the foot supported. 
Palpation 
The joint line is located dorsally by palpation, if this is difficult, add some 
distraction, which will also facilitate the injection. Mark a point on the joint line, 
selecting either side of the extensor tendon. 
B: Technique 
Insert the needle perpendicular to the joint line and once intracapsular deliver the 
injection as a bolus (Figs 10.9 and 10.10). 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Metatarsophalangeal joints and the interphalangeal joints 
B: Indication 
Arthritis. Degenerative, inflammatory or traumatic arthritis may affect these joints. 
B: Patient presentation 
The patient will be able to localise their pain to the particular joint(s) involved. 
On examination, the capsular pattern of limited movement will confirm the 
diagnosis. This pattern may vary, but generally there is a greater limitation of 
flexion at the metatarsophalangeal joints causing them to fix in extension, whilst 
the interphalangeal joints fix in flexion. 
B: Treatment by injection 
Corticosteroid injection reduces the inflammation and may achieve effective pain 
relief. 
B: Needle size 
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25G x 5/8 in (0.5 x 16 mm) orange needle 
B: Dose 
10 mg triamcinolone acetonide, 0.25 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.25 ml 1 % lidocaine 
B: Patient position 
Position the patient in half lying with the foot supported. 
B: Palpation 
Locate the symptomatic joint and identify the joint line. Mark a point on the 
dorsolateral joint line. 
B: Technique 
Insert the needle perpendicularly, into the relevant joint via the dorsolateral or 
dorsomedial surface to avoid the extensor tendon (Figs 10.11 and 10.12). Once 
intracapsular, the injection can be delivered as a bolus. 
B: Patient advice . * 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. 
A: Sesamoiditis 
B: Indication 
Bruising of the sesamoid bone of flexor hallucis longus or traumatic arthritis of 
the sesamo-first-metatarsal joint associated with deformity such as pes cavus 
(Cyriax, 1982). 
B: Patient presentation 
The patient complains of pain on the medial aspect of the plantar surface of the 
forefoot on walking. On examination pain may be provoked by resisted flexion of 
the big toe and there is an area of tenderness to palpation. 
B: Treatment by injection 
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Injection may be curative (Cyriax, 1982). 
B: Needle size 
23G x 1 in (0.6x25mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1 % lidocaine 
B: Patient position 
Position comfortably in sitting or lying with the foot supported. 
B: Palpation 
Palpate and mark the area of tenderness on the plantar aspect of the big toe. ' 
B: Technique 
Insert the needle medially on the plantar surface of the big toe, aiming towards 
the area of tenderness between the first metatarsal and the flexor tendon (Figs 
10.13 and 10.14). Deliver the injection by a bolus technique, avoiding direct 
injection into the tendon. 
Clinical tip: The digital arteries and nerves run alongside the flexor tendons and 
need to be considered when administering the injection. 
A: Retrocalcaneal bursa 
B: Indication 
Retrocalcaneal bursitis. This may be due to the existence of a bony exostosis 
(Haglund's deformity), or ill fitting footwear which exerts excessive pressure over 
the posterior aspect of the heel. The condition may be a manifestation of 
rheumatoid arthritis or one of the spondylarthropathies e.g. Reiter's disease 
(Hutson, 1990; Frey et al, 1992; Baxter, 1994) 
B: Patient presentation 
The patient complains of pain felt on the posterior aspect of the heel. Aggravating 
factors include sporting activities and footwear. 
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On examination the signs may be confusing and it may be difficult to differentiate 
the condition from Achilles tendinitis, with which it may co-exist. Passive 
dorsiflexion, passive plantarflexion and resisted plantarflexion may all squeeze 
the inflamed bursa, but palpation just anterior to either side of the Achilles tendon 
will localise the lesion. 
B: Treatment by injection 
An injection of corticosteroid may give symptomatic relief of pain, but the cause 
of the problem must be addressed to prevent recurrence. 
B: Needle size 
23G x 1 in (0.6x25 mm) blue needle 
B: Dose 
10 mg triamcinolone acetonide, 0.5 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.5 ml 1% lidocaine 
B: Patient position 
Position the patient in prone lying with the foot supported in slight plantarflexion 
over a pillow. Supine lying could also be used. 
B: Palpation 
Frey et al, (1992) used X-ray and contrast medium to demonstrate the existence 
of the retrocalcaneal bursa. It caps the superoposterior surface of the calcaneum 
as a horseshoe shaped bursa separating the calcaneum from the insertion of the 
Achilles tendon (Stephens, 1994). The tender bursa can be located by palpation 
anterior to the tendon either laterally or medially to the distal end of the Achilles 
tendon. Mark the identified point of maximum tenderness. 
B: Technique 
Insert the needle either medially or laterally between the distal end of the Achilles 
tendon and the upper third of the posterior surface of the calcaneum (Figs 10.15 
and 10.16). Deliver the injection as a bolus. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following the injection. The cause of the condition should be addressed by 
avoiding aggravating activities or replacing ill fitting footwear. 
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A: "Dancer's heel" 
B: Indication 
Posterior tibial periostitis. This may occur particularly in ballet dancers where the 
increased mobility into plantarflexion at the ankle joint, resulting from point work, 
causes the calcaneum to bruise the periosteum at the lower border of the 
posterior tibia (Cyriax, 1982). A similar condition can be seen in other athletes 
e.g. footballers, javelin throwers, hockey and squash players (Cyriax and Cyriax, 
1983). 
B: Patient presentation 
The patient complains of pain felt locally at the back of the heel with symptoms 
reproduced at the end of range of passive plantarflexion (Cyriax, 1982). 
B: Treatment by injection 
Injection may be curative providing the cause of the lesion is addressed. 
B: Needle size 
21G x 11/2 in (0.8x40 mm) o r 2 1 G x 2 in (0.8x50 mm) green needle 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine. 
B: Patient position 
Position the patient in prone lying. 
B: Palpation 
Palpate and mark the area of tenderness on the posterior aspect of the lower 
tibia deep to the Achilles tendon. 
B: Technique 
Insert the needle either medially or laterally to the Achilles tendon aiming towards 
the posterior margin of the lower tibia which lies approximately 2 cm above a line 
joining the malleoli and deliver the injection by a peppering technique across the 
periosteum of the lower edge of the tibia (Figs 10.17 and 10.18). 
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B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following the injection. The patient should be made aware of the causative 
factors and measures should be taken to avoid overpointing. 
A: Plantar fascia 
B: Indication 
Plantar fasciitis. This may be due to repetitive microtrauma of the longitudinal 
arch of the foot, producing focal tears and chronic inflammation at the insertion of 
the plantar fascia into the medial tuberosity of the calcaneum (Kibler et al, 1991, 
Karr, 1994, Gibbon and Cassar-Pullicino, 1994; Dasgupta and Bowles, 1995; 
Singh et al, 1997). Repeated intrinsic muscle activity against the stretched 
plantar fascia during gait activities may cause a traction injury of the plantar 
fascia at its insertion (Gibbon and Cassar-Pullicino, 1994). Both of these 
mechanisms may produce a heel spur. Obesity can be a predisposing factor, 
since it may lead to postural overuse of the foot, causing overpronation and 
stretching of the plantar fascia. A tight Achilles tendon may also produce 
overpronation, and inappropriate footwear may predispose to the condition 
(Evans, 1990; Karr, 1994). 
B: Patient presentation 
The patient complains of a gradual onset of pain on the medial aspect of the 
plantar surface of the heel. Characteristically, this is most painful when the first 
few steps are taken as the patient gets out of bed in the morning, but the pain 
then eases (Kibler et al, 1991; Karr, 1994). 
On examination, positive signs may be lacking on routine examination of the foot 
and ankle. Passive extension of the toes may have a 'windlass' effect on the 
plantar fascia reproducing the pain; exquisite tenderness is present specifically 
over the medial calcaneal tuberosity. 
B: Treatment by injection 
A corticosteroid injection can be curative. Sellman (1994) suggested that an 
accurate injection abolishes pain and tenderness, preventing the need for 
repeated injections which have been associated with plantar fascia rupture. 
Singh et al (1997) suggests a comprehensive treatment programme, including 
corticosteroid injection, intrinsic muscle exercises, calf stretches, strapping and 
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heel cushions, and 'cock-up' night splints may be needed to address the 
problem. 
B: Needle size 
21G x 11/2 in (0.8 x 40 mm) or 21G x 2 in (0.8 x 50 mm) green needle 
B: Dose 
20 mg triamcinolone acetonide, 1 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1 ml 1% lidocaine. 
B: Patient position 
Position the patient in prone lying with the knee flexed and the lower leg 
supported on a pillow. The position can be modified to allow the patient to lie 
supine. 
B: Palpation 
Locate the medial calcaneal tuberosity by deep palpation and mark the mid-point 
of the tender area. 
B: Technique 
Insert the needle through the soft tissues on the medial aspect of the foot anterior 
to the marked point (Fig 10.19). Angle the needle posterolateral^ towards the 
junction of the plantar fascia with the medial calcaneal tuberosity (Fig 10.20), and 
deliver the injection by peppering technique. This indirect approach to the plantar 
fascia is more comfortable for the patient since the needle is inserted through 
soft tissue, rather than directly through the fat pad. It also avoids fat atrophy and 
the risk of infection from the sole of the foot. 
Clinical tip: the.lateral plantar artery and nerve and the medial plantar nerves lie 
deep to the origin of the plantar fascia. 
Alternative techniques: Position as above (1) Insert the needle perpendicular to 
the sole of the foot aiming towards the area of tenderness where the injection is 
delivered by a peppering technique. (2) Insert the needle medially, perpendicular 
to the calcaneum, aiming towards the area of tenderness where the injection is 
delivered by a peppering technique. 
B: Patient advice 
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Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. The causative factors should be addressed to prevent,recurrence, 
including weight loss if appropriate. 
A: Peroneal tendons 
B: Indication 
Tendinitis at the teno-osseous junction of peroneus brevis at the base of the fifth 
metatarsal, or tenosynovitis of peroneus longus and brevis in their shared 
synovial sheath at the ankle. An acute lesion may be associated with inversion 
sprain at the ankle; the chronic lesion may be due to overuse. 
B: Patient presentation 
The patient complains of either sudden pain felt on the lateral side of the ankle 
following an inversion injury, or a gradual onset of low-grade pain through 
overuse. 
On examination the symptoms are reproduced by resisted eversion. In acute 
tenosynovitis, passive inversion may also be painful as the tendons are pulled 
through their inflamed sheath. 
B: Treatment by injection 
Corticosteroid injection into the shared synovial sheath or into the teno-osseous 
junction of peroneus brevis at the base of the fifth metatarsal may be curative. 
Alternative treatment may be by physiotherapeutic modalities including 
mobilisation by transverse friction massage and electrotherapy (Cyriax and 
Cyriax, 1983; Cyriax, 1984; Kesson and Atkins, 1998). 
B: Needle size 
25G x 5/8 in (0.5x16 mm) orange needle (teno-osseous junction) or 23G x 1 in 
(0.6x25 mm) blue needle (tendons in sheath) 
B: Dose 
10 mg triamcinolone acetonide, 0.75 ml local anaesthetic 
e.g. 0.25 ml Kenalog®, 0.75 ml 1% lidocaine 
B: Patient position 
Position the patient supine in half lying with the foot supported. 
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B: Palpation 
B: Locate the lesion by palpation. 
If tenosynovitis is the lesion, the tendons run in a shared sheath behind and 
below the lateral malleolus. The peroneal tubercle (one finger's breadth below 
and anterior to the lateral malleolus) marks the distal end of the sheath and the 
point at which the tendons separate. Find the peroneal tubercle and mark a point 
between the two tendons. 
If the lesion is at the insertion (teno-osseous junction) of peroneus brevis, locate 
the base of the fifth metatarsal and mark the tender point. 
B: Technique 
For tenosynovitis, insert the needle at the distal end of the shared sheath (see 
above); angle it posteriorly and between the peroneal tendons (Figs 10.21 and 
10.22). Deliver the injection as a bolus into the shared sheath. 
Clinical tip: If tenosynovitis is due to inversion sprain, treatment using 
physiotherapeutic modalities such as friction massage and mobilisation usually 
achieves excellent results (Cyriax and Cyriax, 1983; Cyriax, 1984; Kesson and 
Atkins, 1998). 
For tendinitis at the teno-osseous junction of peroneus brevis, deliver the 
injection by a peppering technique at the area marked as tender at the base of 
the fifth metatarsal (Figs 10.23 and 10.24). 
Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks 
following the injection. 
A: Achilles tendon 
B: Indication 
Achilles tendinitis. Early tendinitis involves reversible inflammation of the 
paratenon, which may respond well to corticosteroid injection. If the lesion 
becomes chronic, irreversible degenerative changes supersede the inflammatory 
changes and tendinosis is the main problem i.e. focal degeneration (Williams, 
1986; Mahler and Fritschy, 1992). The lesion may be further complicated by 
partial or complete rupture. 
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Causes of Achilles tendinitis range from altered lower limb biomechanics, 
overpronation, ill fitting footwear, pressure from heel counters, and inappropriate 
or excessive training regimes, to an association with rheumatoid arthritis and the 
spondyloarthropathies (Smart et al, 1980). 
B: Patient presentation 
The patient complains of a gradual onset of pain localised to the posterior aspect 
of the heel. Characteristically pain and stiffness is present on first putting the foot 
to the floor after a night's rest, but this subsides after a few steps. The posterior 
location of the pain differentiates Achilles tendinitis from plantar fasciitis. The 
symptoms are aggravated by activity. 
On examination the affected area of the tendon may be observed as thickened. 
Resisted plantarflexion, particularly against the patient's body weight and gravity, 
reproduces the symptoms. 
B: Treatment by injection 
Conflicting evidence exists over the use of corticosteroid injections and their 
relationship to tendon rupture (Kennedy and Baxter Willis, 1976; Smart et al, 
1980; Kleinman and Gross, 1983; Mahler and Fritschy, 1992; Read and Motto, 
1992). Early Achilles tendinitis, involving inflammation of the paratenon, should 
respond well to corticosteroid injection alongside, but NOT into the body of the 
tendon. Chronic lesions of tendinosis where degeneration is the main feature 
may not respond so readily and are prone to rupture whether or not they are 
injected. It remains questionable that rupture is due to a steroid effect or further 
manifestation of degenerate disease (Phelps et al, 1974). Ultrasound scanning 
can help to establish degenerative changes and partial tears within the tendon, 
especially if a tender focal nodule is palpable. 
Since one of the effects of corticosteroid injection is to weaken collagen fibres 
initially, the enforcement of relative rest after injection is of paramount importance 
to prevent this complication. 
B: Needle size 
21G x 11/2 in (0.8x40 mm) green needle 
B: Dose 
20 mg triamcinolone acetonide, 1.5 ml local anaesthetic 
e.g. 0.5 ml Kenalog®, 1.5 ml 1% lidocaine 
B: Patient position 
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Position the patient in prone lying with the lower leg supported and the ankle 
maintained in dorsiflexion. 
B: Palpation 
Two insertions need to be made, therefore palpate the distal tendon for the 
tenderness and mark a point on both sides of the tendon. 
B: Technique 
Clinical tip: Bend the needle slightly at the hub, using the needle sheath to 
achieve this, to facilitate the injection parallel to the tendon. 
Insert the needle to one side of, and parallel to the Achilles tendon advancing it 
to its full length (Figs 10.25 and 10.26). Deliver the injection as a bolus depositing 
half the solution as the needle is withdrawn. Replace the needle and inject the 
remaining solution on the other side. 
Clinical tip: As a weight-bearing tendon and with the likelihood of degenerative 
changes within the tendon predisposing it to rupture, this injection technique aims 
to 'bathe' the tendon in corticosteroid solution and is NOT an injection into the 
body of the tendon itself. 
B: Patient advice 
Advise the patient to maintain a period of relative rest for up to two weeks after 
the injection. This is most important for the Achilles tendon since it is a weight-
bearing tendon, and any possible weakening of the collagen fibre content of the 
tendon could predispose it to rupture. The causative factors need to be 
addressed and a heel raise or orthotics may be appropriate. 
Conclusion 
Section 2 has adopted a regional approach in presenting injection techniques for 
the treatment of peripheral musculoskeletal lesions. The upper limb lesions have 
been covered first, working through the shoulder, elbow and wrist and hand 
regions. Lower limb lesions follow, relating to the hip, knee and ankle and foot 
regions. A consistent format has been used for each injection, providing details of 
indications, presentation, needle size, dosage, patient position, accurate 
palpation of the site, specific technique for the injection and the appropriate 
aftercare advice for the patient. Guidelines for injection doses have been given 
throughout and it has been highlighted that the guidance for the dosage of 
steroid refers to the use of triamcinolone acetonide as an example, with the 
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advice to consult the manufacturer's data sheet if another steroid is to be used. 
The necessity for the use of an 'no touch' technique when injecting has been 
emphasised and Clinical tips have been offered to both ensure safety and 
enhance effectiveness. 
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Appendix 
The capsular pattern is a limitation of movement in a specific pattern that is 
peculiar to each joint and is a useful finding for clinical diagnosis since it indicates 
the presence of an arthritis. The pattern varies from joint to joint and is 
characterised by limitation of movement in a fixed proportion. It is the same 
whatever the cause of the arthritis (Cyriax, 1982; Cyriax and Cyriax, 1983) and 
the history and investigations will suggest and lead to confirmation of the specific 
form. The movements that become limited in the capsular pattern take on a 
defined 'hard' end feel. 
Capsular patterns 
Joint Capsular pattern 
Shoulder joint Most limitation of lateral rotation 
Followed by abduction 
Least limitation of medial rotation 
Elbow joint More limitation of flexion than extension 
Radioulnar joints Pain at end of range of both rotations 
Wrist joint Equal limitation of flexion and extension 
Eventual fixation in the mid-position 
Trapezio-first metacarpal joint Most limitation of extension 
Metacarpophalangeal joints Limitation of radial deviation and extension 
Interphalangeal joints Equal limitation of flexion and extension 
Hip joint Most limitation of medial rotation 
Followed by limitation of flexion and abduction and 
eventual limitation of extension 
Knee joint More limitation of flexion than extension 
Ankle joint More limitation of plantarflexion than dorsrflexion 
Subtalar joint Increasing limitation of supination 
Eventual fixation in pronation 
Midtarsal joint Limitation of adduction and supination 
Forefoot fixes in abduction and pronation 
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First metatarsophalangeal joint Gross limitation of extension 
Some limitation of flexion 
Other metatarsophalangeal joints May vary; usually more limitation of flexion and 
extension 
Interphalanageal joints Fix in flexion 
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SECTION 5 
AN INVESTIGATION OF THE EXPERIENCE OF PHYSIOTHERAPISTS IN 
IMPLEMENTING THEIR INJECTION THERAPY SKILLS 
Key words 
Extended scope, injection therapy, musculoskeletal injections 
Summary 
The scope of physiotherapy practice was extended to include intra-articular-and 
intralesional injections within musculoskeletal therapy in 1995, provided that 
physiotherapists had undertaken 'appropriate training'. 
The purpose of this study was to investigate the experience of physiotherapists in 
applying their injection therapy skills following training. A qualitative study was used, 
based on a phenomenological model to be able to explore the actual experience of 
physiotherapists. Participants volunteered to take part in the study and unstructured 
interviews were conducted, transcribed and analysed. 
The investigation was performed as a step towards establishing facilitating factors and 
barriers to practice as experienced by physiotherapists in implementing their injection 
therapy skills. Four principal themes arose from the interviews relating to professional 
autonomy, professional relationships, affective factors and training issues. Extension 
of the investigation will aim to explore its findings further, to contribute to the theory 
underpinning the development of injection training programmes and to inform the 
profession as a whole. 
Introduction 
The aim of the study was to explore the experience of physiotherapists in implementing 
their injection therapy skills, to administer the intra-articular and intralesional injections1 
used in orthopaedic medicine in the management of musculoskeletal lesions. A 
1 'Intra-articular' injections are administered into the joint cavity, and 'intralesional' injections are 
directed to the site of the lesion within the tissue structure, e.g. tendon, teno-osseous junction or 
ligament. 
phenomenological approach was adopted using unstructured interviews to explore the 
experience of eleven participants, each of whom had undergone training in injection 
therapy since the introduction of injection therapy into the scope of physiotherapy 
practice in 1995. Following analysis, the data was categorised as a basis for the 
description of the physiotherapists' experience, and ensuing discussion. 
Within the data, facilitating factors and barriers to practice emerged that it is my 
intention to explore further from a grounded theory perspective, to be able to establish 
recommendations for the development of training programmes and the continued 
implementation of this skill specialism into practice. 
The Chartered Society of Physiotherapy (CSP), as a professional body, is responsible 
for the validation of education and skills training of its members. It has an important 
role in the consideration of the professional practice issues surrounding the application 
of techniques, including the articular and soft tissue injections used in the management 
of musculoskeletal lesions. Intra-articular and intralesional injections, normally of 
steroid and local anaesthetic, are applicable as a treatment option in the management 
of musculoskeletal lesions, but their inclusion within the scope of physiotherapy 
practice was initially resisted, since injections were not considered to be within the core 
skills of massage, remedial gymnastics and electrotherapy (Williams, 1986). 
With the continued development of autonomy within physiotherapy came the extended 
role of the profession in orthopaedics and rheumatology, where orthopaedic and 
rheumatology 'assistants' or 'practitioners' were being created, whose role included the 
administration of local steroid injection. Hockin and Bannister (1994) examined the 
extended role of a physiotherapist in an outpatient orthopaedic clinic and identified that 
22% of patients had received physiotherapist administered steroid injection. With the 
existence of such a fait accompli and the moves of continuing professional 
development in encouraging the process of developing practice towards skill 
specialism (Bergman, 1990), the CSP was pressed to extend the scope of practice of 
physiotherapy to include intra-articular and intralesional injections in December 1995, 
provided that the physiotherapist was 'appropriately trained'. 
The definition of 'appropriate training' allowed for interpretation in that physiotherapists 
could be directly supervised, mainly in orthopaedic or rheumatology departments, or 
could attend dedicated injection therapy courses. Injection therapy courses are 
normally provided as a sequel to courses in orthopaedic medicine where the principles 
of intra-articular and intralesional injections are taught as part of the syllabus. 
Orthopaedic medicine is a specialism in medicine that is dedicated to the examination, 
diagnosis and non-surgical treatment of disorders of the soft tissues of the 
musculoskeletal system. Courses in orthopaedic medicine are bi-disciplinary, and both 
doctors and physiotherapists have traditionally been taught the theory and practice of 
both manual and injection techniques, but with physiotherapists being unable to 
practice injection therapy following completion of the course. It was apparent that 
physiotherapists would require further training to be able to achieve both the 
competence and confidence to inject. 
With respect to the relationship between education and implementation within 
postgraduate physiotherapy education, following demonstration of competence skills 
learned.can be normally be applied immediately in the appropriate clinical setting and 
with autonomy. However, this has not been always been apparent in the 
administration of injections, even after training, and several potential barriers to 
practice can be proposed. 
For example, in common with other treatment techniques, competence does not 
necessarily imply confidence. The physiotherapist may not feel confident to administer 
injections, especially with the potential threat of the emergency situation of 
anaphylactic shock or introduction of sepsis via this invasive technique. Potential 
problems could also exist with medical colleagues who might not support the 
physiotherapist in injecting their patients, their reasons including lack of confidence in 
the physiotherapist's abilities, particularly in coping with emergency procedures when 
they have not had the experience in professional practice, and threat to financial and 
professional monopoly. Without the prescription of drugs and supportive relationships 
with medical colleagues, physiotherapists would be barred from implementing their 
skills. 
In order to establish the availability of existing research in this area, a literature search 
was carried out using the databases CINAHL, MEDLINE, EMBASE: Physical Medicine 
and Rehabilitation, and the Chartered Society of Physiotherapy's library catalogue. For 
the purposes of this study, the review of the thousands of texts concerning the 
administration of injections as such was irrelevant, since it concentrated on the effects 
of the injections themselves. Issues of scope of practice, extended role/practice and 
theory of professionalism or autonomy were more related to my area of study, but only 
a few references were found that drew parallels within other professions including 
nursing (Head, 1988, Potter, 1990, Howie, 1992, Gilski, 1993 and the Nurse Project in 
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Wilcannia, Australia, 1994, paramedics (Garza, 1993) and chiropody (Society of 
Chiropodists, 1975), as well as within physiotherapy itself (Hourigan and Weatherley, 
1995, Chartered Society of Physiotherapy, 1997, Owen, 1998), notably with the 
inclusion of acupuncture within scope of practice in 1985 (Alltree, 1992, 1993, and 
Hopwood, 1993). 
Sociological issues were explored relating to professional development and the 
relationship of physiotherapy to other professions. Physiotherapy has been 
traditionally a female dominated profession and there may have been gender issues in 
moving the profession forwards. Macdonald (1995) and Davies (1995) were studied as 
a starting point in thèse respective areas, as a basis for thèmes that might arise within 
the study. 
Injection therapy is innovative practice to which both intrinsic and extrinsic barriers 
might be encountered and the aim was to investigate that expérience. 
Methodology 
An exploratory qualitative study within the naturalisée paradigm was performed. The 
study was not based on theory, as such, but was intended to be an initial step towards 
generating theory as an outcome of the induetive reasoning within naturalisée inquiry. 
The expérience of physiotherapists was the prime area of interest. The focus of 
phenomenology is the investigation of everyday expérience (Depoy and Gitlin, 1994), 
and phenomenological methods seek to 'understand, describe and Interpret human 
behaviour from the perspective of the person being studied' (Finlay, 1999). In 
phenomenology the belief is that 'understanding is limited to knowing expérience 
without interpreting that expérience' and Finlay again supports this by stating that 
'phenomenology is committed to describing, not explaining how and why meanings 
arise'. The person needs to be able to provide a comprehensive description of the 
expérience from which the investigator can détermine the meaning of the expérience 
(Moustakas, 1994). A phenomenological approach is commonly used in nursing and 
midwifery studies to enhance understanding of practice skills and this was selected as 
the appropriate method for the investigation. 
For the purposes of the initial investigation, the intention was not to generate theory as 
such from the data collected, as aecording to the principles of grounded theory (Glaser 
and Stauss, 1967), although this will be an aim for further associated studies. Some 
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integration of methods might exist but there was the determination to remain focused 
on that 'experience' to avoid the 'muddling, slurring and blurring' of methods identified 
as a potential pitfall by Wimpenny and Gass (2000), where no clear method may be 
defined. The physiotherapists' perceptions were the 'primary source of knowledge' 
(Moustakas, 1994), through their own description of their experience, in this instance 
concerning the implementation of their injection therapy skills. 
Interviews were conducted with selected physiotherapists who fulfilled the criterion in 
that they had completed training in injection therapy, either through attending 'official' 
injection therapy courses or by direct medical supervision, normally by an orthopaedic 
or rheumatology specialist. Participants were recruited through advertising in 
'Frontline', with a brief explanation of the project. By voluntarily applying to take part, 
the consent of participants was assumed. 
Participants entered the study on a 'first come' basis from the self-selected group, after 
checks that the criteria were fulfilled for each individual entering the study. The sample 
selected in that way formed a convenience sample, and recruitment continued in the 
order that participants volunteered, until the required number was reached. For a study 
of this nature, the aim was to interview eleven participants, allowing for a pilot 
interview. Although arbitrary to a certain extent it was believed that this number would 
allow trends to be established in the experiences described and to reach a point of 
'saturation' with no new themes emerging. The pilot interview allowed for practice with 
subsequent evaluation and refinement of the interview technique but since it was 
conducted without problems, was also used to contribute data to the study. The 
interviews were conducted at a convenient time and venue for each participant. 
Participants represented a range of clinical backgrounds. Five were working for local 
health care trusts, one of whom was an extended scope practitioner in rheumatology, 
one based in a group general practice and one also linked to a University based private 
practice. Five were predominantly in private practice with two of those also having an 
extended scope practitioner role in orthopaedic services. The remaining participant 
was managing the physiotherapy service for a large occupational health department 
supporting the motor industry. Seven female and four male participants were 
interviewed and their experience ranged between five and thirty years of clinical 
experience in musculoskeletal therapy. 
Before committing to interview, complete freedom of speech was assured with 
guaranteed confidentiality and the right to withdraw at any time. The aim from the 
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outsetwas to establish a sensé of trust between the participants and the interviewer. 
An overview of the project was given to each participant prior to the commencement of 
the interview. The research question was deliberately open to encourage the 
physiotherapists to relate their expériences of implementing their injection skills from 
their own perspective. With slight variation in wording the question was: Take me back 
to the beginning before you were able to inject and describe your expérience in 
implementing your injection skills'. To this end the interview was unstructured, to be 
consistent with the purist view of phenomenology, but with prompt questions to explore 
the avenues suggested. Prior notice was given that each interview would be 
completed wrthtn one hour to avoid fatigue and encroaching on the participants' clinical 
time. 
The assumptions of the interviewer had already been identified in that there was the 
expectation that physiotherapists would describe a range of expériences including lack 
of confidence in applying the skill, as well as encountering barriers to practice in not 
being able to prescribe drugs or in the inhibiting attitudes of médical colleagues. It was 
important to 'bracket' the assumptions (Ashworth, 1997) setting them aside at the time 
of interview to avoid leading the informant. 
The interviews were recorded, with informed permission from the participant, and 
transcribed onto computer for subséquent analysis. As a check for accuracy, the data 
were analysed in a form of triangulation (DePoy and Gitlin, 1994), using observation of 
the informants at the time of interview, the interview itself and reflection on the written 
transcription. The possibility of knowing informants, coupled with any influence of 
previous assumptions, begged for démonstration of accuracy in the subséquent 
analysis of the data collected. 
Notes were recorded on how the interview went as soon after its conclusion as 
possible, to include any objective and subjective comments based on the observations 
of the participant and the interviewer. DePoy and Gitlin (1994) acknowledge the 
difficulty in eliminating bias and describe the term 'reflexivity', suggesting that the 
investigator should reflects on their own perspective and the influence that this might 
have had on any stage of the research process. 
Ashworth (1997) daims that 'description is already interprétative' and in transcribing 
the interviews, it was apparent that even at the initial stage of interprétation judgements 
would be made on the meaning of the views of the informants. It was important that 
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these coincided with what the informant had actually said in making their own sense of 
their experience. The transcriptions were forwarded to the participant as a further 
check for accuracy and each participant confirmed that the transcriptions were faithful 
to the interview from their own recollections. The reflections on the data collected, 
away from the interview situation, provided a further means of ensuring and checking 
for accuracy in that there should be a close correlation between the analyses made by 
using triangulation in this way. 
Ethical Considerations 
The investigation was conducted with sensitivity for the ethical issues of confidentiality 
and anonymity. An assurance was given by the CSP, before the interviews were 
conducted, that supervision and advice would be received if unethical behaviour had 
become apparent in any of the participants interviewed. 
Analysis 
A general view is that there is no single right way to analyse qualitative data and it 
might be suggested that qualitative data should present its own method of analysis. 
Within phenomenology, Morse (1992) propounds that 'the process of inquiry is moved 
along by writing and rewriting during the process of reflection'. In preparation for writing 
the report the data were systematically analysed drawing from the guidelines of Miles 
and Huberman (1994), Strauss and Corbin (1990) and Coffey and Atkinson (1996), 
applying identifying labels or 'codes' to each point of the transcript. Coffey and 
Atkinson (1996) suggest that 'many analyses of qualitative data begin with the 
identification of key themes and patterns' and this was the approach used in analysing 
the codes, avoiding any quantification of data. 
Following completion of the coding process, four main categories were identified: 
professional autonomy, professional relationships, affective factors and training issues, 
with some overlap between the former two categories. The codes were clustered on 
the basis of personal analysis and the reader may arrive at another conclusion in 
analysing the codes as listed in Table 1 
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TABLE OF KEY CATEGORIES 
Professional Autonomy 
Codes: 
Motivation to perform injections, 
frustration, freedom, expended scope, 
enhancement of practice, knowledge, 
limitations to practice, service to 
patients, rigour, responsibility, 
autonomy, increased efficiency, more 
effective management, professional 
development, private versus NHS, 
protocols, legal position, informed 
consent 
Professional relationships 
Codes: 
Mutual respect, prescription, involvement, 
expectations, attitudes, collaboration, 
support, communication with colleagues, 
relationship, sociology of professions, 
deferring, gender issues, perceptions, 
knowledge of professional rôles, éducation 
of colleagues 
Affective factors 
Codes: 
Confidence, enjoyment, 'feel good 
factor", familiarity, comfort, fear of 
anaphylaxis, caution, positiveness, loss 
of control, uncomfortable, attitude to 
patient's pain, vulnerability, 
nervousness, possible catastrophe, fear 
of harming patient, invasiveness, 
threatened, unconscious ignorance, 
'doing it right', insecurity 
Training issues 
Codes: 
Interest, motivation for courses, clinical 
supervision, feedback, pharmacology, 
prescription rights, support for injection 
training, implementation, mentoring. 
Description and discussion follow using the catégories as headings and using quotes 
as illustrations for the key points within each section. The bracketed number following 
each quote represents the identification number of the interviewée. 
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Professional autonomy 
Participants tended to begin their account of their personal experience by identifying 
the factors that had led them to pursue injection therapy. There was generally a high 
level of motivation driven by an interest in the area as an extension of their existing 
skills in musculoskeletal therapy in support of their autonomy. 
7 think I have manufactured (support) because of my need and desire to 
develop.' (1) 
7 wanted to have a better understanding of what it felt like to be an injector1 (5) 
'. ..my interest in injection therapy came at a very early stage as soon as I was 
aware that it had a role to play in the kind of conditions that I was involved with 
on a daily basis. ...I soon became acutely aware that there were areas that I 
couldn't treat effectively' (7) 
There were also extrinsic factors towards motivation where the requests were made of 
physiotherapists by physiotherapy managers or medical colleagues to introduce an 
injection clinic. The development of injection therapy skills was seen as part of 
professional development and enhanced practice and was intertwined with extension of 
scope of practice. 
7 was working in rheumatology with a consultant who was injecting quite a lot... 
(he) felt he would like a physiotherapist to develop the skills... it incorporated 
into my practice of extended scope practitioner...' (1) 
'...we had a fund holding practice that... couldn't get the injections done, was 
there anything that physiotherapists could do?...' (3) 
7 qualified in injection therapy... with the idea that we would set up injection 
therapy involving the ... health care trust' (4) 
Frustration was mentioned, linked to motivation, in recognising conditions suitable for 
injection but not being able to either get the injections done, or if so, not accurately; and 
limitations to autonomous practice in not being able to do them themselves. 
'All of us got and still do get frustrated by some of the injections that are given 
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by GPs and if only they'd put it in the right place the response could have been 
much better, so... for most of us it was really good to be given the chance to 
inject' (11) 
7 was always interested in it from when I did my Part A, Part B and Part C 
(Society of Orthopaedic Medicine Membership Course)... and it seemed terribly 
frustrating being taught something I couldn't apply' (3) 
Implications for service to patients featured, again with frustration at not being able to 
bypass potential waiting lists faced by patients who were referred for consultant 
opinion. 
We see an awful lot of patients that at the moment are frustrating me because I 
think they would benefit but at the moment we're having to send them back' (4) 
'Trying to get a consultant's appointment round here can be three, four, six 
months which I think is detrimental to the patient's treatment whereas we know 
that injection can help - so that's the frustration part of it' (4) 
Once the service had been set up it was viewed as an improved service in the 
management of patients. 
'It has expanded the way I manage patients, its another skill that is available. It 
has allowed me to explore effectiveness of treatment and how I can effectively 
manage patients and, if we use the shoulder patients as an example again, I 
think my overall management of shoulder pain has been enhanced as a result 
of using injection therapy because I have been able to select through 
experience and seen the response of patients to physiotherapy and to injection 
therapy. It has allowed me to select the types of presentations that would be 
more effectively managed by physiotherapy or more effectively managed by 
injection therapy' (1) 
'It would just shorten that person's treatment time really' (9) 
The opinion was expressed that it was important that physiotherapists who were 
implementing their injection therapy skills should not become known as only applying 
that technique and that it should remain as an integral component of physiotherapy 
practice in the management of musculoskeletal lesions. 
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'They're saying 'can you come and do a clinic at... which is in the PCT (primary 
care trust), and I say 'No - get other physios trained up' - I don't want to get a 
reputation, which I think I'm in danger of doing already, and end up doing 
everybody else's injections' (9) 
'One of my concerns... is that my name will become synonymous with 
injections and that you suddenly become 'Mr Injector" and your manual skills 
are ignored and that's what you're known for* (7) 
Freedom to practice was implicit within all of the interviews where injection therapy had 
been implemented, but responsibility was acknowledged as a recognised 
accompaniment within professional autonomy. 
. .they never really interfere and it's very much left to with me' (4) 
'...usually they (doctors) say' on to physio - they'll manage you' 
'I'm never laid back with injection therapy... I probably ask people too often if 
they're happy for me to go ahead... Although we have to be 'squeaky clean', I 
think that's how it should be'(9) 
7 was at pains to say 'Look, I really want to take responsibility so that it falls on 
my shoulders...'(10) 
'But I don't want to stop thinking about it (anaphylactic shock) because of my 
professional responsibility' (10) 
Local protocols linked to local legal implications provided a barrier to injection practice 
and therefore to professional autonomy. An example was provided by the experience 
of one participant who had undergone training specifically to set up an injection service 
within his local health area but had been debarred from proceeding for eighteen 
months whilst protocols were being considered. Paradoxically, he had been able to 
apply his skills in the neighbouring health service whilst completing his period of clinical 
supervision, and had continued to deliver injections in his secondary role within the 
private sector. If the latter facility had not been available to him, he would have been 
barred from applying his skills since completing his training and a debate would have 
emerged in terms of his maintained competence and confidence. 
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'If I was purely working in the health service would I have to have an update? 
Somebody who hasn't been able to do that (inject) for a year would be 
struggling' (4) 
The inability to prescribe the drugs administered was acknowledged by participants, 
but systems had been put in place to facilitate access to the drugs required. It was 
apparent that in some situations relevant parties had the facility to sign up to 'group 
protocols' as according to clear guidelines, such that physiotherapists were able to 
deliver drugs without the general practitioner having to sign a prescription each time. 
This was acknowledged as a helpful step towards prescribing rights and thence to full 
autonomy in the administration of musculoskeletal injections. 
Professional relationships 
Support was acknowledged as a major facilitating factor in being able to implement 
injection therapy skills. The support was principally from medical colleagues but also 
from physiotherapy managers and physiotherapy colleagues. 
'He (the meumatologist) was very encouraging for me to develop these skills. 
We decided he would support me to go on a course and also be very 
supportive watching me doing injections here and closely supporting me 
whenever I needed it' (1) 
'...because I'd started on this new job - our boss was very supportive at the 
time so we started doing some injections and this was brought into vicarious 
liability at work' (6) 
'Everyone I've spoken to has been really positive - I haven't had a negative 
response from any of the professionals I've spoken to - the GPs or the 
surgeons...' (10) 
Several contributing factors towards that support could be identified within the 
interviews. A 'good relationship' with medical colleagues was mentioned and this was 
felt to have come about through effective communication, education, mutual respect, 
conscious involvement, knowledge of professional roles and a willingness to 
collaborate in the management of patients. 
12 
'...relationships that we've had with the GPs have atways been excellent and I 
think there's been a graduai building up of respect between professions and 
acknowledgement of what physiotherapists can do rather than 'people who do a 
bit of massage'. So / think the GPs maybe over the past ten years have 
become progressive^ more supportive and more aware of what physiotherapy 
can offer' (6) 
Whilst accepting the several références to the good relationships with médical 
colleagues and their acknowledgment of the rôle of physiotherapists, there was some 
déferrai to both gênerai practitioners and consultants. Macdonald (1995) considers 
how the médical profession itself has attained its autonomy and the way in which this 
has extended into 'dominance' over 'kindred occupations'. Parallels may be drawn 
between physiotherapists and midwives who he later describes as needing the 
sanction of the médical profession as one of the bases for their legitimacy, but not 
wanting to be dominated by it, acting as 'low status assistants'. 
'A. and I stood up in front of 16 orthopaedic consultants and said we were 
expert injectons that we'd developed this orthopaedic Screening service city 
wide and was that okay? A. did it actually - / was at the back - cowehng - but 
they were unanimously supportive' (7) 
'l've spoken to other extended scope practitioners who've tried to set up an 
orthopaedic Screening service up and down the country and they say -
orthopaedic surgeons are a nightmare and the GPs are very destructive - so 
there are plenty of people out there who can make things very difficult' (7) 
Support for the médical professions perception of physiotherapists is provided in a 
study by Sole et al (2000), that surveyed perception of orthopaedic surgeons, sports 
physicians, biokineticists and physiotherapists on the rôle of physiotherapists in sports 
medicine, based on 36 competencies. A gênerai finding was that the orthopaedic 
surgeons, sports physicians and biokineticists perceived the importance of the 
competencies that overlapped with their respective scope of practice, and the 
compétence at which thèse were performed by physiotherapists, significantly lower 
than the physiotherapists. There was some suspicion of this within the interviews in 
terms of the médical practitioners perceptions of the physiotherapists knowledge and 
compétence. 
13 
'We did try initially to contact the consultants in W..., which is our acute trust, 
and did have some very negative response from the rheumatologists in as 
much as no way did they want physiotherapists to do injections' (9) 
7 do remember one group of GPs who I didn't know got very upset about one of 
the patients being given an injection because actually l'd spoken to a locum 
there and it was a sticky situation - they did write and express their concem 
that physiotherapists were doing this' (6) 
'GPs, or some of them are actually reluctant for me to do it, they would rather 
do it themselves... Two reasons for that, the flrst one is that the GPs don't 
realise that you can inject and secondly some of them are a bit touchy about 
having their toes trodden on. I do ring up GPs and generally they're quite 
happy, I think the main concem is that they don't realise that we're qualified to 
do it' (8) 
Effective communication was highlighted as a means of moving the professional 
relationship forwards. 
7 suppose looking back to when we started the things that l've just spoken 
about there have made me much more inclined to communicate with people 
and actually phone and say look this is what l'm intending to do, l've discussed 
it with the patient...so it's not cowtowing just showing a level of professional 
respect really and acknowledging that particulariy in primary care the GP is 
responsible for the patient and they are the person that you do need to 
communicate with, and I think most GPs will respond to that and there aren't 
many that start calling you 'm'dear1 and treating you like a handmaiden... I do 
think that as a profession we're not very good at doing that historically and we 
tend to get a bit strident and a bit protective of our professional compétence but 
actually communicating that, we don't do terribly well' (6) 
Intra-professional opposition had been noted. 
'The most résistance we've had is from other physiotherapists' (6) 
'She went to see this other physio who said 'you shouldn't have injections, you 
shouldn't have this, it's badpractiœ...' (2) 
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Affective factors 
The term 'affective' is intended to encompass the physiotherapists' emotions or 
attitudes whilst going through the process of implementing their injection therapy skills 
following training. 
Frustration and motivation have been mentioned above with respect to professional 
autonomy. Both can be considered to overlap into the affective factors, but the points 
identified as relating to them were generally more pertinent to professional autonomy. 
Confidence was apparent in all of those participants who had successfully applied their 
skills. There were statements supporting that confidence that included terms such as 
'comfort', enjoyment and 'feel good factor1. Participants claimed that their level of 
confidence had stemmed from their sound knowledge underpinning the approach, 
quality of their training programme including supervision, and a familiarity with the 
technique following practice and consolidation. 
All participants volunteered that they had been nervous before and during the 
application of their first few injections. In exploring this further there had been a fear 
that they might not 'do it right', that they might harm the patient and that they were 
aware that the injection might be painful for the patient. 
7 can remember having a complete mental block about how much of each drug 
you used and when you washed your and hands and whether you needed to 
wash your hands two or three times and - like faffing around generally and 
forgetting the drug and going back and forwards an feeling very hot and sweaty 
and trying to look confident in front of the patient and from what I remember the 
injection went well. I can't think that anything terrible happened, but I do 
remember that for quite a long time after I'd started injecting I really did think 
that everybody was going to get an infection there was going to be some 
serious consequences to every injection I did' (6) 
They had felt 'uncomfortable' with a 'loss of control'. The continuing fear of the 
occurrence of adverse reactions, particularly anaphylactic shock, was persistent and 
was associated with expressions of 'vulnerability', 'insecurity' and 'threat'. One 
participant had felt that her confidence had actually decreased in the three year period 
that she had been applying the skill as she had moved from a state of 'unconscious 
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ignorance' to 'conscious ignorance1 of the scope of possibilities in terms of side effects 
and possible consequences e.g. septic arthritis or steroid arthropathy. 
In spite of the more negative affective factors, these had generally been perceived as 
'hurdles' rather than barriers although participants did acknowledge that a general 
discomfort and fear of catastrophe had prevented them from proceeding with injection 
therapy within their specific clinical situation, normally within the private sector. 
'But I have to say that my confidence in the private setting is less - I just don't 
feel that the structure is there' (6) 
"I can't inject private patients because we see them at a different site where we 
don't have the back up for things like anaphylaxis' (10) 
Training issues 
Participants had had varying experiences in their training, particularly with respect to 
their period of clinical supervision. Some felt that they would have liked closer 
supervision and felt the need for more support during the period of supervision. 
7 felt that actually, because I was a novice, that I really needed to be taken back 
to basics and be stood over and told that's right, and come and put it in here, 
and that sort of thing and have him watch over me, but all he did was ask me 
what I was going to put in which I said, and then left me to draw it up with the 
nurse and then left me to actually do the injection on my own' (5) 
'During the training my own theory was that ten injections wasn't enough for me 
to get to the point where I felt competent and so there was a period post 
qualifying where I felt uncertain and nervous about using injection therapy' (7) 
The quality of the supervision had also been inconsistent and appeared to link directly 
to the level of confidence experienced by the physiotherapists after completion of 
training. 
all he did was ask me what I was going to put in which I said, and then left 
me to draw it up with the nurse and then left me to actually do the injection on 
my own' (5) 
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'When I did one of the injections with one of the GPs in F..., when I said 'Do 
you want to corne and watch?', his attitude was very much Wellyou're probabiy 
betteratitthan me anyway, so cany on.' (5) 
Expériences had varied between being asked to assess a patient and then to inject 
after the physiotherapist had decided that an injection was the treatment of choice, and 
being asked to perform the injection as according to the décision of the médical 
practitioner, thus assuming a more technical raie. 
7 was reasonably lucky because I was attached to an orthopaedic consultants 
out patient clinic and I was just given patients as a normal physiotherapist. We 
would examine patients then go back to the consultant and say l've examined 
the patient I don't think an injection is approphate and they should have 
ordinary physiotherapy - or I have examined the patient and they've got a 
bursitis and the consultant would corne in and say well fine - and we went 
aheàd and did it - it wasn't the consultant examining it and saying you do the 
injection'(4) 
7 had twelve injections that I did for the course - supervised injections that I did 
with a GP in L..., which I found very useful although, because he was trying to 
cram a number of injections into one session I found myself injecting patients 
that I maybe wouldn't have injected in the circumstanœ' (7) 
In both instances the specific injection technique preferred by the médical practitioner 
was sometimes performed and the drugs and dosages were at variance with those that 
had been suggested during training. 
There was füll support amongst participants for physiotherapists being given 
prescribing rights, but with some réservations with regard to knowledge of 
pharmacology as mentioned below. 
'ffwe're trained to give injections ofa certain drug I think we should be able to 
prescribe that certain drug that we've been trained to use' (4) 
'My weakness is I don't understand drugs, I don't understand what reacts with 
what' (1) 
'The more you know the more you realise that you don't know anything, and I 
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don't know how much you actually need to know to do what we have to do' (10). 
'I've always been fighting for prescription rights but I'm not sure that's possible -
because I'm not sure what knowledge is missing -1 don't know how big that 
knowledge is and whether once you go down that area whether you have to 
carry the whole lot to be able to understand. I don't know. So certainly if 
prescription rights are coming you might need to do some solid pharmacology' 
(7) 
It was felt that some basic pharmacology could be introduced at undergraduate level, 
not just for training in injection therapy but as a starting point for prescribing in other 
specialisms. 
Commentary 
The research was conducted with full awareness of the associated ethical issues. 
The use of triangulation to ensure rigour in the research carried through into the 
analysis such that the reflections on observation of the informant, the interview itself 
and the subsequent analysis of each component supported the conclusions of the 
other. Any personal bias or perspective was considered through self-evaluation, even 
though the intention was to 'bracket' assumptions, as mentioned above. 
It had been expected that there might be issues surrounding the actual 'invasiveness' 
of the technique but this was unsupported, other than with respect to producing pain or 
harm to the patient. Thoughts in connection with any possible gender issues were also 
not borne out by the participants' experiences. 
The physiotherapists' motivation to pursue injection therapy had derived from an 
interest in extending scope of practice linked to an improved comprehensive service to 
patients. There was frustration in not being able to apply this technique that was 
perceived as an important component in the management of musculoskeletal lesions. 
The inability to prescribe had dented professional autonomy in the use of the skill. 
Support from medical and physiotherapy colleagues was a crucial component in 
implementing skills, both throughout the clinical supervision stage of training and in 
subsequent clinical practice. Effective communication between professions had 
enhanced mutual respect and a spirit of co-operation between professions. Each 
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physiotherapist acknowledged a feeling of nervousness in embarking in injection 
therapy at the outset and a fear of doing harm to the patient, especially in respect of 
infection and anaphylactic shock. Confidence had developed from knowledge and 
continuing practice of the technique. Participants reflected that increased levels of 
supervision would have been desirable both throughout training and in the early stages 
of implementing injection therapy skills. 
Conclusion 
The study set out to investigate the experience of physiotherapists in the 
implementation of their injection skills after training. From this investigation, fresh 
insights have emerged to provide a basis for an extension of the study, towards the 
development of theory to underpin the training of physiotherapists and to facilitate the 
implementation of injection therapy into professional practice. 
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i 
Key messages 
Injection therapy is innovative practice to which intrinsic and extrinsic facilitating 
factors and barriers may exist. 
Investigation of the current status of a sélection of physiotherapists trained in 
injection therapy can provide an initial step towards the identification of 
facilitating factors and barriers to practice. 
Extended study will aim to develop theory to underpin injection therapy courses 
and to facilitate the intégration of injection therapy into professional practice 
Elaine Atkins MA MCSP is Chair of the Education Committee for the 
Society of Orthopaedic Medicine and a private practitioner. 
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